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RESUME 
The chemistry of steroids became a matter of paramount interest in 
recent past because of their immense use in research and industry owing to 
their broad spectrum of biological potentialities. This thesis entitled 
synthesis, chemical, biochemical and spectral studies (with special reference 
to 2D-NMR) of steroids described the results in consistent with the scope of 
the thesis in five different chapters. 
CHAPTER - ONE 
Synthesis of Photosensitizers Conjugated to Steroids : 
One of the most interesting application of porphyrins and 
phthalocyanines involve their use as photosensitizer (PS) in the photodynamic 
therapy (PDT) of tumours. A number of PS are currently in clinical trials for 
PDT of a variety of medical conditions. The treatment is based on the 
localization of the drug in the target tissue and treatment with visible light of 
the affected area. However, the use of most of these compounds is limited due 
to lack of target selectivity. 
Recently efforts have been focussed on the synthesis of PS attached to 
biomolecules (antibodies, peptides, steroids) which could improve target 
selectivity. It has been reported that cholesterol conjugates with porphyrins 
and phthalocyanines. These lipophillic PS exhibit good solubility in lipophilic 
media which promotes uptake by the low density lipoproteins (LDL) 
component of blood. Another approach is the development of steroids 
receptor-based PS. The incorporation of a steroid moiety in the PS molecule 
could improve the target selectivity for the receptor rich tumours. The 
palladium catalyzed coupling reaction has been proven an efficient process to 
modify the porphyrin and phthalocyanine, macromolecule. Recently the 
synthesis of 5,15-diphenyl porphyrin linked to estrogen and progesterone 
derivatives have been reported. Here readily accessible halogenated porphyrin 
derivatives were chosen to link with substituted steroids using palladium 
catalyzed cross coupling methodology. The selected steroids are commercially 
available include 17a-ethynyl estradiol, a compound which have high binding 
affinity for the estrogen receptor, 17a-ethynyltestosterone, a compound with 
good binding affinity to the progesterone receptor and 19-nor-17a-ethynyl 
testosterone, a compound with binding affinity for the androgen receptor. 
Reaction of 5(p-iodo)-5,10,15,20-tetraphenyl porphyrin zinc (II) (I) with 17a-
ethynylestradiol (2), 17a-ethynyltestosterone (3) and 19-nor-17a-
ethynyltestosterone (4) provided 5(p-17a-ethynylestradiol)-5,l 0,15,20 tetra-
phenylporphyrin Zn (II) (Ila), 5 (p-17a-ethynyltestosterone)-5,l0,15,20 
tetraphenyl porphyrin Zn (II) (lib) and 5(p-17a-ethynyl 19-nortestosterone)-
5,10,15,20 tetraphenyl porphyrin Zn (II) (lie). 
Ill 
C=CR' 
aic) 
Reaction of 2-bromotetraphenyl porphyrin Ni (II) (III) and 2,7(12)-
dibromo-tetraphenyl porphyrin Ni (II) (IV) with 17a-ethynylestradiol (2) and 
17a-ethynyl testosterone (3) afforded [2-(17a-ethynylestradiol)-5,10,15,20-
tetraphenyl porphinato] Ni (II) (V), [2,7 bis(17a-ethynylestradiol)-5,l0,15,20-
IV 
tetraphenyl porphinato] Ni (II) (VI), [2-(17a-ethynyl testosterone)-5,10,15^0-
tetraphenyl porphinato] Ni (II) (VII) and [2,7 bis(17a-ethynyl testosterone)-
5,10,15,20-tetraphenyl porphinato] Ni (II) (VIII) 
C=CR 
The reaction of 3,8-diiododeuteroporphyrin IX dimethyl ester Ni (II) 
(IX), 3 (8) (iodo)-deuteroporphyrin IX dimethyl ester zinc (II) (X) and 3,8 
diiododeuteroporph\Tin IX dimethyl ester zinc (II) (XI) with 17a-ethynyl 
estradiol(2) and 17a-ethynyltestosterone(3) under identical reaction conditions 
afforded [3,8 bis(17a-ethynylestradiol)-deuteroporphyrin IX dimethylester] Ni 
(II)(XII),[3,8 bis(l 7a-ethynyltestosterone)-deuteroporphyrinIX dimethylester] 
Ni (II) (XIII), [3(8)(17a-ethynylestradiol)-deuteroporphyrin IX dimethylester] 
zinc (II) (XIV), [3,8 bis(17a-ethynyl estradiol)-deuteroporphyrin IX dimethyl-
ester] zinc(II) (XV), [3(8)(17a-ethynyltestosterone)-deuteroporphyrin IX di-
methylester] zinc(II) (XVI) and [3,8 bis (17a-ethynyltestosterone)-deutero-
porphyrin IX dimethylester] zinc (II) (XVII). 
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Phthalocyanines have strong redshifted absorption band with maxima 
around 680 nm, i.e. at wavelength where tissue transparency is optimal. This 
VI 
allows for the treatment of longer volumes of diseased tissues, rendering this 
class of compounds attractive as second generation PS for PDT. Reaction of 
zinc (II) tri(t-butyl)-4(iodo) phthalocyanine (XVIII) with 17a-ethynylestradiol 
(2), 17a-ethynyltestosterone (3) and 17a-ethynyl 19-nor-testosterone (4) 
provided Zn (II) tri(t-butyl)-4( 17a-ethynyl estradiol) phthalocyanine (XIX), 
Zn (II) tri(t-butyl)-4( 17a-ethynyl testosterone) phthalocyanine (XX) and zinc 
(II) tri(t-butyl)-4(17a-ethynyl-19-nortestosterone) phthalocyanine (XXI). 
C=C-R 
HO (XIX) (XX) (XXI) 
VI1 
A bathochromic shift has been reported when the substituents are 
introduced into benzene ring, particularly at site a to the point of fusion to the 
heterocyclic ring. Accordingly the synthesis of zinc (II) tri(t-butyl)-3 (17a-
ethynyl estradiol) phthalocyanine (XXIII) with 17a-ethynyl estradiol 
conjugated with Zn (II) tri(t-butyl) 3-(iodo) phthalocyanine (XXII) was done. 
The product (XXIII) showed absorption maximum at 691 nm, as compared to 
680 nm for the 3-substituted adduct. 
H9C4 
C4H9 
(XXIII) 
C4H9 
A tetrasubstituted PC was also prepared. The reaction of 17a-ethynyl 
estradiol (2) with 4-iodo 1, 2-dicyanobenzene (XXIV) gave a coupling 
product 17a (4'-ethynyl-r, 2'-dicyanobenzene) estradiol (XXV). Direct 
vni 
product 17a (4"-ethynyl-r, 2'-dicyanobenzene) estradiol (XXV). Direct 
condensation of (XXV) with Zn (OAc)2.2H20 at 180°C for 2 hrs. in the 
presence of urea gave PC (XXVII) in low yield. Alternatively a better yield 
(25-30%) was obtained when tetraiodo PC (XXVI) was treated with 17a-
ethynyl estradiol (2) under Heck coupling conditions in the presence of Pd (II) 
catalyst. 
- j -CECR 
(XXVI) 
IX 
With aim to develop PC-steroid adduct with a multiple choice of red-
shifted excitation wavelength, PC analogoue consisting both the phthalo and 
naphthalo moieties were prepared. They feature spectral characteristic of both 
parent molecule resulting in composite spectra that vary in shift according to 
the number of naphthalene and benzene units. The 4-iodo 1,2 dicyanobenzene, 
4-t-butyl 1,2-dicyanonaphthalene in the presence of Zn(0Ac)2. 2H2O gave a 
complex reaction mixture consisting of mono to tetra iodo benzene units, as 
revealed by mass spectral analysis. Due to difficulty in the purification, the 
reaction mixture was coupled with 17a-ethynyl estradiol (2) and isolated the 
products as 2(3-17a-ethynylestradiol)benzo(b)-10,19,28-tri( 1,1 -dimethyl-
ethyl) trinaphtho [2', 3'-g, 2", 3", 1:2'", 3"'-g] porphyrazinato zinc (II) 
(XXVIII), 2,18 bis(3,17a-ethynylestradiol)-dibenzo [b,l]-10, 26-di(l,l-di-
methylethyl) dinaphtho [2",3"-g; 2"',3"'-g] porphyrazinato zinc (II) (XXIX) 
and 4, 4', 4"-tri(3-17a-ethylestradiol)-tribenzo [b,g,l]-4"'(l,l-dimethylethyl) 
naphtho [2'", 3'" -g] porphyrazinato zinc (II) (XXX). The structure of 
compounds has been established on the basis of UV, H-NMR, Mass and 
HUMS. 
4 - C 3 : R 
C=CR 
XI 
CHAPTER - TtfO (A) 
Synthesis of Benzofuran Derivatives of Estradiol Analogues : 
Benzofuran derivatives are of interest because of their occurrence in 
nature and for their physiological properties. Various methods are known for 
their synthesis and more recently efforts have centered around the use of 
palladium catalyst for C-C bond formation leading to the benzofuran structure. 
A number of estrogen derivatives have been reported as biologically active 
molecules for the treatments of various type of diseases. In connection with 
our studies in the field of biologically active steroidal molecule which could 
be of use as anticancer and antiviral agent, we attempted to synthesize 
estrogen analogue containing such moieties. 
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Reaction of 2-iodo-3-methoxy estrone (XXXI) with l-bromo-2 
methylpropene-1 (XXXIV) provided 2-2'-methylprop-r-ene-3-methoxy 
estrone (XXXV), 3'-isopropyl-2,3 benzofuran estrone (XXXVII), 2-bromo-3-
methoxy estrone (XLI), 3-methoxy estrone (XLII) and estrone (XLVI). Under 
similar reaction conditions 2-iodo-3-methoxy estradiol (XXXII) and 4-iodo-3-
methyoxy estradiol (XXXIII) afforded 2-2'-methyl prop-r-ene-3-methoxy 
estradiol (XXXVI), 3'-isopropyl-2, 3-benzofliran estradiol (XXXVIII), 3-
methoxy estradiol (XLV), estradiol (XLVII) and 3-methoxy-4-2'-methyl prop-
I'-ene estradiol (XXXIX), 3'-isopropyl-3, 4-benzofliran estradiol (XL), 3-
methoxy-4-bromo estradiol (XLIII), 3-methoxy-4-bromo estrone (XLIV) 
respectively. The structure of these compounds were confirmed on the basis of 
analytical and spectral evidences. A tentative mechanism has been proposed 
for the formation of these compounds. 
CHAPTER - T^Q (B) 
Synthesis of Palladium Catalysed Aromatic Heterocyclic Estradiol 
Derivatives : 
Palladium catalysed annulation reactions of alkynes are of eminence for 
the synthesis of variety of hetero and carbocyclic ring system. Recently 
palladium alkyne annulation reaction offered useful and convenient route to 
XIV 
indoles, benzoflirans, benzopyrans, indenones and isocoumarin. Estrogen 
analogue containing such moieties could be of use as anticancer and antiviral 
agent. An attempt has been made to synthesize such steroidal molecules. 
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Reactions of 17a-ethynyl estradiol (XLVII) with o-iodo phenol, o-iodo 
aniline, o-iodo benzaldehyde and with o-iodo methyl ester gave 17a-
XV 
benzofuran estradiol (LI), 17a-benzopyrrole estradiol (LII), 17a-indenone 
estradiol (LIV), 17a-isocoumarin estradiol (LVI). Under similar reaction 
conditions, the reaction of 2'-17a-ethynyl estradiol benzene (XLIX) with o-
iodo aniline and benzaldehyde provided 2'-17a-benzopyrrole estradiol 
benzene (LIII), 2'-17a-indenone estradiol benzene (LV) respectively. The 
other reaction of 2-iodo estradiol (L) with phenyl acetylene, 1-hexyne and 
with diethyl phosphite afforded 2'-phenyl-2-3-fliran estra 17P-ol (LVII), 2'-n-
butane-2-3-furan estra-17^-01 (LVIII) and diethyl estradiol-2-yl phosphonate 
(LIX) respectively. The structure of these compounds were also supported by 
analytical and spectral data. A tentative mechanism for the formation of these 
compounds was also proposed. 
CHAPTER - THREE (A) 
Synthesis of Steroidal Spirothiazolidinones : A Configurational 
Study : 
Steroidal spirothiozolidinones have been the subject matter of a 
detailed study during the last decade. The investigations have high lighted the 
mechanistic and stereochemical aspects and spectral features of these 
compounds which are of significant help in identification and characterization. 
XVI 
Previous work from these laboratories described the synthesis of such 
compounds. 
HSCH2COOH '^^  u u • c 
^ »• H H^ S 
(NH4)2C03, drybenzene n^ , 1 Reflux, 
E 
(LX) Br 
(LXI) I 
O (LXII) 
H-N "S 
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Reaction of 3-bromo-5a-cholestan-6-one (LX) with P mercaptoacetic 
acid-ammonium carbonate afforded S-spiro-(3p-bromo-5a-cholestane-6, 2'), 
thiazolidinone-4' (LXII), S-spiro-(3a,5-cyclo-5a-cholestane-6,2') thiazolidin-
one-4' (LXllI) and R-spiro-(3a, 5-cyclo-5a-cholestane-6, 2')-thiazolidinone-
4' (LXIV). Under identical reaction conditions 3p-iodo-5a-cholestane-6-one 
(LXI) provided S-spiro-[3P-iodo-5a-cholestane-6, 2']-thiazolidinone-4' 
(LXV) and products (LXIII and LXIV). The structure of these compounds and 
stereo chemistry at spirane carbon C(, were established on the basis of IR, ' H -
XVll 
NMR and Mass spectral data. Formation of these compounds were also 
explained by a tentative mechanism proposed. 
CHAPTER - THREE (B) 
Synthesis of Steroidal Diastereomeric Oxathiolanes : A 
Configurational Study : 
Previous work done in our laboratory deals with the synthesis 
and structure elucidation of steroidal oxathiolanes from their respective 
ketones. In continuation with this work and with the interest of obtaining all 
possible isomeric steroidal oxathiolanes to be identified by CD spectral 
studies, following reaction was carried out. 
(LXVI) (LXVII) (LXVIII) 
(LXIX) 
xvni 
Reaction of 5-hydroxy-5a-cholestane 3, 6-dione (LXVI) with (5-
mercaptoethanol-BFs-etherate gave 3P-oxy-3a-thiodimethylene - 5-hydroxy-
5a-cholestan-6-one (LXVII), bis-3, 6-(P-oxy-a-thiodimethylene)-5-hydroxy-
5a-cholestane (LXVIII), 6(3-oxy-6a-thiodimethylene-5-hydroxy-5a-cholestan 
3-one (LXIX) and 3a-oxy-3P-thio, 6P-oxy-6a-thio-bis-dimethylene-5-
hydroxy-5a-cholestane (LXX). The structure of oxathiolanes were established 
on spectral ground and CD data confirms the stereo chemistry of oxathiolanes 
ring. 
CHAPTER - FOUR 
Two - Dimensional NMR Spectroscopy : 
During our four decades in the field of steroids research we have faced 
time and again various stereochemical problems while interpreting spectral 
data of the synthesized compounds. 2D-NMR spectroscopy now has given a 
new spectral technique to overcome the confirmational uncertainity and 
justified the assignments of the spectral data. While writing this chapter we 
are fully aware of the fact that avoiding mathematical and other difficult 
parameter, we are trying to study 2D-NMR spectroscopy taking the examples 
of steroidal compounds. For this purpose we have selected steroidal 
XIX 
compounds such as 3P-hydroxycholest-5-ene (LXXI) 2a, 7a-dibromocholest-
4-ene-3, 6-dione (LXXII), 6-oxa-P-homo-5a-cholestan-7-one (LXXIII), 3^-
acetoxy-6-amino (N, N dimethyl)-cholest-5-ene (LXXIV), 3P-chloro-5a-
cholestan-6-one (LXXV) and 3P-acetoxy-5, 6[3-dibromo-5a-cholestane 
(LXXVI) for homo and hetero, nuclear cosy NMR spectral studies. 
C«H 
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XX 
These compounds were prepared according to the literature procedure 
and characterized by chemical and spectral evidences. 
CHAPTER - FIVE 
Steroidal Compounds Induced Alteration on Lipid Metabolism of 
Different Regions of Rat Brain : 
Steroidal compounds 3|3-acetoxy-5-bromo, 6P-succinimido-5a-cholest-
ane (LXXVII), 3p-chloro-5-bromo-6p-amino 5a-cholestane (LXXVIII) 3^-
acetoxy-6-phathalimido cholest-5-ene (LXXIX) and 6-nitrocholest-5-eno [3a, 
4a-d]oxadolidin-2'-one (LXXX) were designated as A, B, C & D respectively. 
The present study was undertaken to evaluate the neurotoxic effects of these 
steroidal compounds on lipid metabolism. All these compounds were 
administered intraperitoneally (ip) as 3.0 mg/kg body wt. dail>- for ten days to 
a group of albino rats. The compound "A" gave a significant decrease of total 
lipids (brain stem -33%, cerebellum -36.7% and on cerebrum -A4A%). 
Similarly in the content of cholesterol levels "A" gives maximum significant 
decrease of -84.0% on brain stem and then in cerebrum -74.3%). in the 
concentration of gangliosides this compound shows significant increase of 
45.0% on cerebrum and significant decrease of-77.8% on brain stem and 
-27.9% on cerebellum. In the rate of lipid peroxidation compound "A" gives 
XXI 
relatively higher significant decrease of-98.9% cerebellum, -76.7% cerebnim, 
-72.9% on brain stem. 
Similarly compound "B" gives a significant decrease of total lipids 
(cerebrum -57.2%, brain stem -28.5%) . In the concentration of cholesterol 
shows maximum significant decrease of -89.7% and -86.8% on brain stem 
and cerebrum respectively. Where as in the concentration of ganglioside this 
compound shows significant decrease of -62.5% cerebellum, -50.0% 
cerebrum, -45.89% brain stem. While in the rate of lipid peroxidation showed 
significant decrease of-71.6% on brain stem, -31.4%) on cerebrum, and 2.7% 
on cerebellum. In the same manner we can make comparative study of 
remaining two steroidal compounds which are also of importance. 
AcO 
Aco 
(LXXVIII) 
CgHp 
H-N 
\ - 6 NO2 
O (LXXX) 
xxn 
These compounds were prepared according to literature procedure 
characterized by spectral and chemical evidences and comparison with 
authentic sample in known cases. 
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SUMMARY 
The chemistry of steroids became a matter of paramount interest in 
recent past because of their immense use in research and industry owing to 
their broad spectrum of biological potentialities. This thesis entitled 
synthesis, chemical, biochemical and spectral studies (with special reference 
to 2D-NMR) of steroids described the results in consistent with the scope of 
the thesis in five different chapters. 
CHAPTER - ONE 
Synthesis of Photosensitizers Conjugated to Steroids : 
One of the most interesting application of porphyrins and 
phthalocyanines involve their use as photosensitizer (PS) in the photodynamic 
therapy (PDT) of tumours. A number of PS are currently in clinical trials for 
PDT of a variety of medical conditions. The treatment is based on the 
localization of the drug in the target tissue and treatment with visible light of 
the affected area. However, the use of most of these compounds is limited due 
to lack of target selectivity. 
Recently efforts have been focussed on the synthesis of PS attached to 
biomolecules (antibodies, peptides, steroids) which could improve target 
selectivity. It has been reported that cholesterol conjugates with porph>'rins 
and phthalocyanines. These lipophillic PS exhibit good solubility in lipophilic 
media which promotes uptake by the low density Hpoproteins (LDL) 
component of blood. Another approach is the development of steroids 
receptor-based PS. The incorporation of a steroid moiety in the PS molecule 
could improve the target selectivity for the receptor rich tumours. The 
palladium catalyzed coupling reaction has been proven an efficient process to 
modify the porphyrin and phthalocyanine, macromolecule. Recently the 
synthesis of 5,15-diphenyl porphyrin linked to estrogen and progesterone 
derivatives have been reported. Here readily accessible halogenated porphyrin 
derivatives were chosen to link with substituted steroids using palladium 
catalyzed cross coupling methodology. The selected steroids are commercially 
available include 17a-ethynyl estradiol, a compound which have high binding 
affinity for the estrogen receptor, 17a-ethynyltestosterone, a compound with 
good binding affinity to the progesterone receptor and 19-nor-17a-ethynyl 
testosterone, a compound with binding affinity for the androgen receptor. 
Reaction of 5(p-iodo)-5,10,15,20-tetraphenyl porphyrin zinc (II) (I) with 17a-
ethynylestradiol (2), 17a-ethynyltestosterone (3) and 19-nor-17a-
ethynyltestosterone (4) provided 5(p-17a-ethynylestradiol)-5,l0,15,20 tetra-
phenylporphyrin Zn (II) (Ila), 5 (p-17a-ethynyltestosterone)-5,l0,15,20 
tetraphenyl porphyrin Zn (II) (lib) and 5(p-17a-ethynyl 19-nortestosterone)-
5,10,15,20 tetraphenyl porphyrin Zn (II) (lie). 
Ill 
C^CR" 
aic) 
Reaction of 2-bromotetraphenyl porphyrin Ni (II) (III) and 2,7(12)-
dibromo-tetraphenyl porphyrin Ni (II) (IV) with 17a-ethynylestradiol (2) and 
17a-ethynyl testosterone (3) afforded [2-( 17a-ethynylestradiol)-5,l0,15,20-
tetraphenyl porphinato] Ni (II) (V), [2,7 bis(17a-ethynylestradiol)-5,10,15,20-
IV 
tetraphenyl porphinato] Ni (II) (VI), [2-(17a-ethynyl testosterone)-5,10,15,20-
tetraphenyl porphinato] Ni (II) (VII) and [2,7 bis(17a-ethynyl testosterone)-
5,10,15,20-tetraphenyl porphinato] Ni (II) (VIII) 
C=CR 
The reaction of 3,8-diiododeuteroporphyrin IX dimethyl ester Ni (II) 
(IX), 3 (8) (iodo)-deuteroporphyrin IX dimethyl ester zinc (II) (X) and 3,8 
diiododeuteroporphyrin IX dimethyl ester zinc (II) (XI) with 17a-ethynyl 
estradiol(2) and 17a-ethynyltestosterone(3) under identical reaction conditions 
afforded [3,8 bis(17a-ethynylestradiol)-deuteroporphyrin IX dimethylester] Ni 
(II)(XII),[3,8 bis(17a-ethynyltestosterone)-deuteroporphyrinIX dimethylester] 
Ni (II) (XIII), [3(8)(17a-ethynylestradiol)-deuteroporphyrin IX dimethylester] 
zinc (II) (XIV), [3,8 bis(17a-ethynyl estradiol)-deuteroporphyrin IX dimethyl-
ester] zinc(II) (XV), [3(8)(17a-ethynyltestosterone)-deuteroporphyrin IX di-
methylester] zinc(II) (XVI) and [3,8 bis (17a-ethynyltestosterone)-deutero-
porphyrin IX dimethylester] zinc (II) (XVII). 
H3COOC COOCH3 
M El B2 
(IX) Ni I I 
(X) Zn I H 
H I 
(XI) Zn I I 
H3COOC COOCH3 
M R, R2 
(XII) Ni 2 2 
(XIII) Ni 3 3 
(XIV) Zn 2 H 
Zn H 2 
(XV) Zn 2 2 
(XVI) Zn 3 H 
Zn H 3 
(XVII) Zn 3 3 
Phthalocyanines have strong redshifted absorption band with maxima 
around 680 nm, i.e. at wavelength where tissue transparency is optimal. This 
VI 
allows for the treatment of longer volumes of diseased tissues, rendering this 
class of compounds attractive as second generation PS for PDT. Reaction of 
zinc (II) tri(t-butyl)-4(iodo) phthalocyanine (XVIII) with 17a-ethynylestradiol 
(2), 17a-ethynyltestosterone (3) and 17a-ethynyl 19-nor-testosterone (4) 
provided Zn (II) tri(t-butyl)-4(17a-ethynyl estradiol) phthalocyanine (XIX), 
Zn (II) tri(t-butyl)-4( 17a-ethynyl testosterone) phthalocyanine (XX) and zinc 
(II) tri(t-butyI)-4(17a-ethynyI-19-nortestosterone) phthalocyanine (XXI). 
C=C-R 
(XIX) (XX) (XXI) 
Vll 
A bathochromic shift has been reported when the substituents are 
introduced into benzene ring, particularly at site a to the point of fusion to the 
heterocyclic ring. Accordingly the synthesis of zinc (II) tri(t-butyl)-3 (17a-
ethynyl estradiol) phthalocyanine (XXIII) with 17a-ethynyl estradiol 
conjugated with Zn (II) tri(t-butyl) 3-(iodo) phthalocyanine (XXII) was done. 
The product (XXIII) showed absorption maximum at 691 nm, as compared to 
680 nm for the 3-substituted adduct. 
C4H9 
(XXIII) 
C4H9 
A tetrasubstituted PC was also prepared. The reaction of 17a-ethynyl 
estradiol (2) with 4-iodo 1, 2-dicyanobenzene (XXIV) gave a coupling 
product 17a (4'-ethynyl-r, 2'-dicyanobenzene) estradiol (XXV). Direct 
Vlll 
product 17a (4'-ethynyl-r, 2'-dicyanobenzene) estradiol (XXV). Direct 
condensation of (XXV) with Zn (OAc)2.2H20 at 180°C for 2 hrs. in the 
presence of urea gave PC (XXVII) in low yield. Alternatively a better yield 
(25-30%) was obtained when tetraiodo PC (XXVI) was treated with 17a-
ethynyl estradiol (2) under Heck coupling conditions in the presence of Pd (II) 
catalyst. 
C=CR 
(XXVII) 
(XXVI) 
IX 
With aim to develop PC-steroid adduct with a multiple choice of red-
shifted excitation wavelength, PC analogoue consisting both the phthalo and 
naphthalo moieties were prepared. They feature spectral characteristic of both 
parent molecule resulting in composite spectra that vary in shift according to 
the number of naphthalene and benzene units. The 4-iodo 1,2 dicyanobenzene, 
4-t-butyl 1,2-dicyanonaphthalene in the presence of Zn(0Ac)2. 2H2O gave a 
complex reaction mixture consisting of mono to tetra iodo benzene units, as 
revealed by mass spectral analysis. Due to difficulty in the purification, the 
reaction mixture was coupled with 17a-ethynyl estradiol (2) and isolated the 
products as 2(3-17a-ethynylestradiol)benzo(b)-10,19,28-tri( 1,1 -dimethyl-
ethyl) trinaphtho [2', 3'-g, 2", 3", 1:2'", 3"'-g] porphyrazinato zinc (II) 
(XXVIII), 2,18 bis(3,17a-ethynylestradiol)-dibenzo [b,l]-10, 26-di(l,l-di-
methylethyl) dinaphtho [2",3"-g; 2"',3'"-g] porphyrazinato zinc (II) (XXIX) 
and 4, 4', 4"-tri(3-17a-ethylestradiol)-tribenzo [b,g,l]-4'"(l,l-dimethylethyl) 
naphtho [2'", 3 '" -g] porphyrazinato zinc (II) (XXX). The structure of 
compounds has been established on the basis of UV, ' H - N M R , Mass and 
HRMS. 
| - C 3 : R 
C=CR 
XI 
CH APTEE - TWO 
Synthesis of Benzofuran Derivatives of Estradiol Analogues : 
Benzofiiran derivatives are of interest because of their occurrence in 
nature and for their physiological properties. Various methods are known for 
their synthesis and more recently efforts have centered around the use of 
palladium catalyst for C-C bond formation leading to the benzofuran structure. 
A number of estrogen derivatives have been reported as biologically active 
molecules for the treatments of various type of diseases. In connection with 
our studies in the field of biologically active steroidal molecule which could 
be of use as anticancer and antiviral agent, we attempted to synthesize 
estrogen analogue containing such moieties. 
H3CO 
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Reaction of 2-iodo-3-methoxy estrone (XXXI) with l-bromo-2 
methylpropene-1 (XXXIV) provided 2-2'-methylprop-r-ene-3-methoxy 
estrone (XXXV), 3'-isopropyl-2,3 benzofuran estrone (XXXVII), 2-bromo-3-
methoxy estrone (XLI), 3-methoxy estrone (XLII) and estrone (XLVI). Under 
similar reaction conditions 2-iodo-3-methoxy estradiol (XXXII) and 4-iodo-3-
methyoxy estradiol (XXXIII) afforded 2-2'-methyl prop-l'-ene-S-methoxy 
estradiol (XXXVI), 3'-isopropyl-2, 3-benzofuran estradiol (XXXVIII), 3-
methoxy estradiol (XLV), estradiol (XLVII) and 3-methoxy-4-2'-methyl prop-
I'-ene estradiol (XXXIX), 3'-isopropyl-3, 4-benzofuran estradiol (XL), 3-
methoxy-4-bromo estradiol (XLIII), 3-methoxy-4-bromo estrone (XLIV) 
respectively. The structure of these compounds were confirmed on the basis of 
analytical and spectral evidences. A tentative mechanism has been proposed 
for the formation of these compounds. 
CHAPTER - TtfO (B) 
Synthesis of Palladium Catalysed Aromatic Heterocyclic Estradiol 
Derivatives : 
Palladium catalysed annulation reactions of alkynes are of eminence for 
the synthesis of variety of hetero and carbocyclic ring system. Recently 
palladium alkyne annulation reaction offered useful and convenient route to 
XIV 
indoles, benzofurans, benzopyrans, indenones and isocoumarin. Estrogen 
analogue containing such moieties could be of use as anticancer and antiviral 
agent. An attempt has been made to synthesize such steroidal molecules. 
(XLVIII) -C = C-H H 
(XLIX) -C = C-CgHg H 
LVII) C^ Hs 
LVIII)H3C- [CHzts OH 
(LI) R4 = H 
(LII)R4=H 
(LIII)R4 = C6H5 
(LIV)R4 = H 
(LV) R, = C,H5 
(LVI) R, = H 
(LIX) 
Reactions of 17a-ethynyl estradiol (XLVII) with o-iodo phenol, o-iodo 
aniline, o-iodo benzaldehyde and with o-iodo methyl ester gave 17a-
XV 
benzofuran estradiol (LI), 17a-benzopyrrole estradiol (LII), 17a-indenone 
estradiol (LIV), 17a-isocoumarin estradiol (LVI). Under similar reaction 
conditions, the reaction of 2'-17a-ethynyl estradiol benzene (XLIX) with o-
iodo aniline and benzaldehyde provided 2'-17a-benzopyrrole estradiol 
benzene (LIII), 2'-17a-indenone estradiol benzene (LV) respectively. The 
other reaction of 2-iodo estradiol (L) with phenyl acetylene, 1-hexyne and 
with diethyl phosphite afforded 2'-phenyl-2-3-furan estra 17(3-01 (LVII), 2'-n-
butane-2-3-furan estra-17(3-01 (LVIII) and diethyl estradiol-2-yl phosphonate 
(LIX) respectively. The structure of these compounds were also supported by 
analytical and spectral data. A tentative mechanism for the formation of these 
compounds was also proposed. 
CHAPTER - THEEE (A) 
Synthesis of Steroidal Spirothiazolidinones : A Configurational 
Study : 
Steroidal spirothiozolidinones have been the subject matter of a 
detailed study during the last decade. The investigations have high lighted the 
mechanistic and stereochemical aspects and spectral features of these 
compounds which are of significant help in identification and characterization. 
XVI 
Previous work from these laboratories described the synthesis of such 
compounds. 
H H O 
HSCH2COOH 
(NH4)2C03, drybenzene 
Reflux, 
£ 
(LX) Br 
(LXI) I 
(LXIV) (LXV) 
Reaction of 3-bromo-5a-cholestan-6-one (LX) with P mercaptoacetic 
acid-ammonium carbonate afforded S-spiro-(3P-bromo-5a-cholestane-6, 2'), 
thiazolidinone-4' (LXII), S-spiro-(3a,5-cyclo-5a-cholestane-6,2') thiazolidin-
one-4' (LXIII) and R-spiro-(3a, 5-cyclo-5a-cholestane-6, 2')-thiazolidinone-
4' (LXIV). Under identical reaction conditions 3P-iodo-5a-cholestane-6-one 
(LXI) provided S-spiro-[3P-iodo-5a-cholestane-6, 2']-thiazolidinone-4' 
(LXV) and products (LXIII and LXIV). The structure of these compounds and 
stereo chemistry at spirane carbon Cg were established on the basis of IR, ' H -
XVll 
NMR and Mass spectral data. Formation of these compounds were also 
explained by a tentative mechanism proposed. 
CHAPTER - THEEE (B 
Synthesis of Steroidal Diastereomeric Oxathiolanes : A 
Configurational Study : 
Previous work done in our laboratory deals with the synthesis 
and structure elucidation of steroidal oxathiolanes from their respective 
ketones. In continuation with this work and with the interest of obtaining all 
possible isomeric steroidal oxathiolanes to be identified by CD spectral 
studies, following reaction was carried out. 
(LXVI) (LXVII) (LXVIII) 
(LXIX) (LXX) 
XVlll 
Reaction of 5-hydroxy-5a-cholestane 3, 6-dione (LXVI) with (3-
mercaptoethanol-BFs-etherate gave 3P-oxy-3a-thiodimethylene - 5-hydroxy-
5a-cholestan-6-one (LXVII), bis-3, 6-(p-oxy-a-thiodimethylene)-5-hydroxy-
5a-cholestane (LXVIII), 6P-oxy-6a-thiodimethylene-5-hydroxy-5a-cholestan 
3-one (LXIX) and 3a-oxy-3P-thio, 6P-oxy-6a-thio-bis-dimethylene-5-
hydroxy-5a-cholestane (LXX). The structure of oxathiolanes were estabhshed 
on spectral ground and CD data confirms the stereo chemistry of oxathiolanes 
ring. 
CHAPTEE - FOUR 
Two - Dimensional NMR Spectroscopy : 
During our four decades in the field of steroids research we have faced 
time and again various stereochemical problems while interpreting spectral 
data of the synthesized compounds. 2D-NMR spectroscopy now has given a 
new spectral technique to overcome the confirmational uncertainity and 
justified the assignments of the spectral data. While writing this chapter we 
are fully aware of the fact that avoiding mathematical and other difficult 
parameter, we are trying to study 2D-NMR spectroscopy taking the examples 
of steroidal compounds. For this purpose we have selected steroidal 
XIX 
compounds such as 3P-hydroxycholest-5-ene (LXXI) 2a, 7a-dibromocholest-
4-ene-3, 6-dione (LXXII), 6-oxa-P-homo-5a-cholestan-7-one (LXXIII), 3(3-
acetoxy-6-amino (N, N dimethyl)-cholest-5-ene (LXXIV), 3P-chloro-5a-
cholestan-6-one (LXXV) and 3P-acetoxy-5, 6P-dibromo-5a-cholestane 
(LXXVI) for homo and hetero, nuclear cosy NMR spectral studies. 
CsH 8^17 C«H 8^17 
H O 
(LXXII) CeHn 
I 
_ oAX o 
H^i H O 
H 3 / 
(LXXIII) H3C 
V ^ H / " H 
(LXXIV) 
8J^17 
H /\ n ,. 
H H o 
(LXXV) H,C 
H H Br 
(LXXVI) 
XX 
These compounds were prepared according to the hterature procedure 
and characterized by chemical and spectral evidences. 
Steroidal Compounds Induced Alteration on Lipid Metabolism of 
Different Regions of Rat Brain : 
Steroidal compounds 3P-acetoxy-5-bromo, 6(5-succinimido-5a-cholest-
ane (LXXVII), 3p-chloro-5-bromo-6p-amino 5a-cholestane (LXXVIII) 3(3-
acetoxy-6-phathalimido cholest-5-ene (LXXIX) and 6-nitrocholest-5-eno [3a, 
4a-d]oxadolidin-2'-one (LXXX) were designated as A, B, C & D respectively. 
The present study was undertaken to evaluate the neurotoxic effects of these 
steroidal compounds on lipid metabolism. All these compounds were 
administered intraperitoneally (ip) as 3.0 mg/kg body wt. daily for ten days to 
a group of albino rats. The compound "A" gave a significant decrease of total 
lipids (brain stem -33%, cerebellum -36.7% and on cerebrum ^4.4%). 
Similarly in the content of cholesterol levels "A" gives maximum significant 
decrease of -84.0% on brain stem and then in cerebrum -74.3%. in the 
concentration of gangliosides this compound shows significant increase of 
45.0% on cerebrum and significant decrease of -77.8% on brain stem and 
-27.9% on cerebellum. In the rate of lipid peroxidation compound "A" gives 
XXI 
relatively higher significant decrease of-98.9% cerebellum, -76.7% cerebrum, 
-72.9% on brain stem. 
Similarly compound "B" gives a significant decrease of total lipids 
(cerebrum -57.2%, brain stem -28.5%) . In the concentration of cholesterol 
shows maximum significant decrease of -89.7% and -86.8% on brain stem 
and cerebrum respectively. Where as in the concentration of ganglioside this 
compound shows significant decrease of -62.5% cerebellum, -50.0% 
cerebrum, -45.89% brain stem. While in the rate of lipid peroxidation showed 
significant decrease of-71.6% on brain stem, -31.4% on cerebrum, and 2.7% 
on cerebellum. In the same manner we can make comparative study of 
remaining two steroidal compounds which are also of importance. 
CgHn 
AcO 
Aco 
NH2 
(LXXVIII) 
CgH]? 
H-N 
\-6 NO2 
O (LXXX) 
(LXXIX) 
XXll 
These compounds were prepared according to literature procedure 
characterized by spectral and chemical evidences and comparison with 
authentic sample in known cases. 
CHAPTEi 
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THEORETICAL 
The phenomenon of photodynamic action may well date as far back as 
primitive, man with the use of plant extracts and sunlight to cure various skin 
afflictions. In India, as early as 1400 BC, psoralens obtained from the seeds of 
psoralea corylifolia, were used in the treatment of vitiligo. Photodynamic 
action, however, was not formally reported untill the turn of the twentieth 
century, when a medical student, Oscar Raab working under the direction of 
Dr. H. Von Tappeiner in Munich, noticed the lethal effect of an acridine 
orange solution of Paramecia depends on light intensity in the laboratory. This 
phenomenon was more extensively studied by Von Tappeiner and Jodlbauer 
who coined the term "Photodynamic action". It was noted that other such 
compounds such as eosin were able to induce rapid cell kill in the presence of 
light. It was established that dissolved molecular oxygen is needed for the 
reaction to occur. Hausman reported in 1908 the photohemolysis of rabbit 
erythrocytes using hematoporphyrin (HP). Various scientists (Hausman 1911, 
Pfeiffer 1911, Meyer-Betz 1913) went on to demonstrate photosensitization of 
mice, guinea pigs and man respectively, by inoculation with hematoporphyrin 
(HP). 
Several biological system were shown to be susceptible to 
photodynamic action including proteins (enzyme), cells, animals and plants. It 
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was not until three decades following Raab's discovery that virus were 
investigated. 
In 1933, Perdrau and Todd carried out extensive studies outlining the 
photodynamic effect of methylene blue on bacteriophage. The necessity of 
oxygen and light of an appropriate wavelength was confirmed. This is to say 
that the action spectrum of a given photosensitizer was found to resemble the 
absorption spectrum. Following a brief lapse in time, Yamamoto and 
co-workers adequately photoinactivated bacterial viruses and provided the 
first quantitative results in 1958. Hiatt et al. proceeded to inactivate a number 
of DNA containing animal virus such as pox, adeno, herpes and 
papovaviruses. Hiatt and his associates, using pre set experimental conditions 
investigated the kinefics of virus photoinacfivation using toluidine blue. C. W. 
Hiatt proposed a hypothetical reaction mechanism of virus photoinactivation 
based on earlier work by Heinmets in 1952. 
Photodynamic therapy is based on the dyesensitized photooxidation of 
biological matter in the target tissue. As a result three components are required 
to produce a photodynamic effects, a photosensitizers, light and molecular 
oxygen. Although photosensitizers can be naturally occuring with no lethal 
effects in the absence of light, photodynamic therapy necessitiates the delivery 
of a sensitizer to a biological substrate and subsequent light exposure at an 
appropriate wavelength to induce biological damage. The photochemical 
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reactions following photoactivation of the chromophore occur via two routes. 
One where the excited sensitizer reacts with substrate or solvent to generate 
radical, or radical ions, the other where oxygen is the primary reactant 
yielding mainly singlet molecular oxygen ('O2) and on occassion superoxide 
anion (O2") or in other words, it falls into two categories, direct, without an 
administered photosensitizer (the treatment of neonatal Jaundice with 
blue/white light being an important example here) and indirect, where the 
effect is achieved via the administered photosensitizer which the effective 
light absorbs. 
Diagramatic presentation of type I and type II photosensitized 
oxidation reaction. 
Oxygenated Products Sens 
O2 
Radicals or 
Radical ions 
Oxygenated products 
Substrate 
Type I 
Substrate or 
Solvent 
Sens 
. Type II 
O2 
-> 'O2 
Sens OX + O2" 
Proposed mechanism of photodynamic action : 
P(SO) hv 
P(T1) + 3O2 
Biomolecules + 'O2 
P(S1) _LS£ • P ( T l ) 
• P(SO) + 'O2 
• Products 
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Where ISC = Inter system crossing 
SO = Resting Stage 
A molecule such as photosensitizer (Sens) in its lowest energy state, the 
ground electronic state (SO), absorbs a photon of light. There is an electronic 
transition where an electron from one molecular orbital moves to another 
orbital with a concommitant increase in energy. The sensitizer is then said to 
be in a more energetic excited state (Sens ) either in a singlet (opposite spin 
quantum number) or more often in a triplet state (identical spin quantum 
number), as this state is less energetic even though, it is "spin forbidden". 
Those sens in higher excited singlet state (S1) can acts as precursor of longer 
lived triplet state. The excited singlet state (SI) can return to the ground state 
(S°) via photon emission (fluorescence) or experiences internal conversion 
(IC) via heat liberation or under go inter system crossing (ISC) to the excited 
triplet state (Tl) of lower energy. A fourth possibility is an electron transfer 
quenching process due to the presence of quenching co-solutes (organic 
molecule). If quenching occurs the overall efficiency of the photosensitizer to 
induce biological damage is reduce as the formation of reactive species is 
diminished. 
Life times of the singlet excited state are in the order of nanoseconds 
where as those in the triplet excited electronic state are in the milli second 
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range. Therefore, the energetic triplet state (Tl) must dissipiate energy either 
converting back to the singlet state (SI) through phosphoresence or through 
the reaction mechanism involved in photodynamic therapy, a reaction between 
the excited triplet and a substrate. A summary of the intramolecular pathways 
of energy attenuation and competing processes for reaction with the excited 
sensitizer is shown in the form of Jablonski diagram. 
Jablonski diagram illustrating some of the physical processes that can 
occur after a molecule absorbs a photon, excited state level and transition. 
(SO) is the ground electronic state of the molecule. SI and Tl are the lowest 
excited singlet and triplet states respectively, straight arrows represents 
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process involving photons and wavy arrows represent radiationless transition 
(A) Absorption, (F) Fluoresence, (P) Phosphoresence, (IC) Inter Conversion, 
(ISC) Inter System Crossing, (R) Vibrational and Rotational relaxation. 
Sens + hv • • Sens* (SI); Singlet - Singlet, 
Absorption 
SI • • S° + hv : Singlet - Singlet emission 
Fluoresence 
SI • • S° + heat : Internal conversion 
SI + Q • • S° + Q : Physical quenching through 
electron transfer 
SI ^ p- Tl + heat : Intersystem crossing 
Tl • • S° + hv 
TI + S H — - • 'SH or S^  (Type I) 
Tl + O2 • "S" + 'O2 + 'Oi'(Type II) 
Therefore to conclude, the primary interaction of the photosensitizer 
determine the reaction type whether it be type I or II. The relative contribution 
of each reaction pathway to induce biological damage depends on the 
sensitizer used. Oxygen contenment, the availability of suitable substrate and 
whether or not the target of photodynamic damage is directly available or if 
reactive intermediate migratory species are required to assure biological 
impairment. The intra cellular localization of the photosensitizer may 
determine, whether type I or type II reaction predominates. 
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The photodynamic therapy of cancer (PDT) known also as 
photochemotherapy of cancer consists in the destruction of neoplastic tissue 
by light and photosensitizer in the presence of oxygen. 
In 1904, the term photodynamic action was introduced by Tappeiner 
to describe the destructive effect caused by light on living organism, after the 
administration of certain dyes, an effect which has been discovered in 1898 by 
Raab and Tappeiner. The use of hematoporphyrin as a photosensitizer came 
soon after. Hausman in 1908 described for the first time in detail its effects in 
cells and animals. In 1913 Meyer-Bertz sensitized himself and reported 
similar symptoms. Thus porphyrins are to be found since the begining among 
4 
the most common photosensitizers. In 1942 Auler and Banzer reported that 
tumours fluoresced under UV light when porphyrin had been administered, 
showing that certain porphyrins were retained by neoplastic tissue with some 
preference over normal tissue since the moment the way was opened by Figge 
et al to the photosensitized detection and destruction of tumours, but the 
therapeutic aspect was forgotten until 1972, when Diamond et al. who used 
hematoporphyrins that prolonged irradiation of sensitized tumours led to their 
destruction. 
In the meanwhile it had been observed by Schwartz that what had been 
called hematoporphyrin was a mixture of many porphyrins and that one of the 
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impurities was in reality the good tumour localizer and not the pure 
hematoporphyrin IX. In 1975 two different research groups '^ continued the 
work initiated in 1960 by Lipson and Baldes with a porphyrin mixture known 
as hematoporphyrin derivative (HPD) which showed improved selectivity for 
tumour^ ** and after various researcher finally in 1976 Kelly and Snell applied 
HPD for the first time in human beings for the detection and PDT of cancer. 
At present its use is in Phase III clinical trials in several countries and it has 
13 
just been approved for clinical use in Canada for certain bladder cancer . 
The easy elimination of psuedobenzylic acetoxy group is well known in 
porphyrin chemistry and it has been widely used in the synthesis of the 
porphyrin macrocycle '^*. It has been judged desirable for some research group 
to try to find another photosensitizer whose tumour localizing properties low 
dark toxicity, light absorbing properties and chemical stability, make it more 
suitable for its clinical use in PDT. This is the origin, there is the quest for 
second generation photosensitizers. 
C. C. Leznoff and co-workers'^ have synthesized some new ring 
substituted phthalocyanines and they under went preliminary testing for 
photodynamic activity using the colony forming ability of Chinese hamster 
cells in culture as an end point using 4-(3-N,N-diethylaminopropyl) 
phthalonitrile as a precursor. The previously unknown metal free 2,9,16,23-
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tetra(3-N,N-diethylaminopropyl) phthalocyanine was prepared and converted 
to its zinc (II) and its cationic water soluble 2,9,16,23-tetramethylammonium 
zinc (II) iodide derivative. Other new phthalocyanine derivatives tested 
included a 2,9,16,23-tetra(2-hydroxymethyl-2-methylbutoxy)phthalocyaninato 
zinc (II) and 2,3,9,10,16,17,23,24-octahydroxyphthalocyaninato zinc (II) 
derivative. 
. ^ ^ ^ C N 
(Et)2NCH2C^ 
+ (Et)2NCH2C= OH [(Ph)3P]2PdCl2 Cu I, EtzNH 
(II) 
H, 
pd /C 
NH, 
NaOMe 
{Et)2N(CH2)3 (IV) NH 
Me2NCH2CH20H 
A 
(V) NH 
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(VI) 
(VII) 
(VIII) 
dX) 
(X) 
(XI) 
(XII) 
(XIII) 
(XIV) 
R=(Et)2N (CH2)3, R ' = H , M = H 2 
R=(Et)2N (CH2)3, R ' = H , M=Zn 
© 0 , 
R=Me(Et)2N (CH2)3 I, R =H, M=Zn 
R=HOCH2 C(Me)(Et)CH20, R ' = H , M=Zn 
R = R ' = O H , M=Zn 
R = R ' = O C H 3 , M=Zn 
R = R ' = O C H 3 , M = H 2 
R=R'=OH, M=H2 
© © 
R=Me(Et)2N (CH2)3l , R =H, M=H2 
© 0 
(^^ R=Me(Et)2N (CH2)3CI , R ' = H , M - H 2 
I Chapter-1 I Synthesis Of Photosensitizers Conjugated To Steroids Page. 11 
16 Johan E. van Lier et al. have prepared a variety of monosulfonated 
phthalocyanine, benzonaphthoporphyrazine and porphyrin derivatives. 
,, SOaNa t 
/ / ^^ 
(XVI) (XVII) 
_17 In another study of Johan E. van Lier and co-workers reported the 
palladium (II) catalysed carbon-carbon coupling reaction (Heck reaction) 
between a variety of metalated P-monohalosubstituted porphyrin (2-
bromotetraphenyl porphyrin, 2-bromo-3,7,8,12,13,17,18-heptaethylporphyrin 
and 3(8) monoiodo deuteroporphyrin IX dimethylester) and a series of 
terminally substituted acetylenic derivatives is reported . 
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M 
(XVIII): Ni 
(XIX) :Cu 
C ^ C - R 
M 
(XX) : Ni 
(XXI) : Ni 
(XXII) : Ni 
(XXIII): Ni 
(XXIV): Ni 
(XXV) : Ni 
(XXVI): Cu 
(XXVII): Cu 
R 
(CH2)3CH3 
(CHj), CH3 
CfiHs 
CH2 CH2 OH 
(CH2)4 OH 
(CH2)4 CN 
C6H5 
CH2CH2OH 
C = C — C ( ^ 5 
E l R2 
(XXVnia): Br H 
(XXVIII b): H Br 
Rl R2 
(XXIX a): C^C-CgHs H 
(XXIX b) :H C = C-C6H5 
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Bi 
(XXX) : H 
(XXXI): H 
Br 
R2 
H 
Br 
H 
R 
(XXXII) :(CH2)9CH3 
(XXXIII) rC^Hg 
(XXXIV) : CH2CH2OH 
(XXXV) : (CH2)40H 
(XXXVI) : CH2CH2CN 
(XXXVII): C^Hg 
CeHs 
(XXXVIII): (CH2)20H 
(CH2)20H 
Si 
H 
H 
H 
H 
H 
C = 
H 
C= 
H 
B2 
H 
H 
H 
H 
H 
C-C6H5 H 
C=C-C6H5 
^C(CH2)20H H 
C=C(CH2)20H 
Por M^ Asuncion Valles^* have given a very brief idea about 
sensitizers. The first photosensitizer that has been approved for cHnical use for 
the photodynamic therapy of cancer (PDT) is described. The need of second 
generation photosensitizers and the structure activity relationship deduced so 
far for them are presented. 
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CO2H CO2H CO2H 
CO2H CO2H 
El B2 
(XXXIX) Hemato porphyrin IX (XL) CO-CH3, CO-CH3 
(XLI) CO-CH3, H 
(XLII) H, CO-CH3 
R 
(XLIII) CO-CH3 
(XLIV) H 
CO2H CO2H 
R 
(XLV) CO-CH3 
(XLVI) H 
CO2H ^OzH 
(XLVII) Protoporphyrin IX 
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Second Generation Photosensitizers in Clinical Trial: 
(XLVIII) (XLIX) 
OH H 
HOH2C 
A 
HO 
HO 
. 0 
HOH2C 
OH 
OH 
(LII a) 
OH 
(LII b) 
?imax, n m ( e ) 715(53000) 643(41800) 641(44900) 641(48700) 642 
(49000) 
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dose (^iM/kg) 25 3.1 12.5 
depth tumour > 7.29 2.7 5.7 
photonecrosis (mm) 
12.5 3.1 12.5 
dead 6.4 6.4 
12.5 
4.4 
Hermann K. Hombrecher et al.'^ reported the synthesis of a new 
carbohydrate cholesterol substituted porphyrin. 
CHS O 
CH3 
CH2 ^ 
CH 
O (LIII) 
CH, 
D. Wohrle and co-workers^" have reported the synthesis of 
unsymmetrical zinc (II) complexes of benzonaphthoporphyrazine bearing 
between one and eight pyridyloxy substituents by statistical tetramerization of 
6-( 1,1-dimethyl ethyl)-2,3-naphthalene dicarbonitrile with 4-(3-pyridyloxy)-
or 4,5-bis-(3-pyridyloxy)-l,2- benzene dicrbonitrile(2,3). 
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(LV) X = H,Y = Opy 
(LVI) X = Y = Opy 
(LVII) 
Y X 
(LVIII) :X = H,Y = Opy 
(LIX) : X = Y = Opy 
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(LXII): X = H, Y = Opy 
(LX) :X = H,Y = Opy 
(LXI): X = Y = Opy 
Tomas Torres and co-workers^^ have reported the synthesis of new 
type of phthalocyanine based on Chromophore system having two 
metallophthalocyanine rings bound together through ethynyl linkage. 
Bu 
(C^C)n 
(LXIII a)n = 2, M ' = M^ = Zn 
(LXIII b)n = 2, M ' = M^ = Ni 
(LXIVa)n = l ,M' = M^ = Zn 
(LXIV b)n = 1, M ' = Zn, M^ = Ni 
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Johan E. van Lier and co-workers^^ also have reported the preparation 
of unsymmetrical monoflinctionalised zinc phthalocyanines using palladium 
catalysed coupling reaction between zinc (II) tri (t-butyl) - 4-
iodophthalocyanine and a series of terminally substituted acetylenic 
derivatives, diethylvinylphosphonate, methyl acrylate (Heck rxn), vinyltin 
derivative (Still reaction) and aryl boronated acid (Suzuki reaction) are 
described. 
Bu 
(LXVI) 
In extension of this work, R. W. Boyle^^ has reported a meso-
monoiodo-substituted tetramacrocylic compound having formula (LXVII) 
where in each of A through D is independently a-5 membered, nitrogen-
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containing ring having the members necessary to complete a porphyrin, 
chlorine, bacteriochlorine or isobacteriochlorine nucleus. 
.^ ^N 
(LXVII) 
Pd (PPh3)2Cl2/CuI 
triethylamine 
+ HC ^ C R 
\ ^ 
R 
(LXVIII a) = C5H5 
(LXVIII b) = CH(OC2Hg)2 
(LXVIII c) = Si(CH3)3 
OH 
(LXVIII e) (LXVIII d) 
Qian Peng and co-workers '^* have given a brief idea about 
photosensitizers, localization of photosensitizers, background and about 
photodynamic therapy. 
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Richard Decreau and co-workers^^ have reported the synthesis of 
silicon phthalocyanine binded by two cholesterol moieties on each side and 
performed by reacting dihydroxy silicon phthalocyanine with 
chlorocholesteryloxy diphenylsilane, bis(triflate)-silicon phthalocyanine with 
cholesterol or dichlorosilicon phthalocyanine with cholesterol alcoholate. 
(LXIX) X = CI 
(LXX) X = OH (LXXI) 
In the extension of this study Michael J. Therien and co-workers26| 
reported appending unusual organic moieties to the porphyrin periphery has 
often involved elaborate synthetic strategies and difficult separations of 
reactants from products. 
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CeHs CfiH^ 
CfiH: 
"PdL2" 
6^5 
CeHs 
'6f^ 5 
^ 6 ^ 5 
Bu3Sn(CH=CH2) 
CfiH, 6^5 
CgHs 
(LXXIa) 
"Pd L2" (n-Bu) ZnCl2 
i 
CeHg 
CeHs 
CeHs 
(LXXIb) 
CH2(CH2)2Cni 
CeHs 
i27 D. P. Arnold et al have reported the palladium(O) catalysed of 
alkynyl porphyrins with either aryl iodides or P-bromovinyl porphyrin leads to 
symmetrical and unsymmetrical bis (porphyrins) incorporating various 
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unsaturated bridges. Some novel porphyrin bearing enyne and alkyne 
substituents are also described. 
Et Et 
Et Et 
Et Et 
( L X X I c ) 
28 R. Bonnett and co-workers have reported p substitution and meso 
substitution of unsubstituted position at the porphyrin periphery is possible 
then p-substitution is favoured for both bromination and iodination. 
Bromination of deuteroporphyrin IX dimethyl ester and deuteroporphyrin III 
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dimethyl ester is effected using N-bromo succinamide and iodination is 
carried out using iodine in dichloro benzene at 180 °C. This direct iodination 
of the porphyrin system appears to be previously unknown. 
Br2 
(LXXIe) (LXXIf) 
(LXXI g) R = R = H 
(LXXI i)R = Br,H;R^ = H,Br 
(LXXIk)R=R'=Br 
(LXXI m) R = R' = I 
(LXXI h) R = R' = H 
(LXXI j) R = Br, R' = H 
(LXXI I) R = R' = Br 
(LXXI n) R = I, R' = H 
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R, ^ 
v_ 
V 
^ 
-N.H 
-N 
u 
N= 
H-N, 
<>^ 
J 
// 
(LXXI 0) R = Et 
(LXXI p) R = CH(OEt)Me 
(LXXI q) R = H 
(LXXI r) R = R ' = CH(OEt) Me, R^ = Et 
R = R^ = CH(OEt)Me, R ' = Et 
(LXXI s) R = Br 
(LXXI t) R = CH(OMe)Me 
(LXXI u) R = CH = CH2 
(LXXI V) R = CH(OAc)Me 
(LXXI w) R = R ' = Br, R^ = Et 
R = R^ = Br, R* = Et 
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DISCUSSION 
One of the most interesting application of porphyrins and 
phthalocyanines involve their use as photosensitizer (PS) in the photodynamic 
therapy (PDT) of tumours. A number of PS are currently in clinical trials for 
24 
PDT of a variety of medical conditions . The treatment is based on the 
localization of the drug in the target tissue and treatment with visible light of 
the affected area. However, the use of most of these compounds is limited due 
to lack of target selectivity. 
Recently efforts have been focussed on the synthesis of PS attached to 
biomolecules (antibodies, peptides, steroids) which could improve target 
19 25 
selectivity. Cholesterol conjugates with porphyrins and phthalocyanines 
have been reported. These lipophillic PS exhibit good solubility in lipophilic 
media which promotes uptake by the low density lipoproteins (LDL) 
component of blood. Another approach is the development of steroids 
receptor-based PS. The incorporation of a steroid moiety in the PS molecule 
could improve the target selectivity for the receptor rich tumours. The 
palladium catalyzed coupling reaction has been proven an efficient process to 
17 7/i '?7 "jsi yy 
modify the porphyrin ' ' ' and phthalocyanine , macromolecule. Recently 
the synthesis of 5,15-diphenyl porphyrin linked to estrogen and progesterone 
29 
derivatives have been reported . Here we describe the synthesis of porphyrins 
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and phthalocyanines conjugated to estrogen, testosterone and 19-
nortestosterone derivatives. 
C = C R ' 
(LXXV) 
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Here readily accessible halogenated porphyrin derivatives were chosen 
to link with substituted steroids using palladium catalyzed cross coupling 
methodology. The selected steroids are commercially available include 17a-
ethynyl estradiol, a compound which have high binding affinity for the 
estrogen receptor, 17a-ethynyltestosterone, a compound with good binding 
affinity to the progesterone receptor and 19-nor-17a-ethynyl testosterone, a 
compound with binding affinity for the androgen receptor. 
Reaction of 5(p-iodoV5.10.15.20-tetraphenyl porphyrin zinc (ID (LXXID 
with 17a-ethvnvlestradiol (2). 17a-ethvnvltestosterone (3) and 19-nor-
17a-ethvnvitestosterone (i) : 5(p-17a-Ethvnvlestradiol)-5,10.15.20 tetra-
phenylporphyrin zn (U) (LXXIID. 5 (p-17a-ethvnvltestosterone)-
5.10.15.20 tetraphenyl porphyrin zn (II) (LXXIV) and 5 (p-17a-ethvnvl 
19-nortestosterone)-5.10.15.20 tetraphenyl porphyrin zn (II) (LXXV) : 
5(p-iodo)-5,10,15,20-Tetraphenyl porphyrin zinc (II) (LXXII) was 
dissolved in DMF, 2-3 molar excess of estradiol molecule was added, 
followed by the addition of triethylamine as a base, bis(triphenylphosphine) 
palladium (II) dichloride as a catalyst and copper (I) iodide. The reaction 
mixture was stirred at room temperature for 6-8 hours. The reaction mixture 
was monitored by thin layer chromatography (TLC), carried out on pre-coated 
silica plates containing fluorescent indicator (UV 254 nm). Upon completion 
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of the reaction, the solvent was removed under reduced pressure. The residue 
was poured into water, acidified with dilute HCl and extracted with 
chloroform, washed with water, dried (anhydrous Na2S04) and filtered. Crude 
reaction mixture was purified by column chromatography on silica gel. 
Characterization of the compounds : 
5 (p-17a-Ethvnvlestradion-5. 10. 15. 20-tetraphenvlporphvrin Zn (II) 
(LXXIII) : This compound (LXXIII) gave molecular composition 
C64H49N402Zn [MS-FAB (NBA), m/z 971]. UV-Vis spectrum showed ?imax, 
(relative intensity) 590(0.01), 552(0.018), 419(1) and ' H - N M R spectrum 
revealed peaks at §8.87 (d, J=4.8 Hz, IH, p-H), 58.85 (s, 6H, P-H), 58.84 (d, 
IH, J=4.8 Hz, p-H) §8.83 (d, J=7.8 Hz, 2H, 5 phenyl ortho protons). §8.23 (d, 
J=4.1 Hz, 2H, 5 phenyl meta protons), §7.84-7.72(m, 15H, phenyl protons), 
§7.21 (d, J=8.3 Hz, IH, Cl'-H), §6.64 (d, IH, J=8.2 Hz, C2'-H), § 6.56 (s, IH, 
C4'-H), §0.9 (s, 3H, C13'-CH3). The above spectral evidences confirmed the 
structure of compound as (LXXIII). 
5(p-17a-Ethvnvltestosterone)-5.10.15.20-tetraphenyl porphyrin Zn (II) 
(LXXIV) ; 
The compound (LXXIV) gave molecular composition C65H54N402Zn 
[MS-FAB (NBA), m/z 988]. UV-Vis spectrum shows X max (relative 
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intensity), 593(0.01), 550(0.04), 422(1), and ' H - N M R exhibited peaks at 
58.94 (s, 8H, (3-H), 68.2(s, 4H, phenyl ortho and meta protons), 87.76(s, 15H 
phenyl protons), 55.69(s, IH, C4'-H), 6l.25(s, 3H, ClO'-CHs), 50.95(s, 3H, 
CO'-CHs). The above spectral data established the structure of the compound 
as (LXXIV). 
5fp-17a-Ethynyl-19-nortestosterone)-5J0.15,20-tetraphenylporphyrin Zn 
aruLXXV): 
The compound (LXXV) gave molecular composition as C64H52N402Zn 
[MS-FAB (NBA), m/z 974]. UV-Vis spectrum gave X max (relative intensity), 
592.5(0.01), 550(0.04), 422.5(1), ' H - N M R shows 58.96(d, J=4.8 Hz, IH, (3-
H), 88.94(m, 6H, P-H), 68.92(d, J=4.7 Hz, IH, P-H), 58.23(d, J=7.3 Hz 2H, 
phenyl ortho protons), 68.20(d, J=4.7 Hz, 2H, phenyl meta protons), 57.80(m, 
15H, phenyl protons), 65.72(s, IH, C4'-H), 60.93(s, 3H, C13'-CH3). The 
analytical and spectral values confirmed the structure of the compound as 
(LXXV). 
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(LXXVI) R,=R2=H 
(LXXVII) R1=H, R2=Br 
R,=Br, R2=H 
OH 
(LXXVIII) R, = R2 = H 
OH 
I 
HO 
R,= H, R2 = 2 (LXXXI) Rj—H, R2~3 R]=3, R2=H 
Reaction of 2-bromotetraphenyl porphyrin nickel (LXXVI) and 2. 7(12)-
dibromotetraphenyl porphyrin nickel (LXXVII) with 17a-ethynyl 
estradiol (2) and 17a-ethvnvl testosterone (3) : [2-fl7a-Ethvnvl estradioH-
5.10.15.20-tetraphenyl porphinato] nickel riD (LXXVIID. [2.7 bisri7a-
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ethynylestradion-5.10.15.20-tetrapheny[ porphinato] nickel (ID TLXXIX). 
[2-(17a-ethynvl testosterone)-5,10,15,20-tetraphenvl porphinato) nickel 
(m (LXXX^ and [2.7 bisfl7a-ethvnvl testosteroneV5.10.15,20-tetraphenvl 
porphinato] nickel (ID (LXXD ; 
2-Bromotetraphenyl porphyrin nickel (LXXVI) or two bromine i.e. 
2,7(12)- dibromotetraphenyl nickel (LXXVII) were synthesized from the 
reaction of NBS (N-bromo succinamide) with TPP (tetra phenyl porphyrin) in 
29 
chloroform followed by metallation as previously described . Products were 
purified by silica gel column chromatography. The coupling reaction of the 
bromo compound (LXXVI) with steroids 2 and 3 gave the conjugated 
products (LXXVIII) and (LXXIX) respectively, and when (LXXVII) the 
dibromo analogue was treated with steroids 2 and 3, macromolecules (LXXX) 
and (LXXXI) containing two steroids moieties were obtained. 
Characterization of the compounds : 
f2-ri7a-Ethvnvlestradion-5.10.15.20-tetraphenvl porphinato| nickel (II) 
(LXXVIID ; 
The molecular composition of compound (LXXVIII) was found as 
C64H5oN402Ni [MS-FAB (NBA), m/z 964]. UV-Vis spectrum revealed X max 
(relative intensity) 570(0.042), 539.0(0.07), 425(1). Peaks in ' H - N M R 
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spectrum were found at 88.85(s, IH, p-H), 58.70-8.60 (m, 4H, {3-H), 57.98-
7.69 (m, 20H, phenyl protons), 67.1(d, J=8.1 Hz, IH, Cl'-H), 56.6(dd, J=8.2 
and 1.2 Hz, C2'-H), 56.55(d, J=1.2 Hz, C4'-H), 50.85 (s, 3H, CB'-CHj). 
These data confirmed the structure of compound as (LXXVIII). 
[2.7 Bis(17a-ethvnvlestradion-5.10.15,20-tetraphenyl porphinatol nickel 
(II) (LXXIX^; 
The compound (LXXIX) gave molecular composition C84H72N404Ni 
[MS-FAB (NBA), m/z 1258]. UV-Vis spectrum exhibited X max (relative 
intensity) 580(0.05), 542.5(0.08), 429.5(1). ' H - N M R spectrum showed peaks 
at 88.81, 58.80(s, IH, each, p-H), 58.63(s, 2H, (3-H), 58.58(s, 2H, p-H), 57.98-
7.69 (m, 20H, phenyl protons), 57.1 l(d, J=8.8 Hz, 2H, CI', Cl"-H), 56.59 (d, 
8.8 Hz, 2H, C2', C2"-H), 56.54(s, 2H, C4', C 4"-H), 51.0 (s, 6H, C13', C13"-
CH3). The above analytical and spectral data established the structure of the 
compound (LXXIX). 
[2-(17a-EthvnvltestosteroneV5.10.15.20-tetraphenvlporphinato]nickel (ID 
(LXXX); 
The molecular composition of the compound was found as 
C65H54N402Ni [MS-FAB (NBA), m/z 980]. UV-Vis spectrum gave X max 
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(relative intensity) 537(0.07), 547(0.06), 423.5(1). ' H - N M R spectrum 
exhibited peaks at 58.79(s, 2H, (3-H), 58.63(s, 5H, p-H), 87.98-7.70 (m, 20H, 
phenyl protons), 56.1(s, IH, C4'-H), 5l.02(s, 3H, ClO'-CHj), 50.85 (s, 3H, 
Cn'-CHs). These data confirmed the structure as (LXXX). 
[2.7-Bis(17a-ethynyltestosterone)-5J0J5,20-tetraphenylporphinatol 
nickel (U) TLXXXI) : 
The compound (LXXXI) gave molecular formula as Cg6H8oN404Ni 
[MS-FAB (NBA), m/z 1290]. UV-Vis spectrum gave X max (relative 
intensity), 582(0.05), 547(0.06), 431.0(1). ' H - N M R spectrum showed peaks 
at 88.79 (s, IH, (3-H), 88.63(s, IH, P-H), 88.58(s, 4H, |3-H), 5 7.96-7.20(m, 
20H, phenyl protons), 8 6.76(s, 2H, C4', C4"-H), 8 1.21(s, 6H, CIO', ClO"-
CH3), 80.85(s, 6H, CI3', C13"-CH3). These above spectral data were in 
H3GOOC COOCH3 
M El E2 
(LXXXII) Ni I I 
(LXXXIII) Zn I H 
H I 
(LXXXIV) Zn I I 
H3COOC COOCH3 
M El E2 
(LXXXV) Ni 2 2 
(LXXXVI) Ni 3 3 
(LXXXVII) Zn 2 H 
Zn H 2 
(LXXXVIII)Zn 2 2 
(LXXXIX) Zn 3 H 
Zn H 3 
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consistent with the structure (LXXXI). 
The reaction of 3.8-diiododeuteroporphyrin IX dimethyl ester Ni(II) 
(LXXXII). 3(8)(iodo)-deuteroporphyrin IX dimethyl ester zinc (ID 
(LXXXIII) and 3.8 diiododeuteroporphyrin IX di-methyl ester zinc (II) 
(LXXXIV^ with 17a ethvnvl estradiol (2) and 17a-ethvnvltestosterone 
(3); [3.8 Bis(17a-ethvnylestradion-deuteroporphyrin IX dimethylester| 
nickel (II) (LXXXV), [3.8 bis(17a-ethynyltestosterone)-deuteroporphvrin 
IX dimethylester] nickel (ID (LXXXVI). [3f81(17a-ethvnvlestradion-
deutero porphyrin IX dimethylester] zinc (ID (LXXXVID. [3.8 bis(17a-
ethynyl estradiol)-deuteroporphyrin IX dimethylester[ zinc (ID 
fLXXXVIID. [3 f8V17a-ethvnvltestosterone)-deuteroporphvrin IX 
dimethylester] zinc (ID (LXXXIX) and [3.8 bis n7a-ethvnvltestosterone)-
deuteroporphyrin IX dimethylester] zinc (II) (XC): 
The reaction of deuteroporphyrin IX dimethyl ester Ni with IF gave a 
22 
single diiodinated porphyrin (LXXXII),. The reaction of (LXXXII) with 2 
and 3 under the above described palladium catalyzed conditions, gave 
compounds (LXXXV) and (LXXXVI) respectively, since the presence of Zn 
often increases triplet life time enhancing its photodynamic properties. 
Attempts were also made to synthesize the Zn analogues under the Bonnett 
iodination conditions and after metallation, we were not able to obtain a pure 
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diiodinated product. Instead a mixture of mono and di-iodinated products were 
detected. Due to purification problems the mixture was used as such for 
coupling reaction. The mixture of 3(8)(iodo)deuteroporphyrin IX dimethyl 
ester zinc (II) (LXXXIII) and 3,8 diiododeuteroporphyrin IX dimethyl ester 
zinc (II) (LXXXIV) was reacted with 17a-ethynylestradiol (2) to give two 
products (LXXXVII) and (LXXXVIII), similarly the reaction of (LXXXIII) 
and (LXXXIV) with 17a-ethynyl testosterone (3) gave mono and di-
substituted products (LXXXIX) and (XC). 
Characterization of the compounds : 
[3.8 Bis(17a-ethvnylestradiol)-deuteroporphvrin IX dimethvlester] nickel 
ILiLXXXV): 
The compound (LXXXV) gave molecular composition as 
C72H76H408Ni [MS-FAB (NBA), m/z 1182]. UV-Vis spectrum gave X max 
(relative intensity) 564(0.19), 527(0.07), 405(1). ' H - N M R spectrum of the 
compound gave peaks at 59.72, 9.68, 9.27, 9.24(s, IH, each meso-H), 7.2(d, 
J=8.0 Hz, 2H, CV, Cl"-H), 56.82(d, J=7.8 Hz, 2H, C2', C2"-H), 66.48(d, 
J=7.8 Hz, 2H, C4', C4"-H). These spectral data suggested the structure of the 
compound as (LXXXV). 
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[3.8 Bisfl7a-ethvnvltestosterone)-deuteroporphyrin IX dimethvlesterl 
nickel (m fLXXXVD ; 
The molecular composition of the compound was found C74H84N408Ni 
[MS-FAB (NBA), m/z 1214]. UV-Vis spectrum gave X max (relative 
intensity) 564(0.2), 527(0.07), 404(1). ' H - N M R spectrum of the compound 
exhibited peaks at 89.5, 9.3, 9.0, 8.9(s, IH, each, meso-H), 8 5.68, 5.65(s, IH, 
each, C4', C4"-H). The above data confirmed the structure of compound as 
(LXXXVI). 
[3f8V17a-Ethvnvlestradiol)-deuteroporphyrin IX dimethvlesterl zinc (II) 
(LXXXVID : 
The compound showed molecular composition as C52H54N406Zn [MS-
FAB (NBA), m/z 896]. UV-Vis spectrum gave X max (relative intensity) 
578.5(0.08), 539.0(0.131), 401(1). ' H - N M R spectrum of the compound gave 
peaks at 89.50, 8.95, 8.46, 8.39(s, IH, each, meso-H), 8 8.32(s, IH, p-H), 
86.64 (d, J=8.0 Hz, IH, Cl'-H), 8 6.61 (d, J=7.8 Hz, IH, C2'-H), 8 6.52 (d. 
J==7.8 Hz, IH, C4'-H). The above data confirmed that the compound was 
identified as monosteroid porphyrin adduct (LXXXVII). 
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[3.8 Bis(17a-ethynvlestradion-deuteroporphyrin IX dimethvlester] zinc 
(ID (LXXXVIID ; 
The second more polar product gave molecular composition as 
C72H76N408Zn [MS-FAB (NBA), m/z 1190] corresponding to the attachment 
of the two steroid molecules. UV-Vis spectrum exhibited X max (relative 
intensity) 582(0.09), 546(0.07), 418.5(1). ' H - N M R spectrum gave peaks at 
89.2, 9.10 (s, 2H, each, meso-H), 5 7.3(d, J=7.3 Hz, 2H, CI', Cl"-H), 56.7(d, 
J=7.2 Hz, 2H, C2', C2"-H), 8 6.4(d, J=7.4 Hz, 2H, C4', C4"-H). These data 
confirmed the structure of the compound as (LXXXVIII). 
[3(8)(17a'Ethynvltestosterone)-deuteroporphyrin IX dimethvlester] zinc 
(IIULXXXUQ: 
Less polar product was identified as the monosteroid porphyrin adduct. 
The molecular composition of the compound was found as C53H58N406Zn 
[MS-FAB (NBA), m/z 912]. UV-Vis spectrum gave X max (relative intensity) 
578.5(0.07), 539.0(0.05), 410.5(1). ' H - N M R spectrum revealed peaks at 89.5, 
9.2, 9.15, 8.95(s, IH each, meso-H), 8 8.6(s, IH, p-H), 86.1 (s, IH, C4-H). 
The structure of compound was established as (LXXXIX) by above spectral 
evidences. 
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[3.8 Bis(17a-ethvnyltestosteroneVdeuteroporphyrin IX dimethylester] 
zinc (m (XC) : 
The second, more polar product gave molecular composition as 
C74H84N408Zn [MS-FAB (NBA), m/z 1222] corresponding to the attachment 
of the two steroid molecule. UV-Vis spectrum gave X max (relative intensity) 
582(0.09), 546.0(0.07), 413.5(1). ' H - N M R spectrum gave peaks at 810.28, 
810.25, 10.24, 10.23, (s, IH, meso-H), 8 6.2(s,lH, C4'-H), 85.6(s, IH, C4"-
H). These spectral data confirmed the structure of above compound as (XC). 
Phthalocyanines have strong redshifted absorption band with maxima 
around 680 nm, i.e. at wavelength where tissue transparency is optimal. This 
allows for the treatment of longer volumes of diseased tissues, rendering this 
class of compounds attractive as second generation PS for PDT. 
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HgC^ 
C4H9 
(XCII) (XCIII) 
C4HI 4 ^ 9 
(XCIV) 
Reactions of zinc (II) tri(t-butyl)-4(iodo) phthalocyanine (XCD with 17a-
ethynyiestradiol (2). 17a-ethynyltestosterone (3) and 17a-ethynyl 19-nor-
testosterone (4); Zinc (II) tri(t-butvn-4(17a-ethynvlestradiol> phthalocya-
ninefXCin. zinc(II)tri(t-butyl)-4n7a-ethynyitestosterone) 
phthalocyanine fXCIID and zinc (ID tri ft-butylV4 ri7a-etlivnvl)-19-
nortestosterone phthalocyanine (XCIV): 
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Mono iodophthalocyanine (XCI) was dissolved in THF and treated 
with steroid 2 (room temperature, 2-4 hr) in triethylamine containing a 
catalytic amount of bis(triphenyl phosphine) palladium (II) dichloride and 
copper (I) iodide. The coupling product (XCII) gave a strong Q band at 680 
nm and molecular ion at m/z 1039. The analogous reaction of (XCI) with 3 
and 4 gave the corresponding steroids coupling products (XCIII) and (XCIV). 
Characterization of the compounds : 
Zinc (ID Trift-butyn-4a7a-ethvnvlestradion phthalocvanine (XCID ; 
The molecular composition of the compound was found C64H6iN802Zn 
[MS-FAB (NBA), m/z 1039]. UV-Vis spectrum gave X max 680 nm. 
Zinc (m Tri(t-butyn-4(17a-ethvnvltestosterone) phthalocvanine (XCIID : 
The compound gave molecular composition as C65H65N802Zn [MS-
FAB (NBA) m/z 1055]. UV-Vis spectrum of the compound gave X max 
681nm. 
Zinc (II) Tri (t-butyl)-4(17a-ethynyl-19-nortestosterone) phthalocvanine 
(XCIV): 
Molecular composition of the compound was found C64H63N802Zn 
[MS-FAB (NBA) m/z 1041]. UV-Vis spectrum of the compound gave X max 
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680.5 nm. These analytical and spectral data were consistent with the structure 
of compounds (XCII, XCIII and XCIV). 
CaH 
•4^9 
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4-CECR 
(XCIX) 
Reaction of Zn (U) tri(t-butyn3-riodo)phthalocyanine (XCV) with 17a-
ethynylestradiol (2) ; Zinc (ID tri(t-butyn-3(17a-ethvnvlestradion phth -
alocyanine (XCVI): 
A bathochromic shift has been reported when the substituents are 
introduced into benzene ring, particularly at site a to the point of fusion to the 
heterocyclic ring. Accordingly we synthesized the 17a-ethynyl estradiol 
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conjugated with (XCV) using the above reaction condition to yield adduct 
(XCVI) coupled at the 2-position of the PC. The product (XCVI) showed 
absorption maximum at 691 nm, as compared to 680 nm for the analogue 3-
substituted adduct. 
Characterization of the compounds : 
Zinc fin trirt-butyn-3fl7a-ethvnvlestradion phthalocvanine (XCVI) ; 
The chemical composition of the adduct was found as C64H6iN802Zn 
[MS-FAB (NBA), m/z 1039]. UV-Vis spectrum gave X max 691.0 nm. These 
data supported the structure of the adduct as (XCVI). 
Reaction of 1.2 dicyano-4-iodobenzene (XCVII) with 17a-ethvnylestradiol 
(2) : 17a-f4'-Ethvnvl l'.2'-dicvanobenzene) estradiol (XCVII) and zinc 
(m 4.4'.4'\4'''-tetra kis (17a-ethvnvlestradion phthalocvanine (C); 
A tetrasubstituted PC was also prepared. The reaction of 17a-
ethynylestradiol (2) with 4-iodo 1,2-dicyanobenzene (XCVII) gave a coupling 
product 17a(4'-ethynyl-r, 2'-dicyano-benzene) estradiol (XCVIII). Direct 
condensation of (XCVIII) with Zn(OAc)2.2H20 at 180°C for 2 h in the 
presence of urea gave PC (C) in low yield (5-10%). Alternatively a better 
yield (25-30%) was obtained when tetraiodo PC (XCIX) was treated with 2 
under Heck coupling conditions in the presence of Pd (II) catalyst. To a 
solution of 240 mg (1 mmole) of 4-iodo phthalonitrile (XCVII) in 50 ml of 
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THF, 17a-ethynyl estradiol (2) 1.1 mmole equivalent were added, 
triethylamine 2.0 ml, 20 mg of copper (I) iodide and 50 mg of bis(triphenyl 
phosphine) palladium (II) dichloride under an atmosphere of nitrogen. The 
reaction mixture was stirred for 4 hour. The mixture was filtered to separate 
precipitated salt. The residue was extracted with ethyl acetate and work up in 
the usual manner. The residue was purified by column chromatography. 
Characterization of the compounds : 
17a-(4^-Ethvnvl l\ 2'-dicvanobenzene) estradiol (XCVIII); 
The chemical composition of the compound was found as C28H26N2O2 
[MS-FAB (NBA), m/z 422, HRMS : 422.199 (exp.)]. ' H - N M R gave 67.8(s, 
Cl-H), 57.7(s, C2-H), 87.4(s, C4-H), 57.2(d, J=8.6 Hz, IH, Cl'-H), 86.6(dd, 
J-8.6 and 1.8 Hz, IH, C2'-H), 56.5(d, J=1.8 Hz, C4'-H) These analytical and 
spectral data confirmed the structure of the compound (XCVIII). 
Zinc (m 4.4^ 4". 4''^tetra kis(17a-ethvnvlestradion phthalocvanine (C): 
The chemical composition of the compound was found as 
Cu2Hio4N808Zn [MS-FAB (NBA), m/z 1754]. UV-Vis spectrum gave ?imax 
690.0 nm. These analytical and spectral data supported the structure of the 
compound as (C). 
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Reactions of 2-f3-iodo) benzo (b)-lO. 19. 28-tri (1. 1-dimethylethyn 
trinaphtho [2^ 3''-g. 1", y\ \\1"\ y"-%\ porphvrazinato zinc (ID (CI), 2, 
18-bis-(3-iodo) dibenzo [b. 1] 10. 26-di(l. 1-dimethyl ethyH dinaplitho [2^ 
3'-g 1"\ y"-%\ porphvrazinato zinc (II) (CID and of 4. 4 \ 4'Mris(3-iodo) 
tribenzo [b.g.l]-4^^^(l.l-dimethvt ethvinaphtho)[2^^ ^"'-^\ 
porphyrazinato zinc (II) (CUD witli 17a-ethvnvl estradiol (2); 2-(3-17a-
EthynylestradioD-benzo (b)-lO. 19. 28-tri(l. 1-dimethylethyl) trinaphtho 
\l\y-%.l"y\ \'.1"\ 'S"'-^\ porphvrazinato zone (II) (Cla). 2.18 bis(3.17a-
ethynylestradiol)-dibenzo[b.ll-10. 26-di (l.l-dimethylethyl) dinaphtho 
|2^3'-g: T'y"-%\ porphvrazinato zn (II) (Clla) and 4. A\ 4''-tris(3-17a-
ethylestradioi)-tri benzo[b.g.ll-4''7l.l-dimethvlethvnnaphtho \l"'y"-^\ 
porphyrazinato zinc (II) (Cllla): 
With aim to develop PC-steroid adduct with a muhiple choice of red-
shifted excitation wavelength, PC analogues consisting both the phthalo and 
naphthalo moieties were prepared. They feature spectral characteristic of both 
parent molecule resulting in composite spectra that vary in shift according to 
the number of naphthalene and benzene units. The 4-iodo 1,2 dicyanobenzene, 
4-t-butyl 1,2-dicyanonaphthalene in the presence of Zn(0Ac)2. 2H2O gave a 
complex reaction mixture consisting of mono to tetra iodo benzene units, as 
revealed by mass spectral analysis. Due to diffculty in the purification, the 
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mixture was coupled directly with 17a-ethynyl estradiol (2). After the 
completion of reaction, five products were clearly separated on T.L.C using 
5% THF, 5% methanol in toluene as solvent. The same solvents system was 
used to purify products by silica gel column chromatography. The first 
fraction was identified as Zn NPC. The second fraction eluting with 5% THF, 
5% CH3OH in toluene was identified as the mono benzosteroid trinaphthalo 
(Cla). The compound gave a characteristics UV-Vis spectrum with peaks at 
759.5 and 726.5 nm of almost equal intensity. The second fraction was 
identified as the dibenzo steroid dinaphtho adduct (Clla). The mass spectrum 
confirms the presence of two steroid-moieties. The material consists of a 
mixture of cis and trans adducts. In the third fraction the macromolecule 
contains three benzoid units and one of naphthalene. The adduct (Cllla) with a 
maximum at 721 and 691 nm. The MS-FAB confirms the presence of three 
units of steroid moieties. 
Characterization of compounds : 
2-f3-17a-Ethvnvlestradionbenzofb)-10a9.28-tria.l-dimethvIethvn trina-
phtho \2\ 3'-g. r\ y\ X'.l'". y"-i\ porphvrazinato-zinc (ID rCIa) ; 
Molecular composition of the adduct was found, C76H68N802Zn [MS-
FAB (NBA), m/z 1190] UV-Vis spectrum gave X max (relative intensity) 
I Chapter-1 l Synthesis Of Photosensitizers Conjugated To Steroids I Page. 49 i 
759.5(1), 726.5(0.96) nm. These analytical and spectral data were consistent 
with the assigned structure (Cla) of the compound. 
2.18-Bisf3-17a-ethvnvlestra(liondibenzo fb.ll-lO. 26-di(l,l-dimethvlethvn 
dinaphtho \r. 3'-g; 2"\ 3'"-^] porphvrazinato zinc (II) (Clla): 
The chemical composition of the compound was found C88H8oN804Zn 
[MS-FAB (NBA), m/z 1378]. UV-Vis spectrum showed Xmax 724.0 nm. The 
above data confirmed the structure of adduct as (Clla). 
4.4'.4''-Tris(3-17a-ethvnvlestradiontribenzo[b.g.ll-4'''(l. 1-dimethvlethvl 
naphtho \2"'. y"-2} Dorphvrazinato'zinc (ID (Cllla); 
The molecular composition of the compound was found 
CiooHQzNgOeZn [MS-FAB (NBA), m/z 1566]. UV-Vis spectrum gave >.max 
(relative intensity) 721.0(1), 691 (0.95) nm. These analytical and spectral data 
were consistent with the structure of the compound as (Cllla). 
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EXPERTMENTAL 
Reagents and solvents were obtained commercially (Aldrich or Fischer) 
and were of the highest chemical grade available. Thin layer chromatography 
(TLC) was carried out on precoated silica plates containing fluorescent 
indicator (UV A, max 254 nm). Crude reaction mixture were purified by 
column chromatography on 60-200 mesh silica gel. ' H - N M R spectra were 
recorded on a Bruker AC 300 (300 MHz) in CDCI3 or DMF-dy solution. 
Chemical shifts are referenced to the residual solvent signal (CDCI3 6 = 7.26). 
UV-Vis absorption spectra of phthalocyanine were recorded in DMF and 
porphyrin in chloroform on a Hitachi U-2000 spectrophotometer. High and 
low resolution mass spectra (HRMS, MS) were determined with a VG 
micromas model ZAB-IF apparatus at 70 eV Ionization voltage. 
General procedure for coupling of 17a-ethvnvl steroids derivatives 
with halogenated porphyrins and phthalocyanines : 
The porphyrin (20-30 mg) were dissolved in DMF (10 ml) and 
phthalocyanines in THF (10 ml), triethylamine (1.0 ml), bistriphenyl 
phosphine) palladium (II) dichloride (5-10 mg) and cuprous iodide (5 mg) 
were added. The steroid (2-3 molar excess) were added in the reaction mixture 
and was stirred, heated as required. All coupling products were obtained on 
stirring, the reaction mixture at room temperature and at (55-60°C) for 10-12 h 
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was required. The course of the reaction was monitored by TLC. Upon 
completion of the reaction, the solvent was removed under reduced pressure. 
The residue was poured into water acidified with dil HCl and extracted with 
chloroform. Washed with water, dried (anhydrous Na2S04) and filtered. The 
organic solvent was removed under reduced pressure and the residue 
chromatographed over silica gel. All coupling reactions were carried out under 
nitrogen. 
Reaction of S (p-iodo)-5T 10, 15^ 20-tetraphenyl porphyrin zn (11) 
(LXXII) with 17a-ethvnvlestradioi (2), 17a-ethvlnvl testosterone (3) 
and 19-nor-17a-ethvnvltestosterone (4) : 5(p-17a-Ethvnvlestradiol)-
5. 10. 15. 20-tetraphenyl porphyrin zn (II) (LXXIin. 5(p-17a_-
ethynyltestosteroneVS. 10. 15. 20-tetraphenyl porphyrin zn (II) 
(LXXIV) and 5(p-17a-ethvnvl-19-nortestosterone-5, 10, 15. 20-
tetraphenyl porphyrin zn (ID (LXXV^: 
5(p-17a-EthvnvlestradiolV5. 10. 15. 20-tetraphenvl porphyrin 
Zn(II) (LXXIID ; 
Yield : 75%, eluted with 10%, toluene in chloroform. 
UV-Vis X max relative intensity : 590 (0.01), 552 (0.018), 419 (1). 
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' H - N M R : 58.87 (d, J=4.8Hz, IH, p-H), 68.85 (s, 6H, 3-H), 68.84 (d, 
J=^.8Hz, 1-H, P-H), 58.83 (d, J=7.8 Hz, 2H, 5 phenyl ortho protons), 88.23 (d, 
J=4.1Hz, 2H, 5 phenyl meta protons), 57.85-7.72 (m, 15H, phenyl protons), 
67.21 (d, J=8.3Hz, IH, Cl'-H), 86.64 (d, IH, J=8.2 Hz, C2'-H), 66.56 (s, IH, 
C4'-H), 80.9 (s, 3H, CH'-CHj). 
MS-FAB (NBA): m/z 971 (C64H49N402Zn) 
5(p-17a-Ethvnvltestosterone)-5,10J5,20-tetraphenvl porphyrin Zn 
(ID (LXXIV) : 
Yield : 60%, eluted with 10%, toluene in chloroform. 
UV-Vis X max (relative intensity) : 593 (0.01), 550 (0.04), 422 (1). 
' H - N M R : 8 8.94 (s, 8H, p-H), 68.2 (s, 4H, phenyl ortho and meta protons), 
87.76 (s, 15H, phenyl protons), 85.69(s, IH, C4'-H), 81.25 (s, 3H, ClO'-CHj), 
80.95(s, 3H, CB'-CHj). 
MS-FAB (NBA) : m/z 988 (C65H54N402Zn) 
5(p-17a-Ethvnvi-19-nortestosteroneV5.10,15, 20-tetraphenvlporph-
yrin ZndD (LXXV): 
Yield : 55%, eluted with 10% toluene in chloroform. 
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UV-Vls A, max (relative intensity): 592.5 (0.01), 550 (0.04), 422.5 (1). 
' H - N M R : 68.96 (d, J=4.8Hz, IH, p-H), 8 8.94 (m, 6H, p-H), 88.92 (d, 
J=4.7Hz, IH, (3-H), 88.23 (d, J=7.3Hz 2H-phenyl ortho protons), 88.20 (d, 
J=4.7Hz, 2H, phenyl meta protons), 87.80 (m, 15H, phenyl protons) 85.72 (s, 
IH, C4'-H), 80.93 (s, 3H, CH'-CHj). 
MS-FAB (NBA) : m/z 974 (C64H52N4O2 Zn) 
Reactions of 2-broino tetraphenyl porphyrin nickel (LXXVD and 2.7 
(12)-dibroniotetraphenyl porphyrin nickel (LXXVII) with 17a-
ethynyl estradiol (2) and 17a-ethvnvl testosterone (3) ; [2(17a-
EthynyIe$tradiol)-5, 10, 15, 20-tetraphenyl pprphinato] nickel (II) 
(LXXVIID. r2.7-bis(17a-ethvnvl estradioH-S, 10, 15, 20-tetraphenvl 
porphinato] nickel (ID (LXXIXl [2(17a-ethvnvl testosterone)-5, 10, 
15. 20-tetraphenyl porphinato] nickel (ID (LXXX) and [2.7-bis (17a-
ethynyl testosteroneV5. 10. 15. 2Q-tetraphenyl porphinato] nickel 
(II) (LXXXD. 
Two different porphyrin precursors were prepared bearing either one or 
two bromine. These readily accessible porphyrins bearing one halogen at a Im-
position of TPP Ni, are synthesized from the reaction of NBS with TPP in 
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7 
chloroform followed by metallation as previously described . Products were 
purified by silica gel column chromatography. The coupling reaction of bromo 
compound (LXXVI) with steroids 2 and 3 gave the conjugated products 
(LXXVIII) and (LXXIX) respectively. The compounds were characterized by 
the mass spectra which gave a bunch of peaks corresponding to the natural 
58 
abundance of Ni major molecular ions at m/z 964 and m/z 980 (M + Ni) 
confirming the attachment of a single, molecule of steroid. The reactivity of 
(LXXVI) compared to 2 is low requiring higher temperature and longer 
reaction time. This is in agreement with the known high reactivity of aryl 
o 
iodide as compared to arylbromide under Heck coupling reaction condition . 
When (LXXVII) the dibromo analogue was treated with steroids 2 and 3 
macromolecules (LXXX) and (LXXXI) containing two steroid moieties were 
obtained. 
f2-a7a-Ethvnvlestradion-5J0.15,20-tetraphenvl porphinatol nickel 
(ID (LXXVnr): 
Yield : 45%, eluted with 20% chloroform in toluene. 
UV-Vis X max (relative intensity): 570 (0.042), 539.0 (0.07), 425 (1). 
' H - N M R : 58.85 (s, IH, p-H), 58.70-8.60 (m, 4H, (3-H), 57.98-7.69 (m, 20H, 
phenyl protons), 67.1 (d, J=8.1 Hz, IH, Cl'-H), 66.6 (dd, J=1.2 and J=8.2 Hz, 
C2'-H), 66.55 (d, J=1.2 Hz, C4'-H), 60.85 (s, 3H, C13'-CH3). 
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MS-FAB (NBA): m/z 964.(C64H5oN402Ni). 
[2.7Bis(17a-ethvnvlestradion-5J0J5,20-tetraphenvl porphinatolnickel 
(II) (LXXIX): 
Yield : 55%, eluted with 5% acetonitrile in chloroform. 
UV-Vis X max (relative intensity): 580 (0.05), 542.5 (0.08), 429.5 (1). 
^H-NMR : 58.81, 58.80 (s, IH, each P-H), 8.63 (s, 2H, (3-H), 68.58 (s, 2H, (3-
H), 57.98 - 7.69 (m, 20H, phenyl protons), 57.11 (d, J=8.8 Hz, 2H, CI', Cl"-
H), 56.59 (d, 8.8 Hz, 2H, C2', C2"-H), 56.54 (s, 2H, C4', C4"-H), 61.0 (s, 6H, 
C13',C13"-CH3). 
MS-FAB (NBA): m/z 1258 (C84H72N404Ni). 
f2(17a-Ethvnvltestosterone)-5J0.15,20-tetraphenvIporphinatolnickel 
(II) (LXXX): 
Yield : 37%; eluted with 80%, chloroform in toluene. 
UV-Vis X max (relative intensity) : 537 (0.07), 547 (0.06), 423.5 (1). 
' H - N M R : 68.79 (s, 2H, P-H), 88.63 (s, 5H, P-H), 67.98 - 7.70 (m, 20H, 
phenyl protons), 66.1 (s, IH, C4'-H), 61.02 (s, 3H, ClO'-CHj), 50.85 (s, 3H, 
C13'-CH3). 
MS-FAB (NBA) : m/z 980 (C65H54N402Ni). 
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[2.7-Bisri 7a-ethynvltestosterone)-5.10,15.20-tetraphenvlporphinatol 
nickel (m (LXXXD : 
Yield : 40%; eluted with 90%, chloroform in toluene. 
UV-Vis X max (relative intensity) : 582.5 (0.05), 547.0 (0.06), 431.0 (1). 
^H-NMR : 88.79 (s, IH, p-H), 68.63 (s, IH, p-H), 68.58 (s, 4H, P-H) 67.96 
-7.20 (m, 20H, phenyl protons), 66.76 (s, 2H, C4', C4"-H), 61.21 (s, 6H, CIO', 
C10"-CH3) 60.85 (s, 6H, C13', C13"-CH3). 
MS-FAB (NBA): m/z 1290 (C86H8oN404Ni). 
The reaction of 3.8-diiododeuteroporphyrin IX dimethyl ester Ni (II) 
(LXXXII). 3(8)-(iodo)-deuteroporphyrin IX dimethyl ester zinc (ID 
(LXXXIII) and 3.8-diiododeuteroporphyrin IX dimethyl ester zinc 
(U) (LXXXIV^ with 17a-ethvnvl estradiol (2) and 17a-ethvnvl 
testosterone (3) : [3.8 Bisn7a-ethynvlestradiol) deuteroporphvrin 
IX dimethylester]nickel (ID (LXXXV). [3.8 bis(17a-ethvnvltestoster 
one) deuteroporphyrin IX dimethylester] nickel (ID (LXXXVD. 
[3(8^(17a-ethvnvlestradion deuteroporphyrin IX dimethvlesterl zinc 
(II) (LXXXVID. [3.8 bis(17a-ethvnvlestradion deuteroporphvrin IX 
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dimethylester] zinc (U) (LXXXVIID. f3f8¥17a-ethvnvltestosterone) 
deuteroporphyrin IX dimethyiesterl zincdD (LXXXIX) and [3.8 bis 
(17a-ethvnvltestosterone) deuteroporphvrin IX dimethylester] zinc 
(11) (XC); 
The reaction of deuteroporphyrin IX dimethyl ester Ni with IF gave a 
22 
single diiodinated porphyrin (LXXXII). The reaction of (LXXXII) with 2 
and 3 under above described palladium catalyzed conditions gave compounds 
(LXXXV) and (LXXXVI) respectively since the presence of Zn often 
increases triplet life time, enhancing its photo dynamic properties. Attempts 
were also made to synthesize the Zn analogues. Under the Bonnett 
iodination conditions and after metallation, we were not able to obtain a pure 
diiodinated product. Instead a mixture of mono and di-iodinated products were 
detected. Due to purification problem the mixture was used as such for the 
coupling reaction. The mixture of 3(8)(iodo)deuteroporphyrin IX dimethyl 
ester zinc (II) (LXXXIII) and the 3,8-di-iododeuteroporphyrin IX dimethyl 
ester zinc (II) (LXXXVI) was reacted with 2 to give two products based on the 
MS-FAB m/z at 896, the less polar product was identified as the monosteroid 
porphyrin adduct (LXXXVII). The second, more polar product gave MS-FAB 
m/z 1190 corresponding to the attachment of the two steroid molecules 
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(LXXXVIII). Similarly the reaction of (LXXXIII) and (LXXXIV) with steroid 
3 gave mono and di-substituted products (LXXXIX) and (XC). 
[3.8-Bis(17a-ethvnvlestradiondeuteroporphvrin IX dimethyl ester I 
nickel (m (LXXXV) : 
Yield : 50%, eluted with 5% acetonitrile in chloroform. 
UV-Vis A, max (relative intensity): 564.0 (0.19), 527 (0.07), 405 (1); 
' H - N M R : 69.72, 69.68, 69.27, 69.24 (s, IH each meso-H), 67.2(d, J=8.0 Hz, 
2H, C r , Cl"-H), 66.82 (d, J=7.8 Hz, 2H, C2', C2"-H), 66.48 (d, J-7.8 Hz, 
2H, C4', C4"-H), 64.05 (m, 4H, CH?CH?C02CH?). 63.82, 63.75 (s, 3H each, 
OCH3), 63.46, 63.38, 63.26, 63.15 (s, 3H each CH3), 62.85 (m, 4H, a i 2 CH2 
CO2 CH3), 61.12 (s, 6H, C13', C13"-CH3). 
MS-FAB : m/z 1182 (C72H76N408Ni). 
[3.8Bis(17a- ethvnvltestosterone)deuteroporphvrin IX dimethvlesterl 
nickel (ID (LXXXVI) : 
Yield : 55%, eluted with 10% acetonitrile in chloroform. 
UV-Vis X max (relative intensity): 564 (0.2), 527 (0.07), 404 (1); 
' H - N M R : 69.5, 69.3, 69.0, 68.9 (s, IH each meso-H), 65.68, 65.65 (s, IH 
each, C4', C4"-H), 64.05(m, 4H, CH2£H2C02CH3), 63.65, 63.64 (s, 3H each-
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OCH3) 53.48, 63.42, 63.30, 83.21 (s, 3H each, CH3), 62.95 (m, 4H, 
CH2CH2CO2CH3), 61.25 (s, 6H, C13', C13"-CH 3), 60.95 (s, 6H, C10',C10" 
-CH3) 
MS-FAB (NBA) : m/z 1214 (C74H84N408Ni) 
[3(8K17a-Ethvnvlestradion-deuteroporphvrin IX dimethyl ester] zinc 
a n (LXXXVID : 
Yield : 40%, eluted with 15% acetonitrile in chloroform. 
UV-Vis X max (relative intensity): 578.5 (0.08), 539.0 (0.131), 401 (1). 
' H - N M R : 69.50, 68.95, 68.46, 68.39 (s, IH each meso-H), 88.32, (s, IH, (3-
H), 86.64 (d, J=8.0 Hz, IH, Cl'-H), 66.61(d, J=7.8 Hz, IH, C2'-H), 66.52 (d, 
J=7.8 Hz, IH, C4'-H), 64.05 (t.2H.CH?CH?C07CH3). 63.85, (t, 2H, 
CH2Oi2C02CH3), 63.63 (s, 6H, CH3), 83.62, 83.60 (s, 3H each, CH3), 6 3.57 
(s, 6H, CH3), 3.85 (m, 4H, CH2CH2C02CH3), 60.93 (s, 3H, C13'-CH3). 
MS-FAB(NBA) : m/z 896 (C52H54N406Zn). 
[.1.8 Bis(17a-ethvnvl estradiondeuteroporphyrin IX dimethyl esterl 
zinc (m (LXXXVIID : 
Yield : 45%, eluted with 10% acetonitrile in chloroform. 
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UV-Vis >. max (relative intensity): 582 (0.09), 546.0 (0.07), 418.5 (1). 
' H - N M R : 59.2, 89.1, (s, 2H each meso-H), 67.3 (d, J-7.3 Hz, 2H, CI', Cl"-
H), 56.7 (d, J=7.2 Hz, 2H, C2', C2"-H), 56.4 (d, 2H, C4', C4"-H); 63.80 (m, 
4H, CH2CH2CO2CH3), 53.64, 63.61 (s, 3H each, CH3), 53.53 (s, 12H, CH3), 
53.35 (m, 4H, CH2CH2CO2CH3), 50.95 (s, 6H, C13', C13"-CH3). 
MS-FAB (NBA) : m/z 1190 (C72H76N408Zn). 
[3(8U17a-Ethvnvitestosterone)deuteroporphvrin IX dimethyl esterl 
zinc ai) (LXXXIX) : 
Yield : 35%, eluted with 15% acetonitrile in chloroform. 
UV-Vis X max (relative intensity) : 578.5 (0.07), 539.0 (0.05), 410.5 (1). 
' H - N M R : 69.5, 59.2, 59.15, 68.95 (s, IH each meso-H), 58.6 (s, IH, p-H), 
56.1 (s, IH, C4'-H) 54.15 (m, 2H, CH2£H2C02CH3), 53.80 (m, 2H, 
( :H2CH2C02) 53.63, 63.60, 3.58 (s, 6H each, CH3), 63.45 (m, 4H, 
CH2CH2C02CH3), 51.28 (s, 3H, ClO'-CHs), 60.90 (s, 3H, CB'-CHj). 
MS-FAB (NBA) : m/z 912 (C53H58N406Zn). 
[3.8 Bis(17a-ethvnvltestosterone)deuteroporphvrin IX dimethyl ester] 
zinc (ID (XCA : 
Yield : 45%, eluted with 15% acetonitrile in chloroform. 
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UV-Vis X max (relative intensity) : 582 (0.09), 546.0 (0.07), 413.5 (1). 
' H - N M R : 610.28, 510.25, 610.24, 610.23, (s, IH each meso-H), 66.2 (s, IH, 
C4'-H), 65.6 (s, IH, C4"-H), 63.75 (m, 4H, CH2CH?CO?CH7). 63.5, 63.64, 
63.61, (s, 6H each, CH3), 63.45 (m, 4H, CH2CH2C02CH3), 61.30 (s, 6H, 
CIO', C10"-CH3), 60.98 (s, 6H, C13', C13"-CH3). 
MS-FAB (NBA) : m/z 1222 (C74H84N408Zn) 
Now we describe the phthalocyanine here, phthalocyanines have strong 
red-shifted absorption band with maxima around 680 nm, i.e. at wavelength 
where transparency is optimal. This allows for the treatment of longer 
volumes of diseased tissues, rendering this class of compounds attractive as 
second generation PS for PDT. 
Reactions of zinc (ID tri(t-butyl)-4(iodo) phthalocyanine (XCD with 
17a-ethvnvl estradiol (2), 17a-ethvnvl testosterone (3) and 17a-
ethynyl 19-nor testosterone (4) : Zinc (ID tri(t-butyl) 4-(17a-ethvnvl 
estradioh phthalocyanine (XCID. zinc (ID tri (t-butyh 4-(17a-
ethynyltestosterone) phthalocyanine (XCIID and zinc (ID tri(t-
butyl) 4-(17a-ethvnvl-19-nortestosterone) phthalocyanine (XCIV) : 
Monoiodophthalocyanine (XCI) was dissolved in THF and treated with 
steroid 2 (room temp. 2-4 h) in triethyl amine containing a catalytic amount of 
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bis (triphenyl phosphine) palladium (II) dichloride and copper (I) iodide. The 
coupling product (XCII) gave a strong Q band at 680 nm and molecular ion at 
m/z 1039. The analogous reactions of (XCI) with 3 and 4 gave the 
corresponding steroid coupling products (XCIII) and (XCIV). 
Znrmtri(t-butvn4-(l 7a-ethvnvlestradiol) phthalocvanine(XCII): 
Yield : 75%, eluted with 15% ethyl acetate in toluene. 
UV-Vis : X max 680 nm. 
MS-FAB(NBA) : m/z 1039 (C64H6iN802Zn) 
Zn(intri(t-butvn4-a7a-ethynvltestosterone)phthalocvanine(XCIII): 
Yield : 60%, eluted with 10% ethyl acetate in toluene. 
UV-Vis : 91 max 681 nm. 
MS-FAB (NBA) : m/z 1055 (C65H65N802Zn) 
Zn(IIHri(t-butyn4-fl7a-ethvnvi-19-nor-testosterone)phthalocvanine 
(XCIV): 
Yield: 70%, eluted with 15% ethylacetate in toluene. 
UV-Vis :?. max 680.5 nm. 
MS-FAB (NBA) : m/z 1041 (C64H63N802Zn) 
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Reaction of Zn(Tn tri(t-butyn3-nodo^phthalocyanine (XCW) with 
17a-ethvnvlestradiol(2): Zincai)tri(t-butvl)3-(17a-ethvnvIestradion 
phthalocyanine (XCVD : 
We synthesized the 17a-ethynyl estradiol conjugated with (XCV) using 
the above reaction condition to yield adduct (XCVI), coupled at the 2-
position of the PC. The product (XCVI) showed absorption maximum at 691 
compared to 680 nm for the analogue 3-substituted adduct. 
Zinc(II)tri(t-butyI)3-a7a-ethvnvlestradiol)phthalocyanine(XCVI): 
Yield : 75%, eluted with 15% ethyl acetate in toluene. 
UV-Vis: ?i max 691.0 nm. 
MS-FAB (NBA) : m/z 1039 (C64H6iN802Zn). 
Reaction of 1.2 dicyano-4-iodobenzene (XCVII) with 17a-ethvnvl 
estradiol (2) : 17a-(4^-Ethvnvl l\2^-dicvanobenzene) estradiol 
iXCYIII}: 
To a solution of 240 mg (1 mmol) of 4-iodophthalonitrile (XCVII) in 
50 ml of THF, 17a-ethynylestradiol (2) 1.1 mmole equiv. triethylamine (2.0 
ml), 20 mg of copper (I) iodide and 50 mg of bis (triphenyl phosphine) 
palladium (II) dichloride were added under an atmosphere of nitrogen. The 
reaction mixture was stirred for 4 h. the mixture was filtered to separate 
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precipitated salt. The residue was extracted with ethylacetate and worked up in 
usual manner. The residue was purified by column chromatography. 
17a-(4'-Ethvnvl iM'-dicvanobenzene) estradiol (XCVIII) : 
Yield : 80%, elution with chloroform: acetonitrile (95:5). 
' H - N M R : 67.8 (s, Cl-H), 67.7 (s, C2-H), 67.4 (s, C4-H), 67.2 (d, J=8.6 Hz, 
IH, Cl'-H), 66.6 (dd, J=8.6 and 1.8 Hz, IH, C2'-H), 66.5 (d, J=1.8 Hz, C4'-
H), 60.95 (s,3H, CI3'-CH3). 
MS-FAB (NBA) : m/z 422, HRMS; 422.19 (exp.),(C28H26N202).. 
Reaction of 17a-(4^-ethvnvl 1^2^-dicvanobenzene)estradiol (XCVIII) 
with urea and Zn(OAc;>2 and of zinc (ITt 4. 4\ 4", 4'''-tetra kis 
(iodoVphthalocyanine (XCIX) with 17a-ethvnvl estradiol (2) : Zinc 
a n 4.4'.4'\4''Metra kis (17a-ethvnvlestradion phthalocvanine (C) : 
The products which we are getting by (XCVIII) and (XCIX) is same 
but we prepare this PC by different route. 17a-(4'-ethynyl-r, 2'-
dicyanobenzene) estradiol (XCVIII) (10 mg) and zinc acetate (300 mg), urea 
(500 mg) were heated at 200°C for 2 hours. After chromatography 
purification, the compound found similar in all respect as obtained by (XCIX). 
The compound (XCIX) with 17a-ethynyl estradiol (2) lead a substitution of 
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iodo to addition of steroid at 4, 4', 4", 4"' positions and it forms compound 
(C). 
ZincfID 4A\4"A'''-tttr2i kis(17a-ethvnvl estradiol) phthalocvanine 
Yield : 64%, eluted with 10% THF + 10% methanol in ethyl acetate. 
UV-Vis : X max 690.0 nm. 
MS-FAB (NBA) : m/z 1754 (Cii2Hio4N808Zn). 
Reactions of 2-(3-iodo) benzo (b)-lO. 19. 28-tri (14-dimethylethyn 
trinaphtho f2^ S'-g. r\ y\ \'.r'\ y"'S^ porphvrazinato zinc (II) 
(CD 2. 18-bis(3-iodo)dibenzo[b.Il-10. 26. did.l-dimetliyl ethyl) 
dinaphtho \2\ 3'-g. 1"\ y"-^\ porphvrazinato-zinc(II) (CIl) and of 
4,^  4 \ 4''-tris(3-iodo)tribenzo[b,g,lj-4''7ia di-methvl ethyl 
naphtho)[2'''. 3'''-gl porphvrazinato-zinc(II) (ClII) with 17a-ethvnvl 
estradiol (2) : 2-(3-17a-Ethvnvlestradiol)benzo(b)-10. 19. 28-tri(l.l-
dimethyl ethvl trinaphtho) t2\3^-g. 2"y\ 1 : 2"\ 3^"-gl 
porphyrazinato zinc (II) (Cla). 2. 18-bis(3-17a-
ethynylestradioDdihenzo lb.l]-10. 26-di(l.l-
dimethylethyl)dinaphthof2\3'-g.2^'\3^''-glporphvrazinato zinc (II) 
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fCIIa) and 4.4^4'MrisG-17a-ethvnvlestradion tribenzo [b.g,ll-4''' 
(1.1-dimethyIethyl naphtho^ \2'". 3^ ^^ -g1 porphvrazinato zinc (II) 
(Cllla): 
With the aim to develop a PC steroid adduct with a multiple choice of 
red-shifted excitation wavelength, PC analogues consisting both of phthalo 
and naphthalo moieties, were prepared. They feature spectral characteristic of 
both parent molecule resulting in composite spectra that vary in shift 
according to the number of naphthalene and benzene units. The 4-iodo-l, 2-
dicyanobenzene, 4-t-butyl 1, 2-dicyanonaphthalene in the presence of 
Zn(0Ac)2. 2H2O gave a complex reaction mixture consisting of mono to tetra 
iodo benzene units, as revealed by mass spectral analysis. Due to the difficulty 
in the purification, the mixture was coupled directly with 2. After completion 
of the reaction five products were clearly separated on T.L.C. using 5% THF, 
5% methanol in toluene as solvent. The same solvent system was used to 
purify products by silica gel column chromatography. The first fraction was 
identified as ZnNPC. The second fraction eluting with 5% THF, 5% CH3OH 
in toluene was identified as the mono-benzosteroid trinaphthalo (Cla). The 
compound gave a characteristic UV-Vis spectrum with bands at 759.5 and 
726.5 nm of almost equal intensity. The second fraction was identified as the 
dibenzosteroid dinaphtho adduct (Clla). The mass spectra confirms the 
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presence of two steroid moieties. The material consists of a mixture of cis and 
trans adductln the third fraction of the macromolecule contain three benzoid 
units and one of naphthalene. The adduct (Cllla) with a maximum at 721 and 
691 nm. The MS-FAB confirms the presence of three units of steroid moieties. 
2-G-17a-Ethvnvlestradionbenzo(b)-10J9,28-tri(ia-di-methvl ethyl) 
trinaphtho {2\ 3'-g 1:2^ \^ 3''^ -gl porphvrazinato zinc (11) (Cla): 
Yield : 60% eluted with 25% ethyl acetate in toluene. 
UV-Vis X max (relative intensity) : 759.5 (1), 726.5(0.96) nm. 
MS-FAB (NBA) : m/z 1190 (CveHegNgOiZn). 
2.18-Bis(3-17a-ethvnvIestradiondibenzofbX1-10.26-di (1,1 dimethyl 
ethyl) dinaphtho \r. 3 -^g. r'\ 3'''-g1 porphyrazinato zinc (IDtCIIa): 
Yield : 48%, eluted with 3% THF + 3% MeOH in toluene. 
UV-Vis : X max 724.044. 
MS-FAB (NBA) : m/z 1378 (C88H8oN804Zn) 
4A\4'' Tris(3-17a-ethynylestradiomribenzo[b, g, 1)-4'''(1, 1-
dimethyl ethynnaphthof2'''. 3^ ^^ -g| porphvrazinato-zinc (II) (Cllla): 
Yield : 40%, eluted with 5% THF + 5% MeOH in toluene. 
UV-Vis X max (relative intensity) : 721.0 (1), 691 (0.95) nm. 
MS-FAB (NBA) : m/z 1566 (CiooH92N806Zn). 
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THEORETTCAL 
Metallation reactions are very often the method of choice for the 
activation of relatively unreactive carbon hydrogen bonds. Especially 
interesting for this purpose is the application of transition metals as catalyst. 
The activation of olefmic , acetylenic and even intramolecular aromatic , 
C-H bonds is a key step of palladium catalyzed coupling reaction with vinyl 
and aryl halides. These well established reactions have been proven to be 
extremely useful for forming C-C bonds by dehydrohalogenation. Little 
information is available on the catalytic C-H activation at saturated alkyl and 
heteroalkyl groups, although such reaction could open up new and exciting 
synthetic pathways. 
It is true that many transition metals are now used in organic synthesis, 
but it is widely recognized that palladium is the most versatile in promoting or 
catalyzing reactions particularly those involving C-C bond formation. There 
are several characteristic feature of Pd-promoted or catalyzed reaction. Pd-
cataiyzed reaction can be carried out without protection of these functional 
groups. Pd-reagents and catalyst are not very sensitive to oxygen and moisture 
or even to acid. Of course Pd is a noble metal and expensive, but it is much 
less expensive than Rh, Pt and Os. The toxicity of Pd has posed no problem so 
far. In our synthesis two kinds of Pd compound namely Pd(II) salts and Pd(0) 
complexes are used. Pd(II) compounds are used either a stoichiometric 
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reagents or as catalyst Pd(II) compounds such as PdCli and Pd (0Ac)2 are 
commercially available and widely used as unique oxidants. As especially 
active Pd(0) catalyst can be prepared by a rapid reaction of Pd (OAc)2 with n-
BU3P in 1:1, ratio in THF or benzene. Pd(0) is d and has four coordination 
sites. Two complexes are commercially available Pd(Ph3P)4 is light sensitive, 
unstable in air, yellowish green, crystals and a co-ordinatively saturated Pd(0) 
complex. The complex is prepared from PdCl2(Ph3P)2 with various reducing 
4 5 6 
agents such as hydrazine or alkate metal alkoxide in the presence of Ph3P . 
W. G. Lioyd has reported the homogenous oxidation of alcohol with 
palladium (II) salts in which primary and secondary alcohols are smoothly 
oxidized to the corresponding acetals and ketones by palladium (II) salts under 
mild conditions, typically 70-120°. This reaction which becomes catalytic in 
the presence of oxygen and a reoxidant compound is retarded by the chloride 
ion and by more than small amounts of water. Tertiary alcohols do not react 
under these conditions. 
Pd i > • C R 
C R Pd 
X ^ H R ' X H R ' 
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Zen-ichi Yoshida and co-workers reported the palladium catalyzed 
oxidations of secondary alcohol making use of bromobenzene as an oxidant, 
where six kinds of alcohols have been oxidized to the corresponding ketones 
in excellent yield. 
(lOmmoI) 
(I) (II) 
Pd(PPh3)4 (0.08 mmol) 
K2CO3(10mmol) 
DMF (6 ml) 
(III) 
+PhH+HBr 
(95 % yield 
Zen-ichi Yoshida and co-workers have reported that the saturated and 
unsaturated secondary alcohols are oxidized to the corresponding ketones in 
good or excellent yields by using an aryl halide (phenyl bromide or mesityl 
bromide) as an oxidant and palladium (O) or II as a catalyst (0.6-3.0 mol % 
relative to alcohol) in the presence of a base (NaH or K2CO3). The similar 
oxidation of primary alcohols provides the corresponding aldehydes and / or 
esters. 
10 Jiro Tsuji and co-workers reported the treatment of alkyl allyl-
carbonates derived from various alcohols with a palladium catalyst in MeCN 
affords ketone and aldehyde in high yields. This new method of oxidation of 
alcohols can be applied to various alcohols except simple primary alcohols. 
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A=Pd-Phosphine free 
B=Pd-PPh3 
J. K. Stille and co-workers have reported the palladium-catalyzed 
coupling reaction of aryl triflate with alkyl, vinyl, acetylenic and aryl tin 
reagents in the presence of lithium chloride takes place in high yields under 
mild conditions. However, allyl trialkyl tin reagents coupled in lower yields 
and unselective transfer of the allyl group was observed. The aryl coupling 
reaction was applied to a synthesis of the quinoline alkaloid dubamine. The 
palladium catalyzed coupling of aryl triflates with hexamethylditin gave 
aryltrimethyl stannanes or homo coupled products depending on the amount of 
tin reagent. 
1) Effect of varying catalyst and reaction conditions on the coupling 
reaction. 
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.OSO2CF3 
(XI) W OTf 
O Pd(PPh3)4, LiCl 
Q/dioxane(98°C), 
(XII) 68h, 79 % 
N' 
(XIII) 
12 Gerald Dyker reported the palladium catalyzed C-H activation of 
methoxy groups as the key step in a cross coupling reaction of o-iodo 
methoxybenzenes with bromoolefms. By this method, substituted benzofurans 
are synthesized in moderate to good yields. 
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(XV) 
Terence N. Mitchell has reported palladium catalysed reaction 
involving organotin compounds are of rapidly increasing importance in 
organic synthesis. C-C bond formation via cross coupling reaction is of 
primary interest in view of the variety of functionalities which can be used. A 
variety of applications in natural product synthesis have been described and 
intramolecular reaction can be used for formation of small, medium and large 
rings. 
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(XVI) 
OTf 
SnBu 3 + Pd(PPh3)4 / LiCl 
(XVII) 
(XVIII) 
t-BuPhjSi 
(XIX) 
SnMe3+ I 
OSiPr-13 
Pd(PPh3)4 / THF^ 
90% 
(XX) OSi Pr-ij 
OSi Pr-ij 
BU4NF / THF 
Akira Suzuki and co-workers^'* reported the cross coupling reactions of 
9-alkyl-9-borabicyclo [3, 3, 1] nonane [9-R-9-BBN], 1-alkenyl-l, 3, 2-benzodi 
oxaborole, or aryl boronic acid with 1-alkenyl or aryl triflate in the presence of 
K3PO4 (1.5 equiv) and a catalytic amount of Pd(PPh3)4 or Cl2Pd(dppf) 
resulted in high yields. The reaction conditions are sufficiently mild so that a 
variety of functional ized alkenes, alkadienes and arenes are readily obtained. 
i'^( Ace. No > -
UmifW* ^ * l a 
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Vs W 
(XXIII) 
/ Pd-catalyst 
-OTf + R - B - ^ base ' 
/ Pd-catalyst 
OTf + R - B ^ r *• 
\ base 
Y. 
\ \ R 
(XXIV) 
(XXV) 
X 
(XXVI)\ 
R 
R = alkyl, 1-alkenyl, aryl 
\ / Bx, ^ 
(XXVII) 
Pd(PPh3)4 ^ 
3PO4, dioxane 
85 °C 
" % - B 
(XXVIII) 
T D — / V - B r l-9[Me02CCMe2(CH2)3]-9BBN/ ^ 
/ Pd(PPh3)4 / K3PO4 in dioxane 
165°C for 5h 2,9(C8H|7>9BBN / 85°C forS h 
(XXIX) 
CcH / / ^ 17 (CH2)3CMe2C02Me 
76% 
(XXX) 
15 L. Buchwald et al. has published the paper deaUng with finding on a 
trans amination / Pd-catalysis protocol which provides a fairly general and 
attractive route to arylamines. The PdCl2[P(o-tolyl)3]2 catalyzed reaction of 3-
bromoanisole with (N, N-diethylamino) tributyltin (toluene,105°C, 4 hr) 
afforded 3-(N,N-diethylamino) anisole (83%, isolated yield). 
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Ar purge,80°C 
BU3 Sn - NEt,+ HNRR' >• Buj Sn - NRR 
(XXXI) ^ -HNEt2 (XXXII) 
R! _ 
^ ' ' R 
\ \ / / "" (, / ^ N R R ' 
1-2.5 mole % Pd catalysis 
105°C ( » « " I ) 
Laszlo Kollar et al. reported the 17-iodo-A steroids undergo 
selective dimerization and carbonylative dimerization in the presence of 
palladium catalyst in the dimethylformamide which result in 16-17' coupled 
dienes and 17-carbox.ylic anhydrides respectively. 
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(XXXVI a) R = Me 
(XXXVI b) R = H 
(XXXVII a) R = Me, 
(XXXVII b) R = H 
N-R 
17 L. Buchwald et al. has reported new developed, a reasonably efficient 
protocol with which to convert aryl iodides to anilines. Thus significantly 
expanding our amination process. 
R 
(XXXVIII) 
•1 + HN(R)R' cat Pd2 (dba)3 
P (o-tolyl)3NaOtBu 
Dioxane65°Cor 100°C 
R' 
/ ^ N ( R ) R ' 
(XXXIX) 
18 Shiro Terashima and co-workers have prepared in an enantionerically 
pure form via the asymmetric palladium catalyzed bicycloannulation of the (3-
keto ester (XL) with 2-methylene-l, 3-propanediol diacetate. The chiral ferro 
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cenylphosphine ligand gave the highest enanetioselectivity of 64% in the 
asymmetric bicycloannulation (XLIII). 
OMe 
O^^ Pd(QAc)2, PPh3 ^ 
TMG, 1,4-dioxane 
O COsMe 
(XLI) 
02Me 
(XLII) 
NH2 
Me (XLIII) 
( Hyperzine A 
(+1) 
19 
L. Buchwald et al. pubhshed the paper dealing with a general 
procedure for palladium-catalyzed intramolecular carbon-nitrogen bond 
formation which proceed at room temperature and affords the desired product 
in good to excellent yields. 
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Me / ^ 
/ 
1+ HN 
(XLIV) 
0.5 mol % Pd2(dba)3 
BINAP 
NaOtBu, 18°C 
THF 
Me "X 
(XLV) 
85% 
20 Richard C. Larock and co-workers reported convenient palladium-
8 
alkyne annulation methodology, which offers useful routes to indoles , 
indenones , benzofurans and isocoumarins. 
'XH 
+ R, Ri 
cat. Pd(0) 
base 
(XLVI) 
Ri 
(XLVII) 
X=NR, O, CO,CO 
21 Bemhard Witulski et al. have reported that morpholinobenzenes with 
up to four N-morpholino groups have been synthesized efficiently from the 
corresponding bromobenzene via palladium catalyzed multiple aryl amination 
reaction. 
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Br" 
Br 
C ^) N N-H 
(XLIX) 
K 
(XLVIII) 
./N 
N 
Br 
N 
N N 
N- (L) 
N 
Br 
N^ 
// \ / \ N NH 
\ / ' 
(Lll) 
Br Br 
(LI) 
N N 
N- N 
(LIII) 
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Catalyst and Condition 
(I) Pd(dba)2 (2 mol%) P(o tolyl)3 (4 mol%), 3,6 eq, 19, 4.2 eq. NaOBu, 
toluene, 100°C, 2d 60%. 
(II) Pd2(dba)3[(l mole%) BINAP)] (3 mo]e%), 3.6 eq. NaOBu, toluene, 
100°C, Id, (98%). 
Br Br 
•'^ -^ x / - ^ ' 
Br ' " ^ Br 
o- o 
N N 
/ \ r=^ / \ 
O N—<\ / ^ N O \ / y ^ \ / 
•N N' 
O—^ ^—O 
(LV) 
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DISCUSSION 
Benzofuran derivatives are of interest because of their occurrence in 
22 23 
nature and for their physiological properties . Various methods are known 
for their synthesis ' ' ' and more recently efforts have centered around the 
use of palladium catalyst for C-C bond formation leading to the benzofliran 25 
structure . A number of estrogen derivatives have been reported as 
26 biologically active molecules for the treatments of various type of disease . In 
connection with our studies in the field of biologically active steroidal 
12 
molecule which could be of use as anticancer and antiviral agent, we 
attempted to synthesize estrogen analogue containing such moieties. 
H3CO 
^Br 
(LIX) H,C 
Rl 
(LVI) I 
(LVII) I 
(LVIII) H 
R2 
H 
H 
1 
E3 
0 
/OH 
R 
(LX) 0 
( L X I ) ^ O H 
\H 
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(LXVI) 
(LXVII) 
(LXVIII) 
(LXIX) 
(LXX) 
X 
Br 
H 
H 
H 
H 
Y 
H 
H 
Br 
Br 
H 
R 
O 
O 
/ O H 
\ H 
O 
/OH 
(LXXI) O 
/ O H 
(Lxxn)<f 
^ H 
H 
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Reaction of 2-iodo-3-methoxy estrone (LVI) with l-bromo-2 
niethylpropene-l(LIXh2-2'-Methylprop-r-ene-3-methoxy estrone(LX), 
3^-isopropyl-2,3 benzofuran estrone (LXII), 2-bromo-3-methoxv estrone 
(LXVD. 3-methoxy estrone TLXVID and estrone fLXXD. 
2-Iodo-3-methoxy estrone (LVI) was dissolved in DMF. n-Tetrabutyl 
ammoniun bromide, an excess of potassium carbonate as a base and 
Pd(0Ac)2 as catalyst, were added and reaction mixture was heated at 90-
100°C for 24-30 h under nitrogen atmosphere. After usual workup, the 
reaction mixture was purified by silica gel column chromatography. 
Analytically pure samples were obtained using reverse phase column 
chromatography (HPLC methanol: water, 85:15). From the reaction mixture 
of 2-iodo-3-methoxy estrone (LVI) five products (LX), (LXII), (LXVI), 
(LXVII) and (LXXI) were isolated which have been characterized on the basis 
of MS, HRMS and ' H - N M R . 
Characterization of the compounds : 
2-2^-Methyl prop-r-ene-3-methoxy estrone (LX) : 
Compound was eluted at Rt = 26 min. The mass spectrum gave a molecular 
ion at m/z 338 which coiTesponds to (LX) which is formed by the substitution 
of 2'-methylprop-l'-ene for iodine moiety and H-NMR gave two singlets at 
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57.1, 86.57 for C4-H and Cl-H confirming the presence of 2'-methylprop-r-
ene moiety at C-2 position. 
Compound as 3'-isopropyl-2,3-benzofuran estrone (LXII) : 
The MS of the compound ekited at Rt = 19.0 min, gave a peak at m/z 336 
which corresponds to the cychsed product (LXII) leading to benzofuran ring 
moiety. H-NMR gave singlets at 57.49, 57.2 for C4-H and Cl-H respectively, 
which confirms the presence of benzofuran ring between C-2 and C-3 
positions. The singlet corresponding to O-CH3 group was absent suggesting an 
involvement of the group during the cyclization . 
Compound as 2-bronio-3-methoxy estrone (LXVI) : 
Compound was eluted at Rt = 18 min. The mass spectrum showed peaks at 
m/z 362 and 364 with almost equal intensity suggests the presence of bromine 
atom and this was further supported by HRMS 362.0873 for Ci9H23Br02. H-
NMR revealed singlets for C4-H and Cl-H at 57.4 and 56.6 which established 
the presence of bromine atom at C-2 position and singlet for O-CH3 protons at 
64.1 confirming the structure of compound (LXVI). 
Compound as 3-methoxy estrone (LXVII) : 
Compound eluted at Rt == 16 min, gave a peak at m/z 284 in the MS 
spectrum, this confirms compound (LXVII) as 3-methoxy estrone. 
Compound as estrone (LXXI) : 
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Compound eluted at Rt = 10 min and its MS shows peak at m/z 270 
corresponds to the estrone (LXXI) which was further substainatiated on 
comparison its physical properties to an authentic sample (mp, TLC and 
' H - N M R ) . 
Reaction of 2-iodo-3-methoxy estradiol (LVII) with l-bromo-2-methyl 
prop-1-ene (LIX) ; 2-2'-Methvl prop-l^-ene-3-methoxy estradiol (LXI), 3'-
isopropyl-2.3 benzofuran estradiol (LXIII). 3-methoxy estradiol (LXX). 3-
methoxy estrone (LXVII) and estradiol TLXXID . 
Under the above reaction conditions gave required benzofuran 
derivative in the A-ring (LXIII) along with the other products (LXI), (LXVII), 
(LXX) and (LXXIl). Surprisingly from the reaction mixture, products 
containing the 17-keto group were also obtained along with normal 17-
alcohol. However this is not unusual in the sense that such type of 
7 9 10 
transformation has already been reported in palladium chemistry ' ' . 
Characterization of compounds: 
Compound as 2-2^-methvl prop-l^-ene-3-methoxy estradiol (LXI) : 
Compound eluted at Rt = 27.81 min and the MS spectrum shows m/z at 
340 confirming the presence of 2' methyl prop-l'-ene moiety attached with 3-
methoxy estradiol and H-NMR spectrum shows singlets for C4-H at 67.1 and 
for Cl-H at 56.6 confirming the presence of moiety at C-2 position and singlet 
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for exocyclic vinylic proton at 66.2 confirming the presence of double bond at 
C-l' position and one singlet for -OCH3 at 63.7 confirming the presence of-
OCH3 at C-3 position and singlet for 17-OH proton at 63.5 and two singlets 
for6-CH3 protons at 6I.8 and 51.6 and singlet for CI3-CH3 at 60.8. 
Compound as 3'-isopropyl-2.,3 benzofuran estradiol (LXIII) : 
Compound eluted at Rt = 41.87 min and MS spectrum gave a 
molecular ion peak at m/z 338, confirming the presence of cyclised ring 
leading to benzofuran with attached isopropyl moiety. H-NMR spectrum 
revealed that singlets for C4-H at 67.4 and for Cl-H at 67.2 confirming the 
presence of cyclised ring at C-2 and C-3 positions and one singlet for 
endocyclic vinylic proton at 67.0 confirming the presence of double bond at 
C2' position and singlet for 17-OH proton at 63.7 and two singlets for two 
CH3 at 61.3 and at 61.2 confirming the presence of isopropyl group at C3' and 
singlet for CI3-CH3 at 60.9. 
Compound as 3-methoxy estradiol (LXX) : 
Compound eluted at Rt = 16.90 min and MS-spectrum gave a 
molecular ion peak at m/z 286 which confirms the presence of methoxy group 
containing compound and H-NMR gave singlets for C4-H at 67.2 , C2-H at 
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87.0 and for Cl-H at 56.8, confirming the presence of methoxy group at C-3 
position. One singlet for -OCH3 at 54.3 confirming position at C-3. 
Compound as 3-methoxy estrone (LXVII) : 
Compound eluted at Rt ^ 12.86 min and MS spectrum gave a peak at 
m/z 284, this confirms the conversion of 17-alcohol to ketone, which has been 
7 9 10 1 
reported earlier ' ' , H-NMR also revealed that singlets for C4-H at 67.3, C2-
H at 57.1 and for Cl-H at 66.9 confirming the presence of-OCH3 at C-3 
position, but no peak for 17-OH proton, this confirms above structure. 
Estradiol rLXXID : 
Compound eluted at Rt = 8.60 min and MS spectrum shows peak at 
m/z 272, this corresponds to estradiol compound and H-NMR shows singlets 
for C4-H at 67.1, C2-H at 66.9, Cl-H at 66.6 and for -OH-proton at 66.3 
which established the structure (LXXII) and singlet for 17-OH proton at 64.5 
and singlet for C-13-CH3 at 61.0. 
Reaction of 4-iodo-3-methoxy estradiol (LVIII) with l-bromo-2-methyl 
prop-1-ene (LIX) : 3-Mettioxv-4-2^-metiivlprop-r-ene estradiol TLXIV), 
3Msopropyl-3,4-benzofuran estradiol (LXV), 3-methoxy 4-bromo 
estradiol (LXVIID and 3-methoxy-4-bromo estrone (LXIX). 
Characterization of compounds : 
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Compound as 3-methoxy-4-2^-methyl prop-r-ene estradiol (LXIV) : 
Compound eluted at Rt = 26 min and MS spectrum shows m/z 340 
confirmed the presence of 2'-methyl-r-propene moiety. H-NMR shows the 
doublets for C2-H and Cl-H at 57.2 and 56.7 with J=6.4 Hz, confirming the 
attachment of the moiety at C-4 position. The appearance of a singlet at 56.3 is 
due to exocyclic vinylic proton and 3-methoxy protons shows singlet at 63.8 
and singlet for 17-OH proton at 53.6. This corresponds to the structure 
(LXIV). 
Compound as 3Msopropvl-3,4-benzofuran estradiol (LXV): 
The MS of the compound eluted at Rt = 22.0 min. gave a peak at m/z 
338 confirming the presence of cyclised ring leading to benzofuran ring. H-
NMR spectrum gave two doublets for C2-H at 57.2 and Cl-H at 57.0 
confirming the presence of benzofuran ring at C3-C4 positions and singlet 
peak for endocychc vinylic proton at 56.8. this confirms the presence of 
double bond in benzofuran ring between C2'-C3'positions, and singlet for 17-
OH proton at 54.1 and singlets for 6-isopropyl methyl proton at 51.6 and 51.4 
is obtained. 
3-Methoxy-4-bromo estradiol (LXVIII) : 
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Compound eluted at Rt = 26.69 min, and MS spectrum shows peaks at 
m/z 364 and 366 with almost equal intensity suggests the presence of bromine 
atom and this was further supported by HRMS 364.1029 for Ci9H2502Br and 
' H - N M R revealed that singlets for C2-H at 57.1 and for Cl-H at 66.8, which 
established the presence of bromine atom at C-4 position and one singlet for 
-OCH3 at 54.6 confirmed this above structure. 
Compound as 3-methoxy-4-bronio estrone (LXIX) : 
Compound eluted at Rt = 22.60 min and MS spectrum shows peak at 
m/z 362 and 364 with almost equal intensity suggesting the presence of 
bromine atom and H-NMR spectrum revealed that singlets for C2-H at 57.2 
and for Cl-H at 66.8 confirming the presence of bromine atom at C-4 position 
and singlet for -OCH3 at 64.1 confirms the presence of -OCH3 at C-3 
position, but no peak is found for 17-OH group and one singlet for C13 -CH3 
at 60.9. 
A tentative mechanism for the formation of these compounds is 
given below : 
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H,CO 
H,CO 
Mechanism (LX) and (LXID 
O 
(LXXI) 
(LXVII) 
H,(X) 
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(LXII) 
Formation of (LXVD. (LXVID and (LXXD 
X = H 
or 
n-t-Bu NH4 
(LXXI) 
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H3CO 
H,CO 
H,CO 
(LXX) 
(LXXII) H3CO j Br (LXVIII) 
Formation of (LXI), (LXIII), (LXVIII), (LXX) and (LXIV), (LXV), (LXVIII), 
(LXIX) and (LXXII) can be explained on the basis of similar steps involved in 
the formation of (LX), (LXII), (LXVI), (LXVII) and (LXXI). It has been 
reported that during palladium catalysed reaction a secondary alcohol is 
9 
converted to ketone . 
Chapter - 2(A)| Synthesis Of Benzofuran Derivatives Of Estradiol Analogues I Page. 97 I 
EXPERIMENTAL 
General: Reagents and solvents were obtained commercially (Aldrich or 
Fisher) and were of the highest chemical grade available. Thin layer 
chromatography (TLC) was carried out on pre-coated silica plates containing 
fluorescent indicator (UV 254 nm), crude reaction mixtures were purified by 
column chromatography on 60 - 200 mesh silica gel and on HPLC in 
methanol and water. H-NMR spectra were recorded on a Bruker AC 300 (300 
MHz) in CDCI3 or DMF-d^ solution. Chemical shifts are referenced to the 
residual solvent signal (CDCI3 5=7.26). High and low resolution mass spectra 
(HRMS, MS) were determined with a VG micromas model ZAB-IF apparatus 
at 70 eV ionization voltage. 
Coupling of 2-iodo-3-methoxy estrone (LVI) with l-bromo-2-methyl 
prop-1-ene (LIX) ; 2-2^-Metliyl prop-r-ene-3-methoxy estrone (LX), 3'-
isopropyl-2.3-benzofuran estrone (LXII). 2-bronio-3-methoxy estrone 
rLXVn. 3-methoxy estrone (LXVID and estrone fLXXD. 
Reaction of 2-iodo-3-methoxy estrone (LVI) (264 mg; 0.644 m mol) 
with l-bromo-2-methyl-l-propene (LIX) (1.35 gm; 10 m mol) in DMF (10 
ml) was added, n-tetrabutyl ammonium bromide (645 mg; 2 m mol), an excess 
of potassium carbonate (1.1 gm; 8.0 m mol) as a base, Pd(0Ac)2 (22.0 mg; 
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0.10 m mol) as catalyst and heated at 90-100°C for 24-30 h under nitrogen 
atmosphere. After usual work up, the reaction mixture was purified by silica 
gel column chromatography and a number of products were isolated. 
Analytically pure compounds (LX, LXll, LXVI, LXVII and LXXI) were 
obtained using reverse phase column chromatography (HPLC methanol: 
water, 85:15). 
2-2^-Methyl prop-r-ene-3-methoxy estrone (LX): Rt = 26.0 min (methanol 
: water, 85:15), (35 mg), m.p. 150° 
Analysis Found : C, 81.5; H, 8.85 
C23H30O2 requires : C, 81.6; H, 8.87 % 
IR : Vmax 1745 (>C=0), 1665 (>C=C<), 1240 cm"' (C-0) 
^H-NMR : 67.1 (s, IH, C4-H), 6.55 (s, IH, Cl-H), 6.27 (s, IH, Cl'-H 
exocyclic vinyl proton), 3.8 (s, 3H, -OCH3), 1.91 and 1.90 (s, 3H each, C2' -
methyl protons). 0.80 (C13 - CH3). 
Mass : m/z 338 (M+), HRMS : 338.2254 (exp.) 
3Msopropyl-2- 3-benzofuran estrone (LXII): Rt == 19.0 min. (methanol : 
water, 85:15), (70 mg), m.p. 80°. 
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Analysis Found : C, 82.05; H, 8.31 
C23H28O2 requires : C, 82.1; H, 8.33% 
IR : Vmax 1740 (>C-0), 1100-1080 cm'' (=C-0-C=) 
'H-NMR : 5 7.49 (s, IH, C4-H), 7.2 (s, IH, Cl-H), 7.1 (s, IH, C2'-H), 1.35, 
1.2 (s, 3H each, methyl protons of isopropyl group), 0.85 (CI3-CH3). 
Mass : m/z 336 (M+), HRMS : 336.1740 (exp.) 
2-Bronio-3-methoxy estrone (LXVI): Rt = 18.0 min, (methanol : water, 
85:15), (40 mg),(m.p. 180°) 
Analysis Found : C,62.85; H, 6.32 
Ci9H2302Br requires : C, 62.9; H, 6.35% 
IR : Vmax 1744 (>C=0), 1245 (-O-CH3), 665 cm"' (C-Br) 
*H-NMR : 67.4 (s, IH, C4-H), 6.6 (s, IH, Cl-H), 4.1 (s, 3H, -OCH3), 0.90 
(CI3-CH3). 
Mass : m/z 362/364 (M+), HRMS : 362.0873 (exp.) 
3-Methoxv estrone (LXVID; (Rt = 16.0 min, methanol : water, 85:15), (35 
mg) (Oil). 
Analysis Found : C, 80.23; H, 8.43 
C,9H2402 requires : C, 80.28; H, 8.45% 
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IR : Vn,ax 1745 (>C=0), 1240 (-O-CH3). 
' H - N M R : 57.1 (s, IH, C4-H), 67.0 (s, IH, C2-H), 56.8 (s. IH, Cl-H), 4.5 (s, 
3H,-OCH3 ), 50.8(C13-CH3). 
Mass : m/z 284 (M+). 
Compound as estrone (LXXI) : (Rt == 10.0 min, methanol : water, 85:15), 
(30.mg), m.p. and m.m.p. 260-261) 
Analysis Found : C, 79.8%; H, 8.11 (m/z 270; M+) 
C18H22O2 requires : C, 80.0; H, 8.14% 
TLC, IR, ' H - N M R and Mass of the compound (LXXI) were found identical 
with the authentic sample of estrone. 
Reaction of 2-iodo-3-methoxy estradiol (LVII) with l-bronio-2 methyl 
prop-1-ene TLIX) : 2-2'-Methvl prop-l'-ene -3-methoxv estradiol (LXI), 
3Msopropvl-2-3-benzofuran estradiol (LXIII), 3-methoxy estradiol 
rLXX). 3-methoxy estrone fLXVID and estradiol (LXXID. 
Reaction under the above conditions gave required benzofuran 
derivative in the A-ring (LXIII) alongwith the other products (LXI), (LXX) 
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and estradiol (LXXII). Surprisingly from the reaction mixture, products 
containing the 17-keto group were also obtained along with the normal 17-
alcohol. However this is not unusual in the sense that such type of 
7 9 10 
transformation has already been reported in palladium chemistry ' ' . 
2-2^-methvl prop-r-ene-3-niethoxv estradiol (LXI): (Rt = 27.81 min, 
methanol : water, 85:15 ), (40 mg), (Oil). 
Analysis Found : C, 81.05; H, 9.40 
C23H32O2 requires : C, 81.1; H, 9.41% 
IR : Vmax 3590 - 3495 (-0H), 1655 (>C=C<), 1240 cm"' (O-CH3). 
' H - N M R : 67.1 (s, IH, C4-H), 6.6 (s, IH, Cl-H), 6.2 (s, IH. exocyclic vinylic 
proton), 3.7 (s, 3H, -OCH3 ), 3.5 (s, IH, C17-0H), 1.8, 1.6 (s, 3H each, of two 
methyl at C2'), 0.8 (CI3-CH3). 
Mass : m/z 340 (M+) 
3'-Isopropvl-2-3-benzofuran estradiol (LXIII): (Rt = 41.87 min, methanol : 
water, 85:15), (80 mg), (Oil). 
Analysis Found : C, 81.55; H, 8.83 
C23H30O2 requires : C, 81.6; H, 8.87% 
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IR : v„,ax 3595-3480 (OH), 1105-1075 (-C-0-C=) 
*H-NMR: 57.4 (s, IH, C4-H), 7.2 (s, IH, Cl-H), 7.0 (s, IH, endocyclic vinyl 
proton), 3.7 (s, IH, C17-0H), 1.3, 1.2 (s, 3H, each, methyl protons of 
isopropyl group), 0.9 (CI3-CH3) 
Mass : m/z 338 (M+) 
3-Methoxv estradiol (LXX): (Rt = 16.90 min, methanol : water, 85:15), (35 
mg), (Oil). 
Analysis Found : C, 79.6; H, 9.05 
C,9H2602 requires C, 79.7; H, 9.09% 
IR : Vn,ax 3585-3490 (OH), 1235 cm"' (-OCH3) 
'H-NMR : 57.2 (s, IH, C4-H), 7.0 (s, IH. C2-H), 6.8 (s, IH, Cl-H), 4.3 (s, 
3H,-OCH3), 0.7(C13-CH3) 
Mass : m/z 286 (Mf) 
3-Methoxv estrone fLXVlI): (Rt= 12.86 min, methanol : water, 85:15), (30 
mg), (Oil). 
Analysis Found : C, 80.23; H, 8.43 
C19H24O2 (m/z 284, M+) requires : C, 80.28; H, 8.45% 
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TLC, IR, ' H - N M R and mass spectral data were found identical with same 
compound i.e. 3-methoxy estrone (LXVII) found earlier, This confirms the 
conversion of C17-0H to ketone.^ "'^ ''^  
Estradiol TLXXID: ( Rt = 8.60 min, methanol : water, 85:15), (35 mg), (m.p. 
andm.m.p 178-179°).^^ 
Analysis Found : C, 79.40; H, 8.80 
C18H24O2 (m/z 272, M+) requires : C, 79.41; H. 8.82% 
TLC, IR, ' H - N M R and Mass spectral data were found identical with the 
authentic sample of estradiol. 
Reaction of 4-ioclo-3-methoxy estradiol (LVIII) with l-bromo-2 methyl 
prop-1-ene fLIX) : 3-Methoxy-4-2'-prop-r-ene estradiol (LXIV). 3'-
isopropyl-3-4-benzofuran estradiol (LXV). 3-methoxy-4-bromo estradiol 
(LXVIID and 3-methoxy-4-bromo estrone (LXIX .^ 
This reaction is carried out in the same conditions as above and 
afforded compounds (LXIV). (LXV), (LXVllI) and (LXIX). 
3-Methoxv-4-2' methyl prop-l'-ene estradiol (LXIV): ( Rt - 26.0 mm, 
methanol : water, 85:15), (45 mg), (Oil). 
Analysis Found : C, 81.05; H. 9.65 
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C23H32O2 requires : C, 81.1; H, 9.70% 
IR : Vniax 3595-3490 (OH), 1635 (>C=C<), 1230 (-OCH3). 
' H - N M R : 57.2 (d, j-6.4 Hz, IH, C2-H), 6.7 (d, j= 6.4 Hz. IH. Cl-H), 6.3 (s, 
IH, exocyclic vinyl proton at CI'), 3.8 (s, 3H. -OCH3), 3.6 (s, IH, C17-0H), 
1.5 and 1.4 (s, 3H each, methyl protons at C2'), 0.70 (CI3-CH3). 
Mass : m/z 340 (M+), HRMS : 340.2397 (exp.j 
3^-Isopropyl-3-4-benzofuran estradiol (LXV); ( Rt = 20.0 min, methanol : 
water, 85:15), (76 mg), (Oil). 
Analysis Found : C, 81.58; H, 8.5 
C23H30O2 requires : C, 81.6; H, 8.87% 
IR : Vmax 3595-3490 (-0H). 1100-1070 cm"' (=C-0-C=) 
'H-NMR : 57.2 (d, j - 7 Hz, IH, C2-H), 7.0 ( d , j - 7Hz, IH, Cl-H), 6.8 (s, IH, 
endocyclic vinyl proton). 4.1 (s, IH, C17-0H), 1.6 and 1.4 (s, 3H each, methyl 
protons of isopropyl group), 0.75 (CI3-CH3) 
Mass : m/z 338(M+) 
I Chapter - 2(A)| Synthesis Of Benzofuran Derivatives Of Estradiol Analogues I Page. 105 i 
3-Methoxy-4-bromo estradiol (LXVllI): ( Rt = 26.69 min, methanol : water, 
85: 15), (55 mg). (Oil). 
Analysis Found : C. 62,61; H, 6.84 
CigUisOiBv requires : C, 62.6; H, 6.86% 
IR : 3590-3495 (-0H). 1250(-OCH3), 665 cm' (C-Br) 
' H - N M R : 57.1 (s, IH, C2-H), 6.8 (s. IH, Cl-H), 4.6 (s, 3H, -OCH3), 3.8 (s, 
lH,C17-OH), 0.70(C13-CH;) 
Mass ; m/z 364/366 (M+), HRMS : 364.1029 (exp.) 
3-Methoxy-4-bromo estrone (LXIX): ( Rt = 22.60 min, methanol : water, 
85:15), (43 mg), (Oil). 
Analysis Found : C, 62.88; H. 6.33 
Ci9H2302Br requires : C. 62.9; H, 6.35% 
IR : Vmax 1740 (>C=0), 1240 (-OCH3), 660 cm"' (C-Br). 
' H - N M R : 57.2 (s, IH, C2-H), 6.8 (s, IH, Cl-H), 4.1 (s, 3H, -OCH3), 0.9 
(CI3-CH3). 
Mass: m/z 362/364 (iVH) 
(Chapter-2(A)| Synthesis Of Benzoruran Derivatives Of Estradiol Analogues I Page. 106 I 
REFERENCES 
1. R. F. Heck, Org. Read; (N.Y.), 27, 345 (1982) 
2. S. Takahashi, ^'. Kuroyama. K. Sonogashiraand N. Hagihara, 
Synthesis; 627 (1980). 
3. G. Bringmann, R. Waller and R. Weirich, Angew Chem, Int. Ed. Engl; 
29,977(1990). 
4. D.R. Coulson, Inorg. Synth; 13, 121 (1972). 
5. P. Roffia. G. Gregori^^ F. Conte and G. F. Pregaglia, J. Mol. Catal; 2, 
191 (1977). 
6. M. loelc. G. Oriaggi. M. Scarsella and G. Sletter, Polyhedron; 10, 2475 
(1991). 
7. W. G. Lloyd, J. Org. Chem; 32, 281 (1967). 
8. Y. Tamaru, .^' Yamamoto, Y. Yamada, and Z. Ichi Yoshida, 
Tetrahedron Letters; 16. 1401 (1979). 
9. Y. Tamaru, Y. Yamada, K. Inoue, Y. Yamamoto and Z. Ichi Yoshida, 
J. Org. Chem;-18. 1286(1983). 
10. J. Tsuji. I. MiiKimi and I. Shimizu, Tetrahedron Letters; 25, 2791 
(1984). 
11. A. M. Echavancn and J. K. Stille, J. Am. Chem. Soc; 109, 5478 
(1987). 
12. G. Dvker, J. Org. Chem; 58, 6426 (1993). 
iChapter - 2(A)j Synthesis Of Benzofuran Derivatives Of Estradiol Analogues | Page. 107 I 
13. T. N. Mitchell, Synthesis; 803, (1992). 
14. T. Oh-e, N. Miyaura and A.Suzuki, J. Org. Chem; 58, 2201 (1993). 
15. A. S.Guram and S. L. Buchwald, J. Am. Chem. Soc; 116, 7901 (1994). 
16. R. S. Foldes, 7. Csakai, L. KoUar, G. Szalontai, J. Horvath and Z. 
Tuba. Steroids; 60. 786 (1995). 
17. J. P. Wolfe and S. L. Buchwald, J. Org. Chem; 61, 113 (1996). 
18. S. Kancko, T. Yoshino, T. Katoh and S. Terashima, Tetrahedron; 8, 
829(1997). 
19. J. P. Wolfe and S. L. Buchwald, J. Org. Chem; 62, 6066 (1997). 
20. R. C. Larock and Q. Tian, J. Org. Chem; 63, 2002 (1998). 
21. B. Witulski, S. Senft and A. Thum, Synlett Lett; 505 (1998). 
22. W. Karrcr. in Clicmische reine, 12, birkhauser base! (1958). 
23. P. Cagniant and D, Cagniant, Adv. Heterocycl. Chem; 18, 337 (1957). 
24a. N. Ci. Kundu, f.. N. Chaudhary and S. K. Dasgupta, J. Chem. Soc. 
Perkin Trans-I; 'S:2(1990). 
24b. N. G. Kundu, B. Das, C.P. Spears, A. Majumdar and S. 1. Kang, J. 
Med. Chem; 33. 1975(1990). 
24c. N. G. Kundu an ! I,. N. Chaudhary. J. Chem. Soc; Perkin Trans-I; 1677 
(1991). 
25. D. M. X. Donnelly and M. J. Meegan; In Comprehensive heterocyclic 
I Chapter - 2(A)j Synthesis Of Benzofuran Derivatives Of Estradiol Analogues I Page. 1081 
chemistry, Vol. 4, 657-712 ed., A. R. Katratzky and C. W. Recs. 
Pergamon, Oxf( rd, 1984. 
26. R. Clarock and 1). Estinn, Tetrahedron Letters; 29, 4687 (1988). 
27. Bhatt and Kulknn.i, Synthesis; 24 (1983). 
28. L. F. Ficscr anc' M. Ficser, Steroids, Reinhold Publishing Corporation 
New \\)i-k; 463. 466 (1959). 
' 'x 
CHAPTER - 2 CB) 
\^ 
Chapter-2(B) Synthesis Of Palladium Catalyzed Aromatic Heterocyclic 
Estradiol Derivatives 
Page 109 
THEORETICAT. 
The transition metal mediated cycloaddition reactions of alkynes are of 
great current interest . While palladium is among the most widely studied 
2a b 
metals for such processes ' , multiple alkyne insertion, or insertion and 
subsequent cyclization back onto a preexisting aromatic ring usually 
predominates. Since the palladium complexes are readily available, generally 
not oxygen or moisture sensitive and accomodate a number of different 
3 
functional group . We now report that the chemistry provides a valuable new 
route to a wide variety of heterocycles including benzoflirans, benzopyrrole, 
Indenone and isocoumarins. 
Indenones are useful intermediate in the synthesis of a variety of 
4a b 
molecules including C-nor-D-homosteroid ring system ' , photochromic 
indenone oxide , 2, 4-and 3, 4-disubstituted-l-naphthols , gibberellins , 
8 9 
indanones and indenes . Indenones themselves have also been used as 
alcoholic fermantation activators , fungicides and potential estrogen 
binding receptors . Although tradiational indenone syntheses have largely 
relied upon Friedal-Crafts type cyclization and the addition of Grignard 
reagent to 2-substituted indandiones. A number of organometallic approaches 
utilizing alkynes have been reported over the last few years. These approaches 
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tend to stoichiometric in the metal and/or use carbon mono oxide to form the 
carbonyl group of the indenone, many different metal complexes have been 
employed including nickel , rhodium , iron , manganese and 
„ ,. 13,17,18, 
palladium 
Indole or benzopyrrole nucleus is prevalent in a wide variety of 
biologically active naturally occurring compounds and numerous approaches 
to their synthesis have been reported including many employing transition 
metal '^ , particularly palladium *' . Our interest in the palladium catalyzed 
21 22 a b c 
annulation of 1,2-dienes , 1,3-dienes ' ' ' and unsaturated cyclopropanes 
23 
and cyclobutane encouraged us to examine analogue alkyne chemistry for 
24 
the synthesis of benzofuran, isocoumarins . 
The prepration of organo-phosphorus compound has attracted enduring 
interest because of their biological and physical properties as well as their 
25 
Utility as synthetic intermediate . Among phosphorous containing derivatives 
phosphonate plays an important role. Indeed the stability of the phosphonate 
linkage to enzymatic hydrolysis allows to use them as complements of 
phosphate in biologically active compounds. Phosphonates have been found to 
act as antibiotics '^ ''^ ' , antisense inhibitors of gene expression in 
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28 29 
mammalian cells , antiviral agent and in the area of agriculture chemistry as 
27 27 29 27 30 
insecticides , fungicides ' , herbicides ' and growth regulator 
30 
31 P. Vermeer et al. has published the paper dealing with the reaction of 
17-a ethynyl steroid with phenyl zinc chloride which gives mainly the 
antiproduct in the presence of Pd-catalyst, antistereo selectivity was observed 
AcO 
+ PhZnCl 
Pd (Ph3P)4 
80% 
,Ph 
MeO 
in the reaction of (R)-(-)-l-a. 
32 B. Pietroni and co-workers have reported the synthesis of the 
steroidal-acetoxylenic ester (V) formed by this reaction, undergoes the 
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hydroarylation of the triple bond, with aryl iodide and formic acid to give 
lactone (VI). 
HO .c= 
+ CO + M e O H ^ ' ^ ^ 
CuClj, 84% 
w // I, HC02H, BU3N 
Pd (0Ac)2, (0-tol)3P 
CO^Me 
M. Nilsson and co-workers reported the treatment of o-iodophenols 
with ethyl propiolate in the presence of copper (I) tert-butoxide affords 
isocoumestam (6H-benzofiiro[2,3-c] [1] benzopyran-6-one) in a one pot 
synthesis, the reaction is considered to be an extended castro cyclization 
where an intermediate cupriated benzofuran couples with additional 
o-iodophenol and the product lactonizes to isocoumestan. 
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(VII) 
+ H ^ COOEt 
tBu O Cu, Pyridine 
DME; reflux 2h 
(a) 79 % ; (b) 72 % 
R 
R 
(Villa) H 
(VIII b) tert-Bu 
34 
Castro et al. have shown a cross couphng of 2-iodo phenol with 
copper acetyHdes giving 2-hydroxy aryl acetylenes, which cyclize to 
benzoflirans . 
R- -I + Cu-w // 
( I ^ OH r^ 
0° 
W // -OH 
R 
-COOEt 
COOEt 
R 
(Xa) H 
(Xb) tert-Bu 
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35 
Richard C. Larock and co-workers published the paper dealing with a 
new approach to indoles involving the palladium-catalyzed heteroannulation 
of internal alkynes using o-iodo aniline and its derivative. 
= CR. 
5 mol% Pd(0Ac)2 
[5 mol% PPhj] 
1 equiv MCI 
(M=nBu4N,Li) 
5 eqiv. base 
100OC,DMF 
(XII) 
Hiroshi Yamanaka et al. reported the synthesis of 
ethoxyethynylarenes (XIV) by the palladium-catalyzed cross coupling 
reaction of aryl iodide (XIII) and ethoxy (tributylstannyl) acetylene. The 
ethoxyethynyl arenes (XIV) were easily hydrated to ethyl areneacetates (XV). 
Bu3SnC = C0Et 
Arl *• ArC; COEt-
H2SO4 
(XIII) Pd(PPh3)2Cl2 Et4NCl, DMF (XIV) 
H2O, Me2C0 
reflux 
ArCH2 COOEt 
(XV) 
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37 
R.C. Larock et al. have reported the two general procedures for the 
annulation of internal alkyne by o-iodo or o-bromobenzaldehyde, the use of 
which depends on the alkyne under going annulation : 
O 
H^ + 2 Rr 
Procedure 
-R2 » • 
AorB 
X 
(XVI) 
(XVII) 
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38 L. Kollar and co-workers have reported direct and carbonylative 
coupling reactions of various steroid derivatives possessing iodo and bromo-
alkenyl moiety (17-iodo androst-16-ene (XXII), 1.17-bromoandrost-2, 16-
diene (XXIII), 17-iodo-4-aza-4- methylandrost -16-en-3-one (XXIV) and 17-
iodo-4-aza androst-16-en-3-one (XXV) with vinyltributyl stannane and 
ethyltributyl stannane in the presence of various palladium catalysts. 
CH=CSnBu3 
(XXII), (XXIV), (XXV) : X = I 
(XXIII) : X = Br 
Pd(PPh3), 
(XXVI) 
CH ^ CSnBu3;C0^ 
Pd(PPh3)4 
(XXVII 
24 R.C. Larock et al. have published the paper dealing with a new route 
to a wide variety of heterocycles, including 1,2-dihydroisoquinoline, 
benzofurans, benzopyrans and isocoumarins. Their result is summarized in 
table. 
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S.No. Aryl iodide (equiv.) Alkyne Chloride source Product 
base (equiv.)PPh3 
temp, f C) time(4) 
Isolated 
Yield 
1. 
2. 
P h C ^ CC02Et(2) 
NHAc (XXIX) 
I 
(XXVIII) 
(XXVIII) 
LiCl, KOAc, 
-10(P 
PhC^Ph 
(XXIX) 
nBu4NCl, KOAc, 
120°.24h 
80% 
83% 
(XXX b) Ph 
(XXVIII) 
(XXVIII) 
P h C = CMe nBu4NCl, NajCOj 
(XXIX) 100°, 48 h 
-OH 
P h C = CCHO LiCl, NaOAc, 
(XXIX) 100°, 24 h 
t BuC= CMe nBu4NCl, Na2C03 
(XXXII) 100°, 24 h 
62% 
(XXX d) 
CHO 
O 
(XXXI) 
.OH 
(9) 
(13) 
^BuC^ CMe iiBu4NCl,K0Ac 
(XXXII) 100°, 24 h 
Ac I Ac' 
(XXXTV) 
COzMe 
^BuC^ CMe LiCl, NajCOj 
pCXXn) 100°, 24 h 
I 
(XXXVI) 
(XXXIII) 
o 
Bu 
Me 
66% 
Bu 
75% 
(XXXV) \ Me 
O 
72% 
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(XXXVIII) 
NHR, 
+ R3C = CR3 
I (XXXIX) 
cat Pd(0) 
base 
R, 
N 
(XL) 
Ri 
^R"! 
39 S. Cacchi et al. have reported the palladium-catalysed vinylic 
substitution of vinyl triflates with diethylvinyl phosphonate to afford the 
corresponding conjugate dienyl phosphonates. 
o Pd(0Ac)2 
base I v base ^^^^V"^^^^^-^^ 
•^  > OTf + \ s / P—OEt ->- ^ - ^ 
/ ^ DMF, 80 C 
p 
P OEt 
(XLI) 
ROTf + Ph 
(XLIV) 
OEt 
O (XLII) 
/ ^ V - N o E t "^ ^^ ^^ ^^  
OEt 
(XLV) 
O 
ROTf + % p 
-OMe 
MeOOC 
(XLIV) OMe 
(XL VII) 
KOAc 
DMF, St? C 
48h 
Pd2dba3 
DMF, 6(f C 
2h 
R 
OEt 
(XLIII) 
R 
Ph 
tEO — P = 0 
OEt 
9 (XLVI) 
-OMe 
OMe 
COOMe 
(XL VIII) 
40 J.W Guiles et al. reported the resin bound aryl boronic acid reagent 
(XLIX) with alkyne gave this compounds. 
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o 
?X o 
(XLIX) 
PdCl2(dPPf) 
HO 
+(iPr-0)2B^(CH2)3CH3 
W // (L) 
-0. 
/ 
o 
^-(CH2)3CH3 
(LI) 
R. C. Larock et al.'*^  have published the paper deahng with the presence 
of a palladium catalyst, internal alkynes undergo carboannulation by cyclic 
and a cyclic vinylic iodides and triflates bearing a neighbouring aromatic ring 
to produce a variety of carbocycles. For example, a number of 9,10-
disubstituted-l,2,3,4-tetrahydrophenanthrene have been prepared in good 
yield through the palladium catalyzed annulation of internal alkynes by 2-
phenyl-1-cyclo-hexenyltriflate or l-iodo-2-phenyl cyclohexene (LII). This 
annulation process is fairly general and highly regioselective. The process 
appears involve oxidative addition of the vinylic substrate to Pd(o) to produce 
a vinylic palladium intermediates. 
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+ P h ^ P h 
2% Pd(0Ac)2 
4% PPhj 
EtjN, CH3NO2 
100°C, 2days 
•XH 
base 
X = NR, O, CO, CO2 
(LIV) 
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DISCUSSION 
Palladium catalysed annulation reactions of alkynes are of eminence for 
1 42 
the synthesis of variety of hetero and carbocyclic ring system ' . Recently 
palladium-alkyne annulation reaction offered useful and convenient route to 
mdoles , Denzoiurans , benzopyrans , mdenones and isocoumanns . 
Estrogen analogues containing such moieties could be of use as anticancer 
and antiviral agent. An attempt has been made to synthesize such steroidal 
molecules. 
HO 
R2 
(LVI) -C = C-H H 
(LVII) -C = C-CfiHs H 
(LVIII)H I OH 
I 
(LXV) C^ Hg 
(LXVI)H3C-[CH2t3 OH 
C2H5O 
(LX) R^=H 
(LXI) R^  = c H s 
(LXII) R4 = H // 
(LXm)R4 = C6H5 // 
(LXIV) R4 = H 6 
(LXVII) 
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Reactions of 17a-ethvnvl estradiol (LVD with o-iodo phenol, o-
iodoaniline. o-iodobenzaldehyde and with o-iodo-methyl ester : 17oc^  
Benzofuranestradiol (LTX). 17a-benzopvrroleestradiol (LX). 17a-
indenoneestradiol (LXTD and 17(x-isocoumarinestradiol (LXIV). 
Reactions of 17a-ethynyl estradiol (LVI) with o-iodo (phenol, aniline, 
benzaldehyde and methyl ester), dissolved in DMF, added triethylamine, 
P(PPh3)2 PdCli and Cul in o-iodophenol and K2CO3 (anhydrous) as a base, 
LiCl, Pd(0Ac)2 were added in case of o-iodo aniline and Na OAc as a base 
and n-tetrabutyl ammonium chloride, Pd(0Ac)2 were added in 
o-iodobenzaldehyde and in case of o-iodo-methyl ester, triphenyl phosphine 
and excess of sodium carbonate as a base, Pd(0Ac)2 as catalyst, heated at 90-
100°C for 24-30 hr under nitrogen atmosphere. 
After usual workup, the reaction mixture was purified on silica gel 
column chromatography and products were isolated, analytically pure samples 
were obtained using reverse phase column chromatography (HPLC methanol : 
water) (85:15) in case of o-iodo-aniline and o-iodo-methylester and ratio of 
(methanol :water) (80:20) in case of o-iodo phenol and o-iodobenzaldehyde 
and finally gave the four products (LIX), (LX), (LXII) and (LXIV) 
respectively. 
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Characterization of the compounds : 
17a-Benzofuran estradiol (LIX): 
Compound eluted at Rt = 11.21 min, was assigned as compound (LIX) 
from its spectral properties. The mass spectrum gave a molecular ion peak at 
m/z 388, corresponds to the substitution of iodine leads to benzofuran ring and 
this was fiirther supported by HRMS 388.2032 (exp.) and 'H-NMR^^'"*^ gave 
doublets for C4'-H at 67.5 J-8.1 Hz, C5'-H at 67.1, J=7.6 Hz, C6'-H at 67.2, 
J=8.0 Hz, for C7'-H at 67.4, J=7.8 Hz and a singlet at 6 6.5 for C3'-H, this 
confirms the structure of above compound as (LIX). 
Compound as 17a-benzopyrrole estradiol (LX): 
Compound eluted at Rt = 19.95 min. and the MS-spectrum shows a 
peak at m/z 387 which confirms the presence of benzopyrrole ring moiety 
attached at 17a-position of estradiol and this was further supported by HRMS 
387.296 (exp.) gives the composition of C26H29NO2 in the mass spectrum. H-
NMR''^  gave a singlet at 66.0 for C3'-proton of benzopyrrole ring. The 
structure has been confirmed on the mass spectrum required two endocyclic 
vinylic proton, one in benzopyrrole ring another one in five membered ring of 
estrone skeleton, but since H-NMR, we are getting one singlet for endocyclic 
vinylic proton, which is already decided for endocyclic benzopyrrole ring 
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proton. It seems that during electron impact, in the process of mass spectral 
analysis tertiary hydroxy group of estradiol is eliminated as water molecule 
leading to structure (LX), and doublets for C4'-H at 67.6 J=8.0 Hz, C5'-H at 
87.0, J=7.5 Hz, C6'-H at 57.2, J=8.4 Hz and for C7'-H at 57.4, J=8.0 Hz and 
broad singlet for N-H proton at 5 6.58 confirming the benzopyrrole ring in 
above structure. 
Compound as 17a-indenoneestradiol (LXII) : 
Compound eluted at Rt = 20.15 min and the MS-spectrum gave a 
molecular ion peak at m/z 400 which corresponds to cyclised ring leading to 
compound (LXII) and this was further supported by HRMS 400.204 (exp) and 
'H-NMR^^ gave doublets for C4'-H at 67.7, J=8.0 Hz, C5'-H at 57.0, J=7.8 
Hz, C6'-H at 67.2, J=8.2 Hz and for CT-H at 67.4, J=7.5 Hz and singlet for 
C3'-proton at 56.3. these above data correspond to structure (LXII). 
Compound as 17a-isocoumarinestradiol (LXIV): 
Compound eluted at Rt = 11.90 min and the mass spectrum shows peak 
at m/z 416 which corresponds to the cyclised ring structure leading to 
compound (LXIV) and 'H-NMR'*^''''''''* spectrum shows doublets for C8'-H at 
57.8, J=7.2 Hz, C7'-H at 57.2, J=7.4 Hz, C6'-H at 67.4, J=8.2 Hz and for C5'-
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H at 57.5, J=7.9 Hz and singlet for C3'-proton at 86.6 confirming the above 
structure as (LXIV). 
Reactions of 2^-17a-ethvnylestradiol benzene (LVII) with o-iodo (aniline 
and benzaldehyde) ; 2^-17a-Benzopyrrole estradiol benzene (LXI) and 1'-
17a-indenone estradiol benzene (LXIII). 
Reactions of 2'-17a-ethynyl estradiol benzene (LVII) with o-iodo 
aniline, benzaldehyde dissolved in DMF and triethylamine and P(Ph3)2PdCl2 
and Cul were added in o-iodo aniline and K2CO3 (anhydrous) as a base, LiCl 
and Pd(0Ac)2 were added in case of o-iodobenzaldehyde. After the 
completion of reaction, reaction mixture was work up as usual and purified by 
silica gel column chromatography and products were isolated, analytically 
pure samples were obtained using reverse phase column chromatography 
HPLC methanol: water, (85:15) in case of (LXI) and ratio of methanol : water 
(75:25) in case of (LXIII) and finally gave the compound (LXI) and (LXII) 
respectively. 
Characterization of compounds : 
Compound as 2^-17a-Benzopvrrole estradiol benzene (LXI) : 
Compound eluted at Rt = 10.07 min and mass spectrum shows peak at 
m/z 463 which corresponds to cyclised ring leading to benzopyrrole ring 
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moiety attached with phenyl group at 17a- of estradiol compound and H-
NMR spectrum gave a cluster of peaks in aromatic region from 56.5 to 57.5 
accounting for nine aromatic protons confirming the presence of one more 
benzene ring is attached in the cyclised part of molecule and one broad singlet 
for N-H proton at 56.2 confirming the above structure (LXI). 
Compound as 2^-17a-indenone estradiol benzene (LXIII) : 
Compound eluted at Rt = 19.0 min and mass spectrum shows peak at 
m/z 476, this corresponds to compound (LXIII) and H-NMR spectrum shows 
the cluster of peaks in aromatic region from 56.4 to 57.7 accounting for nine 
aromatic protons. This confirms the presence of one more benzene ring is 
attached in the cyclised part of the molecule and this is further supported by 
the fact that there is no singlet peak for C3'-proton around 56.3, these data are 
for structure of compound (LXIII). 
Reactions of 2-iodo estradiol (LVIII) with phenyl acetylene. 1-
hexyne and with diethyl phosphite : 2^-Phenvl-2-3-furan estra-17 P-
ol (LXV^. 2'-n-butane-2-3 furan estra-17 P-ol (LXVI), diethyl 
estradiol-2-yl phosphonate (LXVID. 
Dissolved in DMF and added triethylamine as base and dichlorobis 
triphenyl phosphine palladium (II) and copper iodide in phenyl acetylene and 
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same reagents were added in case of 1-hexyne and diethyl phosphite. After 
usual work up the reaction mixture was purified on silica gel column 
chromatography and products were isolated, analytically pure samples were 
obtained using reverse phase column chromatography (HPLC methanol : 
water, 75:25) in case of (LXVII), (80:20) in case of (LXV) and (90:10) in case 
of (LXVI). Finally we are getting (LXV), (LXVI) and (LXVII) compounds 
respectively. 
Characterization of the compounds : 
2'-Phenvl 2-3 furan estra-17 p-ol (LXV) : 
Compound eluted at Rt = 10.05 min and MS spectrum shows peak at 
m/z 372, this corresponds to cyclised ring leading to furan with phenyl 
attached with estra-17P- ol (LXV). H-NMR spectrum revealed that singlets 
for C4-H at 67.2 and for Cl-H at 67.0 and broad singlet comprising for C6H5 
at 66.7, this confirms the presence of cyclised ring at C-2 , C-3 positions and 
one phenyl group is also attached. One singlet for C3'-proton at 56.5, 
corresponding the above structure as (LXV). 
2'-n-Butane-2-3 furan estra-17 P-ol (LXVI) : 
Compound eluted at Rt = 32.70 min and MS spectrum shows molecular 
ion peak at m/z 352, which corresponds to cyclised ring leading to compound 
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(LXVI), and it has been further supported by HUMS 352.2411 (exp) and H-
NMR spectrum gave singlets for C4-H at 87.3 and for Cl-H at 57.0 
confirming the presence of cycHsed ring at C-2', C-3' positionsand one singlet 
for C3'-proton at 56.2, these data correspond to compound (LXVI). 
Diethyl estradiol-2-yl phosphonate TLXVID : 
Compound eluted at Rt = 13.5 min and MS spectrum shows molecular 
ion peak at m/z 408 which corresponds to uncyclised ring leading to structure 
(LXVII) and this was further supported by HRMS 408.2077 (exp) and ' H -
NMR spectrum revealed that singlets for C4-H at 57.2 and C3-0H proton at 
56.8 and for Cl-H at 56.5 confirming the presence of diethyl phosphonate 
40 
moiety is at C-2 position, such type of work has been reported . These data 
confirms the structure of compound (LXVII). 
A Tentative mechanism may be written for the formation of 
compounds. 
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Formation of TLXD and (LXITTt: 
OH ^ 
oC^ C-C5H5 
H O 
(LVII) 
OH ^'^' 
.c=c 
OH ^CeHs 
„c=c: 
N' 
I 
H 
(LXI) 
Similar steps may be written for compound (LXIII). 
Formation of (LXIV>. (LXV> and (LXVD 
(LVI) 
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HO 
HCEC-fCH2lTCH3 + 
I 
(LXVI) 
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EXPERIMENTAL 
General: Reagent and solvents were obtained commercially (Aldrich or 
Fischer) and were of the highest chemical grade available. Thin layer 
chromatography (TLC) was carried out on pre-coated silica plates containing 
fluorescent indicator (UV 254 nm) Crude reaction mixture were purified by 
column chromatography on 60 - 200 mesh silica gel and on HPLC in 
methanol and water. H-NMR spectra were recorded on a Bruker AC 300 (300 
MHz) in CDCI3 or DMF-d7 solution. Chemical shifts are referenced to the 
residual solvent signal (CDCI3 57.26). High and low resolution mass spectra 
(HRMS, MS) were determined with a VG micromas model ZAB-IF apparatus 
at 70 eV ionization voltage. 
General procedure for the reactions of 17a-ethynyl estradiol (LVI) 
with o-iodo (phenol, aniline, benzaldehyde and methyl ester) : 17a-
Benzofuran estradiol (LIX). 17(X-benzopyrrole estradiol (LX), 17a-
indenone estradiol (LXID and 17a-isocoumarin estradiol (LXIV). 
Reaction of 17a-ethynyl estradiol (LVI), (100 mg; 0.337 mol) with 
o-iodo phenol (73.0 mg; 0.331mmol) dissolved in DMF (10 ml), triethylamine 
(2.0 ml) and P (Ph3)2 PdC^ (20 mg; 0.030 mmol) and Cul (25.0 mg; 0.135 
mmol) were added and with o-iodo aniline (73.0 mg; 0.333 mmol), K2CO3 
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(anhydrous) (15.0 mg; 0.110 mmol) as a base and LiCl (5.0 mg; 0.121 mmol) 
and Pd(0Ac)2 (20 mg; 0.095 mmol) were added and with o-iodo 
benzaldehyde (73.0 mg; 0.314 mmol), Na OAc as a base and n-tetrabutyl 
ammonium chloride (50 mg; 0.454 mmol) and Pd(0Ac)2 (20.0 mg; 0.095 
mmol) as a catalyst were added and with o-iodo methyl ester (73.0 mg; 0.278 
mmol), triphenyl phosphine (25.0 mg; 0.095 mmol) in excess and as a catalyst 
Pd(0Ac)2 (20 mg; 0.095 mmol) and excess of sodium carbonate (40.0 mg; 
0.377 mmol ) as a base, heated at 90-100 °C for 20-24 hours under nitrogen 
atmosphere, this gave the compounds (LIX), (LX), (LXll) and (LXIV) 
respectively. 
17a-Benzofuran estradiol (LIX) ; (Rt = 11.2 min, methanol : water, 
85:15), (80 mg),(m.p. 120°). 
Analysis Found : C, 84.0; H, 7.10 
C26H28O3 requires : C, 84.01; H, 7.21% 
IR : v a^x 3585-3330 (C17-0H, C3-0H), 1660 (>C=C<), 1235 cm"' (=C-0-C=) 
' H - N M R : 67.5 (d, j=8.1, IH, C4'-H), 57.10 (d, j=7.6 Hz, IH, C5'-H), 67.2 (d, 
j=8.0 Hz, IH, C6'-H), 67.4 (d, j=7.8 Hz, IH, C7'-H), 6.5(s, C3'-proton), 6.11 
(s, IH, phenolic -OH), 4.2 (s, IH, C17-0H), 0.85 (CI3-CH3). 
Mass : m/z 388 (M+), HRMS : 388.2032 (exp.) 
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17a-Benzopyrrole estradiol (LX) : (Rt = 19.5 min, methanol : water, 
85:15), (75 mg),(m.p.220°C) 
Analysis Found : C, 80.58; H, 7.47 
C26H29NO2 requires : C, 80.6; H, 7.49% 
IR : Vn,ax 3590-3340 (C3-0H, C17-0H andN-H), 1665 cm' (>C=C<). 
' H - N M R : 57.6 (d, j=8.0 Hz, IH, C4'-H), 67.0 (d, j=8.4 Hz, IH, C5'-H), 57.2 
(d, j=7.5 Hz, C6'-H), 57.4 (d, j=8.0 Hz, IH, CT-H), 6.58 (brs, IH, -NH), 6.0 
(s, IH, C3'-proton), 6.3 (s, IH, phenolic -OH), 4.1 (s, IH, C17-0H), 0.8 
(CI3-CH3). 
Mass : m/z 387 (M+), HRMS : 387.2960 (exp.) 
17a-Indenone estradiol (LXII) : ( Rt = 20.15 min, methanol : water, 
85:15), (65 mg),(m.p. 115°) 
Analysis Found : C, 80.88; H, 7.1 
C27H28O3 requires : C, 81.0; H, 7.0% 
IR : Vn,ax 3580-3350 (C3-0H and C17-0H), 1700 (>C=0), 1640 cm"'(>C=C<) 
' H - N M R : 67.7 (d, j=8.0 Hz, IH, C4'-H), 67.0 (d, j=7.8 Hz, IH, C5'-H), 57.2 
(d, j=8.2, IH, C6'-H), 57.4 (d, j=7.5, C7'-H), 66.3 (s, IH, C3'-H), 56.0 (s, IH, 
phenolic -OH), 53.9 (s, IH, C17-0H), 0.9 (CI3-CH3). 
Mass : m/z 400 (M+), HRMS : 400.2044 (exp.) 
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17a-Isocoumarin estradiol (LXIV) : (Rt = 11.90 min, methanol : water, 
85:15), (73 mg),(m.p. 110°) 
Analysis Found : C, 75.98; H, 6.72 
C27H28O4 requires : C, 76.0; H, 6.73% 
IR : Vmax 3575-3360 (C3-0H and C17-0H), 1720(>C=O), 1635 (>C-C<), 
1240-1105 cm''(C-0), 
' H - N M R : 67.8 (d, j=7.2 Hz, IH, C8'-H), 7.2 (d, j=7.4 Hz, IH, C7'-H), 7.4 (d, 
j=8.2 Hz, IH, C6'-H), 7.5 (d, j=7.9 Hz, IH, C5'-H), 6.6 (s, IH, C3'-H), 6.2 (s, 
IH, phenolic -OH), 4.0 (s, IH, C17-0H), 0.90 (CI3-CH3). 
Mass : m/z 416 (M+), 416.1979 (exp.) 
Reactions of 2^-17a-ethvnvl estradiol benzene (LVII) with o-iodo 
(aniline, benzaldehyde) : 2^-17a-Benzopvrrole estradiol benzene 
(LXD and 2^-17a-indenone estradiol benzene (LXIII). 
Reaction of 2-17a-ethynyl estradiol benzene (LVII) (100 mg; 0.268 
mmol) with o-iodo aniline (73 mg; 0.333 mmol ) dissolved in DMF (10 ml), 
K2CO3 anhydrous (15.0 mg; 0.110 mmol) as a base and LiCl (5.0 mg; 0.121 
mmol) and Pd(0Ac)2 (20 mg; 0.095 mmol) were added, under nitrogen 
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atmosphere, gave compound (LXI) and in case o-iodo benzaldehyde (73 mg; 
0.314 mmol), Na OAc as a base and n-tetrabutyl ammonium chloride 
(50mg; 0.454mmol) and Pd(0Ac)2 (20mg; 0.095mmol) were added 
corresponding to product (LXIII). After usual work up the reaction mixture 
was purified on silica gel column chromatography and products were isolated, 
analytically pure samples were obtained using reverse phase column 
chromatography (HPLC, methanol: water, 85:15) in case (LXI), and (75:25) in 
case of LXIII. 
2^-17a-Benzopvrrole estradiol benzene (LXI) : (Rt = 10.07 min, 
methanol: water, 85:15), (85 mg), (Oil). 
Analysis Found : C, 82.85; H, 7.10 
C32H33O2N requires : C, 82.9; H, 7.12% 
IR : Vn,ax 3570-3350 (C3-0H, C17-0H and -N-H), 1660 cm"'(C=C) 
' H - N M R : 57.5-6.5 (Cluster of peaks for nine aromatic protons), 56.2 (brs, 
IH, N-H), 56.1 (s, IH, phenolic -OH), 3.8 (C17-0H), 50.85 (CI3-CH3). 
Mass : m/z 463 (M+) 
2^-17a-Indenone estradiol benzene (LXIII) : (Rt = 19.0 min, methanol : 
water, 85:15), (75 mg), (Oil). 
Analysis Found : C, 83.17; H, 6.50 
C33H32O3 requires : C, 83.19; H, 6.51% 
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IR : Vmax 3585-3345 (C3-0H and C17-0H), 1690 (C=0), 1630 cm"' (>C=C<) 
' H - N M R : 57.7-6.4 (Cluster of peaks of nine aromatic protons), 6.1 (s, IH, 
phenolic -OH), 3.9 (s, IH, C17-0H), 0.9 (CI3-CH3). 
Mass : m/z 476 (M+). 
Reactions of 2-iodo estradiol (LVIID with phenyl acetylene. 1-
hexyne and with diethyl phosphite : 2^-phenvl-2-3-furanestra-17P-ol 
(LXV^. 2'-n-butane 2-3-furanestra-17p-ol (LXVW diethvlestradiol-
2-yl phosphonate. 
The reaction of 2-iodo estradiol (39.8 mg; 0.1 mmol) (LVlll) when 
reacted with phenyl acetylene (20 fil), triethyl amine (1.0 ml) as a base and 
P(Ph3)2PdCl2 (5.0 mg; 0.0076 mmol) and copper iodide (3.8 mg; 0.024 mmol) 
were added and in case of 1-hexyne (25 |il) same reagents were added to 
obtain compounds (LXV), (LXVI) respectively. Same reagents were used in 
case of diethyl phosphite (0.2 ml) to get (LXVII). After usual work up the 
reaction mixture was purified on silica gel column chromatography and 
products were isolated. Analytically pure samples were obtained using reverse 
phase column chromatography (HPLC, methanol : water) (75:25) in case of 
(LXVII) and (80:20) in case of (LXV) and (90:10) in case of (LXVI). 
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2'-Phenvl 2-3 furan estra-17p-ol (LXV) : (Rt = 10.05 min, methanol : 
water, 80:20), (30 mg), (m.p. 180°) 
Analysis Found : C, 83.75; H, 7.50 
C26H28O2 requires : C, 83.8; H, 7.52% 
IR : Vn,ax 3510-3490 (C17-0H), 1655 (>C=C<) 1105-1075 (=C-0-C=) 
' H - N M R : 87.2 (s, IH, C4-H), 7.0 (s, IH, Cl-H), 6.7 (brs, phenyl protons at 
C2'), 6.5 (s, IH, C3'-H) 
Mass : m/z 372 (M+), HRMS : 372.2097 (exp.) 
2'-n-Butane-2-3 furan estra 17p-ol (LVD : (Rt = 32.70 min, methanol ; 
water, 90:10), (25 mg), (m.p. 110°) 
Analysis Found : C, 81.82; H, 9.08 
C24H32O2 requires : C, 81.8; H, 9.09% 
IR : Vmax 3505-3495 (C17-0H), 1645 (>C=C<), 1095-1070 cm"'(=C-0-C=) 
' H - N M R : 57.3 (s, IH, C4-H), 7.0 (s, IH, Cl-H), 6.2 (s, IH, C3'-H) 2.5-1.0 
(methyl and methylene protons of H3C-[CH2]3- group at C2'), 0.9 (CI3-CH3). 
Mass : m/z 352 (M+), HRMS : 352.2411 (exp.) 
Diethyl estradiol-2-yl phosphonate (LXVID : (Rt = 13.5 min, methanol : 
water, 75:25), (30 mg), (m.p. 190°) 
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Analysis Found : C, 64.65; H, 8.06 
C22H33O5P requires : C, 64.7; H, 8.08% 
IR : v„,ax 3500-3490 (C3-0H and C17-0H), 1275 (-P=0), 1050 cm"'(P-0-) 
' H - N M R : 67.2 (s, IH, C4-H), 6.8 (s, IH, C3-0H), 6.5 (s, IH, Cl-H), 3.85 (s, 
C17-0H), 2.5-1.5 (mc, lOH, 0=P-(OC2H5)2 at C2), 0.90 (CI3-CH3) 
Mass : m/z 408 (M+), HRMS : 408.2077 (exp.) 
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THEORETICAL 
In recent years, much efforts are being applied by chemists in 
synthesizing such organic compounds which must possess high degree of 
biological activities. Synthesizing any useful organic compound is easier than 
to isolate the same from natural resources. Many organic compounds 
particularly those steroids having additional rings containing heteroatoms such 
as oxygen, nitrogen and sulphur, were found to be potent biologically active 
agents. 
SpirothiazoHdinones have been recognised an important biologically 
active agents " with varied degree of effects and often quite pronounced. The 
active of these is actithiazic acid, an antibiotic which was isolated from a 
species of streptomyces and found to show a high, specific in vitro activity 
4 5 
against M. tuberculosis ' . Degradation and synthesis have shown that the 
compound which has been named as actithiazic acid to be (-)2-(5-
carboxypenthyl)-4-thiazolidinone. Derivatives of thiazolidines in which there 
is a carbonyl group at 4 position are termed as thiazolidinones. 
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H-Ni 
H2C2 
S' 
( I ) 
5CH2 
^ According to Pennington et al. , reaction under reflux of benzaldehyde 
with mercaptoacetamide ammonium carbonate in dry benzene under 
dehydrating conditions gave the spirothiazolidinone (II) 
O 
C6H5CH=0 + HSCH2 - C - NH2 ^— CgHsCH 
S ^ C H 2 
/ 
\ 
N — C = 0 
I 
H 
(11) 
J Later on Surrey et al. synthesized a number of 2-substituted-4-
thiazolidinones (IV) by heating a mixture of any appropriate aldehyde or 
ketone (III) with mercaptoacetic acid and ammonium salts such as ammonium 
carbonate or acetate. 
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RCH = 0 + HS - CH2 - COOH + NH3 
(III) 
- 2H2O 
H 
N - C = 0 
S-CH2 
(IV) 
y Steroidal thiazolidinones too exhibit some degree of biological activity. 
Paryzek and kielczewski prepared isomeric thiazolidinones (VI), (VII), (IX) 
and (X) from 5a-cholestan-3-one (V) and its 5(3 epimer (VIII). 2-Pentyl 
substituted ketone (XI) also behaved in similar manner. 
H ijCs 
(XI) (XII) (XIII) 
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In the case of less reactive ketones such as 5a-cholestan-4-one (XIV), 
5a-cholestan-6-one (XVII) and 3P-hydroxyandrost-5-en-17-one-acetate (XX) 
a modification of the above method was made and ammonia gas was passed 
through a boiling solution of the ketone and P-mercaptoacetic acid in benzene. 
In the last case only one isomer (XXI) was formed. The other exception in 
which only one product was formed is 5(3-cholestan-7-one (XXII). 
(XVI) 
H 
O 
(XVII) 
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AcO 
(XX) (XXI) 
( XXIII) 
3P-Acetoxy-5a-cholestan-6-one (XXIV) when treated with (3-
mercaptoacetic acid in the presence of ammonium carbonate, only one 
thiazoHdinone (XXV) was obtained in addition to unreacted substrate and its 
hydrolysed product 3P-hydroxy-5a-cholestan-6-one. Using the ammonia gas 
AcO AcO 
( XXIV ) 
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method both the expected isomers (XXV) and (XXVI) were obtained. 
In order to study the spectral correlations of different derivatives of 
isomers (VI) and (VII); alkyl, aryl or acyl substituents were incorporated at 
nitrogen of the thiazolidinone rings . Alkylation or acylation of isomer (VII) 
was easily possible. The yields were appreciable (60-90%). The alkylated or 
acylated products were obtained in pure form, even the bulkier groups could 
be substituted. 
Table ^ 1 
CgHn 
3'-Substituted-S-spiro 
(5a-cholestane-3', 2')-
thiazolidinone-4' 
( V I ) 
( X X V I I ) 
( XXXIII) 
R 
H 
CH3 
CH3CO 
3'-Substituted-R-
(5a-cholestane-3' 
thiazolidinone-4' 
( V I I ) 
( XXVIII) 
( XXIX ) 
( X X X ) 
( X X X I ) 
( XXXII ) 
( XXXIV ) 
( X X X V ) 
( X X X V I ) 
spiro 
,2')-
R 
H 
CH3 
C2H5 
n-C4H9 
C6H5CH2 
C6H5 
CH3CO 
C2H5CO 
CfiHgCO 
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On the other hand alkylation or acylation of isomer (VI) proved very 
difficult. Methyl derivative XXVII could be obtained in pure form whereas 
bulkier groups like ethyl or n-butyl could not be substituted easily and gave 
mixtures of isomers, separation of which could not be achieved by 
chromatography or by crystallization. Similarly acetyl derivative (XXXIIl) 
was obtained in poor yield (15%) in contrast to acetyl (XXXIV), propionyl 
(XXXV) and benzoyl (XXXVI) derivatives which were obtained in 70-90% 
yield. Propionyl and benzoyl derivatives of VI could not be prepared even in 
very low yield. 
The explanation for above observations is that, in case of isomer (VI) 
due to the steric hindrance caused by a-axial hydrogen of the steroidal ring A 
the introduction of substituents is prevented and isomerization is faster than 
alkylation or acylation, in case of isomer (VII) site of reaction is not hindered 
by a-hydrogen, making the reaction much facile and reactions with bulkier 
reagents such as propionic anhydride, benzoyl anhydride also, accomplished 
successfiilly. 
The IR spectra of unsubstituted thiazolidinones showed the absorption 
bands corresponding to stretching vibrations of N-H bond and stretching 
vibrations of the carbonyl group, which are characteristic of free and 
8-12 
associated lactam group . Association due to NH group is a general 
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phenomenon. In CCI4 the association is more pronounced, therefore, the 
intensity of the band corresponding to stretching vibrations of free NH group 
is lower, whereas the shape and intensity of bands corresponding to vibrations 
of associated NH group are very similar to those are observed in the solid 
state. Parkzey and Kielczewski ' evaluated the ratio of intensities of 
associated and free NH group which are given in table 2. 
Table-2 
Compound 
(VI) 
(VII) 
(IX) 
(X) 
(XII) 
(XIII) 
(XV) 
(XVI) 
(XVIII) 
(XIX) 
Configuration 
of CN bond 
E (P) 
A (a) 
A(P) 
E (a) 
E(P) 
A (a) 
A(P) 
E (a) 
A ((3) 
E (a) 
VN-H 
free 
3420 
3430 
3433 
3425 
3422 
3432 
3448 
3420 
3444 
3421 
VN-H 
assoc 
3200 
3200 
3200 
3200 
3200 
3200 
3200 
3200 
3200 
3200 
'^ NHassoc 
'^ NHfree 
0.37 
0.27 
0.55 
0.18 
0.32 
0.29 
0.03 
0.20 
0.03 
0.51 
c=o 
1683 
1682 
1684 
1688 
1685 
1684 
1687 
1684 
1682 
1682 
C-N 
1416 
1408 
1407 
1417 
1418 
1409 
1406 
1416 
1403 
1414 
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(XXIII) 
(XXV) 
(XXVI) 
A ( a ) 
E ( P ) 
A ( P ) 
E (a) 
Page 
3435 
3422 
3445 
3418 
3200 
3200 
3200 
3200 
0.44 
0.45 
0.07 
0.48 
1685 
1680 
1690 
1688 
152 
1406 
1416 
1408 
1415 
E = equatorial, A = axial. 
Comparison of the values of absorption bands of free NH group in the 
individual pairs of thiazolidinones, having different configuration at spirane 
carbon atom helped in the assignment of orientation of C-N and C-S bonds. 
Bathochromical shift by about 10 cm" of N-H band vibrations was observed 
in the isomers containing equatorial C spirane N bond. The band concerning 
C=0 stretching vibrations was found between 1680-1690 cm" and no 
noticeable difference was observed in the carbonyl frequencies of both the 
type of isomers. 
As for as C-N bond vibrations are concerned, it appeared at about 1410 
cm in medium intensity, in the spectra of thiazolidinones, unsubstituted at 
nitrogen atom. This band corresponds to stretching vibrations between the 
nitrogen atom and the carbonyl group of the heterocyclic ring. Absence of this 
characteristics band indicates the presence of substituent on the nitrogen of 
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thiazolidinone ring. The band for C-N vibrations in N-substituted 
thiazolidinones was detected in the 1400-1300 cm" region and its position 
depends upon the electronegativity of the substituent. The shift in the position 
of this characteristic band (between 1410-1425 cm~ ) was found to be very 
helpful in differentiating the two isomers. In the isomer containing axial C 
spirane N bond, this band was always found to be bathochromically shifted by 
about 10 cm' . 
The position of characteristic signals in the NMR spectra of 
spirothiazolidinones are shown in table-3. The signal of methylene protons of 
thiazolidinone ring has been observed between 6 3.65 and 3.64. In the isomer 
having C spirane N bond axially oriented, these methylene protons always 
13 
shifted downfield by 0.04-0.01 ppm . This downfield shift provided a tool to 
differentiate it from other isomer. This can be explained on account of the 
anisotropic effect of carbon-carbon bonds of the alicyclic ring. The effect of 
thiazolidinone ring on the position of CH3-I9 and CH3-I8 methyl group 
protons depends on the distance between the heterocyclic ring and the angular 
methyl groups and on the configuration of the spirane carbon atom. 
Chapter - 3(A) Synthesis of Steroidal Spirothiazolidinones 
A Configurational Study. 
Page 154 
Tat)le-3 
Compound 
(VI ) 
(VII) 
( IX) 
( X ) 
(XII) 
(XIII) 
(XVIII) 
(XIX) 
(XXI) 
(XXIII) 
(XXXV) 
(XXVI) 
Configuration 
ofC-Nbond 
E ( P ) 
A ( a ) 
A ( P ) 
E ( a ) 
E ( P ) 
A ( a ) 
A ( P ) 
E ( a ) 
A ( a ) 
E ( P ) 
A ( P ) 
E ( a ) 
N-H 
7.91 
8.42 
8.75 
8.11 
7.76 
7.74 
5.26 
5.01 
8.33 
8.01 
6.70 
6.21 
SCH2-C 
3.52 
3.58 
3.58 
3.52 
3.45 
3.55 
3.49 
3.45 
3.48 
3.56 
3.56 
3.50 
CH3-I9 
0.80 
0.82 
0.99 
0.96 
0.83 
0.82 
0.92 
0.90 
1.04 
0.98 
0.98 
0.93 
CH3-I8 
0.64 
0.65 
0.66 
0.64 
0.65 
0.65 
0.66 
0.66 
0.89 
0.65 
0.68 
0.66 
6 Units, TMS Standard, 
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DTSCUSSION 
Steroidal spirothiozolidinones have been the subject matter of a 
detailed study during the last decade. The investigations have high lighted the 
mechanistic and stereochemical aspects and spectral features of these 
compounds which are of significant help in identification and characterization. 
Previous work fi'om these laboratories described the synthesis of such 
compounds,S-spiro-(3[3-chloro-5a-cholestane-6,2')-thiazolidinone-4'(XXXIX) 
S-spiro-(3a, 5-cyclo-5a-cholestane-6, 2')-thiazolidinone-4' (XL) and R-spiro-
(3a, 5-cyclo-5a-cholestane-6, 2')-thiazolidinone-4' (XLI) from 3|3-chloro-5a-
cholestan-6-one (XXXVII) and 3a, 5-cyclo-5a-cholestan-6-one (XXXVIII). 
SpirothiazoHdinones (XL) and (XLI) were diastereomeric, common in both 
HSCH.COOH ^ 
(NH4)2C03, drybenzene 
Reflux, 32 hrs 
HSCH7COOH ^ 
(NH4)2C03, drybenzene 
Reflux, 32 hrs 
O (XXXIX) 
(XL) (XLI) 
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the reactions 14 
5a-Cholestane-3, 6-dione (XLII) under identical reaction conditions 
provided S-spiro-(5a-cholestan-6-one-3, 2')-thiazolidinone-4' (XLIII) and R-
15 
spiro-(5a-cholestan-6-one-3, 2')-thiazolidinone-4' (XLIV) . 
CRH 
O 
8J^17 
H O 
(XLII) 
HSCH2COOH 
(NH4)2C03, dry benzene 
reflux, 
5a-Hydroxyketones (XLV, XLVI and XLVII) afforded corresponding 
thiazolidinones (XLVIII - XLIX, L - LI and LII) when these ketones were 
subjected to same reaction condition 16a, b 
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CRH 8^17 
HS-CH2COOH,(NH4)2C03 ci 
drybenzene, Reflux, 
R 
(XLV) CI 
(XLVI) OH 
(XLVII)oAc 
6 (Lii) 
In continuation to our above work, we are still trying to synthesize 
steroidal spirothiazolidinones because of their anaesthetic , antibiotic and 
amoebicidal activities and selected halogen containing ketones such as 3(3-
bromo-5a-cholestan-6-one (LIII) and 3P-iodo-5a-cholestan-6-one (LIV) to 
provide spirothiazolidinones. Biochemical screening of these compounds may 
exhibits the effect of halogen on known biological activities of such 
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compounds. As in the case of 3P-chloro-5a-cholestan-6-one (XXXVII), 3[3-
bromo-5a-choIestan-6-one (LIII) and 3p-iodo-5a-choIestan-6-one (LIV) gave 
S-spiro-(3[3-bromo-5a-cholestane-6, 2')-thiazolidinone-4' (LV), S-spiro-(3a, 
5-cyclo-5a-cholestane-6, 2')-thiazolidinone-4' (XL), R-spiro-(3a, 5-cyclo-5a-
choIestane-6, 2')-thiazolidinone-4' (XLI) and S-spiro-(3[3-iodo-5a-cholestane-
6, 2')-thiazolidinone-4' (LVI) and thiazolidinones (XL and XLI) respectively. 
HSCH2COOH 
O 
(XXXVII) 
R 
(LIII) Br 
(LIV) I 
(NH4)2C03, dry Benzene 
Reflux, 
(XLI) O (LVI) 
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Reaction of 3P-bromo-5a-cholestan-6-one (LIII) with p-
mercaptoacetic acid-ammonium carbonate: S-spiro-(3p-bromo-
5a-cholestane-6, 2^Vthiazolidinone-4^ (LV). S-spiro-(3a, 5-
cvclo-5a-cholestane-6. 2 )^-thiazolidinone-4^ (XL) and R-spiro-
Qg. 5-cvcIo-5a-cholestane-6, 2 )^-thiazoIidinone-4^ (XLI). 
3P-Bromo-5a-cholestan-6-one (LIII) was treated with (3-
mercaptoacetic acid and ammonium carbonate in dry benzene under refluxed 
condition with the removal of water in a Dean Stark apparatus. At the end of 
the reaction and removal of the solvent provided semi solid which was 
chromatographed over silica gel affording three compounds, semi solid, m.p. 
226 °C and a noncrystallizable oil. 
Characterization of the compounds : 
S-Spiro-(3P-bromo-5a-cholestane-6, 2'Vthiazolidinone-4^ (LV) : 
The compound, a semi solid (positive Beilstein test) was analysed 
correctly as C29H48NOSBr. The IR spectrum exhibited bands 3420, 3190 (H-
N), 1680 (NH-CO), 1410 (C-N), 690 cm"^  (C-Br). ^H-NMR spectrum of the 
compound under discussion gave peaks at 6 6.8 (brs, IH, N-H), 3.75 (mc, IH, 
H-3a, w'/z = 16 Hz) '^^ , 3.55 (s, 2H, S-CH2-CO). The mass spectrum of the 
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compound gave molecular ion peaks at m/z 537/539 (M+) followed by some 
important fragment ion peaks, such as m/z 491/493 and 476/478. 
H-N-C=0 
+ O^ (LV) 
m/z 537/539{M+] 
N=C=0 
m/z 491/493 
m/z 476/478 
On the basis of above evidences the compound obtained as semi solid 
is characterized as S-spiro-(3(3-bromo-5a-cholestane-6, 2')-thiazolidinone-4' 
(LV). 
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S-Spiro-(3a. 5-cvclo-5a-cholestane-6,2^)-thiazolidinone-4^ (XL): 
The compound, m.p 226° was analysed correctly for C29H47NOS. The 
IR spectrum of the compound gave bands at 3430, 3180 (-N-H), 3080 
(cyclopropane), 1665 (NHCO) and 1409 cm"' (C-N), ' H - N M R spectrum gave 
signals at 6 8.73 (brs, IH, NH-CO), 3.45 (s, 2H, S-CH2-CO), 0.55 - 0.3 (mc, 
cyclopropane protons). Mass spectrum of the compound gave molecular ion 
peak at m/z 457 (M +) followed by some important fragment ion peaks at m/z 
411 and m/z 384. 
m/z 411 O (XL) 
m/z 457 (M +• ) 
m/z 384 
On the basis of above analytical and spectrum evidences the compound, 
m.p 226° is characterized as S-spiro-(3a, 5-cyclo-5a-cholestane-6, 2')-
thiazolidinone-4''^''^ (XL). 
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R-Spiro-(3a.5-cvclo-5a-cholestane-6.2^Vthiazolidinone-4^ (XLI): 
The compound as an oil was correctly analysed for C29H47NOS (isomer 
of compound XL). The IR spectrum of the compound exhibited bands at 3410, 
3192 (N-H), 3075 (cyclopropane), 1685 (NHCO) and 1420 cm'' (C-N). 
'H -NMR spectrum gave signals at 6 8.73 (brs, IH, NHCO), 3.32 (s, 2H, S-
CH2-CO), 0.50 - 0.30 (mc, cyclopropane protons). As in the case of XL, the 
mass spectrum of compound (an oil) gave molecular ion at m/z 475 (M+) 
followed by fragment ion peaks at m/z 411, m/z 384 and other low mass 
peaks. Formation of these ions are similar to (XL). On the basis of these 
evidences the structure of the compound obtained as an oil is confirmed as 
R-spiro-(3a,5-cyclo-5a-cholestane-6,2')-thiazolidinone-4' ' (XLI) 
Reaction of 3p-io(io-5a-cholestan-6-one (LIV) with P-mercapto-
acetic acid-ammoniumcarbonate : S-spiro-[3p-iodo-5a-cholestane -
6.2'1 -thiazolidinone-4'(LVD.S-spiro-[3a,5-cvclo-5a-cholestane-6,2'1-
thiazolidinone-47XL) and R-spiro-t3a.5-cvcIo-5a-cholestane -6. l'\-
thiazolidinone-4^ (XLD: 
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3P-Iodo-5a-cholestan-6-one (LIV) was treated with p-mercaptoacetic 
acid and ammonium carbonate in dry benzene under identical conditions (as 
followed with LIII). Three compounds an oil, m.p 226° and another oil (both 
oils were noncrystallizable) were obtained. 
Characterization of compounds : 
S-Spiro-[3p-iodo-5a-cholestane-6.2^1-thiazolidinone-4^ (LVD : 
The compound as an oil (positive Beilstein test) was analysed correctly 
C29H48 NOSI. The IR spectrum of the compound exhibited bands at 3415, 
3195 (N-H), 1685 (NHCO), 1412 (C-N) and 510 cm"^  (C-I). ' H - H M R 
spectrum gave peaks at 6 6.5 (brs, IH, NH), 3.8 (mc, IH, H-3a, W'A = 18 
17 
Hz) , 3.56 (s, 2H, -S-CH2-CO). The mass spectrum of the compound gave 
molecular ion at m/z 585 (M+) followed by fragment ions at m/z 539, m/z 524 
and other lower mass peaks. 
(LVI) 
m/z 585 (M + ) 
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S-Spiro-[3a. 5-cvcIo-5a-cholestane-6, 2n-thiazolidinone-4^ (XL) and 
R-Spiro-[3a. 5-cvclo-5a-cholestane-6, 2^1-thiazolidinone-4'' (XLI) : 
The compounds m.p 227° and a noncrystallizable oil obtained are 
identical (analysis, IR, H-NMR and Mass) with S-spiro-[3a, 5-cyclo-5a-
cholestane-6, 2']-thiazolidinone-4'-) (XL) and R-spiro-[3a, 5-cyclo-5a-
cholestane-6, 2']-thiazolidinone-4' (XLI) (isomers) obtained when 3P-bromo-
5a-cholestan-6-one (LIII) was treated with P-mercaptoacetic acid-
ammonium carbonate and therefore their structures (XL) and (XLI) are the 
same. 
Regarding the configuration at C6-spirane carbon atom in 
thiazolidinone (LV) and (LVI), since in IR spectrum bathochromic shift of 8 -
10 cm" was noted in C-N stretching band vibrations and down field chemical 
shifts of 5H 0.23 - 0.24 in ' H - N M R spectra of (LV) and (LVI) for -S-CH2-
CO-protons were observed therefore C spirane-N bond is axially oriented in 
(LV) and (LVI). The mass spectral studies also supported the assignment of 
configuration at spirane carbon C6. The relative abundance of fragment in m/z 
384 is less pronounced in (XL) as compared to (XLI) because in (XL) 
fragmentation is difficult because of 1, 3-axial equatorial interaction between 
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CIO-CH3 (axial)-C6-S (equatorial) bonds. The mass spectra of (LV) and (LVI) 
exhibit less abundance for m/z 476/478 and m/z 524 respectively 14,18 
The formation of steroidal spirothiazohdinones from the steroidal 
ketones involves ketimine intermediate which reacts with P-mercapto acetic 
acid to give thioglycolamide to be cyclized to afford spirothiazohdinones (LV 
and LVI) 
CBH 
X 
8^17 
H 
O 
(LIII) Br 
(LIV) I 
(NH4)2C03 
-H2C03 
-H20 
X 
-H,0 
Ketimine 
HS-CH2-COOH 
Thioglycolamide, X = Br, I 
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EXPERTMENTAL 
All melting points are uncorrected. I.R. spectrum were obtained with a 
Perkin-Elmer 237 Spectrophotometer in KBr and U.V spectra in 95% EtOH 
with a Beckman DB Spectrophotometer. H-NMR spectrum were run in a 
Varian A 60 and HA 100 M.C. instruments in CDCI3 with TMS as the 
internal standard. Thin layer chromatographic plates were coated with silica 
gel and perchloric acid (20%) was used as spraying agent. Light petroleum 
refers to a fraction on b.p. 60-80°. H-N.M.R. values are given in 6 p.p.m. (s = 
singlet, d = doublet, t = triplet, br = broad, m.c. = multiplet centered at). 
3p-Chlorocholest-5-ene (LVII) 
Freshly purified thionyl chloride (75 ml) was added gradually to 
cholesterol (100 g) at room temperature. A vigorous reaction ensued with the 
evolution of gaseous products. When the reaction slackened the mixture was 
gently heated at a temperature of 50-60° on a water bath for 1 hour, and then 
poured onto crushed ice with stirring. The yellow solid thus obtained was 
filtered under suction and washed several times with ice-cooled water and air -
dried. Recrystallization from acetone gave 3P-chlorocholest-5-ene (LVII) 
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19a b 
(95.5 g), m.p. 95-96° (reported ' m.p. 96-97°). It gave positive Beilstein test 
and a yellow colour with tetranitromethane in chloroform. 
3P-ChIoro-6-nitrocholest-5-ene(LVIII) 
To a well stirred mixture of 3P-chlorocholest-5-ene (LVII) (12 g), 
glacial acetic acid (80 ml) and nitric acid (25 ml.; d. 1.52) at temperature 
below 20°, was added sodium nitrite (3.0 g) gradually over a period of 2 
hours. After the complete addition of sodium nitrite, the mixture was further 
stirred for about 1 hour. Ice-cooled water (200 ml) was added and the 
yellowish solid thus separated, was filtered and air-dried. The desired product 
(LVIII) was recrystallized from methanol as needles (8.3 g), m.p. 151-152° 
(reported m.p. 153°). 
3P-Chloro-5a~choIestan-6-onerXXXVII) 
To a solution of 3P-chloro-6-nitrocholest-5-ene (LVIII) (12 g) in hot 
glacial acetic acid (240 ml), zinc dust (24 g) was added gradually in small 
portions with shaking. The suspension was heated under reflux for 4 hours and 
water (24 ml) was added at regular intervals during the course of heating. The 
hot solution was filtered and the filtrate was cooled at room temperature 
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followed by dilution with large excess of ice-cooled water. The organic matter 
was extracted with ether and the ethereal solution was washed with water, 
sodium bicarbonate solution (10%) and water and dried (anhydrous sodium 
sulphate). Evaporation of the solvent furnished (XXXVII) as an oil which 
21 
crystalhzed from methanol (8.7 g), m.p. 128-129° (reported m.p. 129°). 
3a. 5-Cvclo-5a-cholestan-6-one (XXXVIII) 
A mixture of 3p-chloro-5a-cholestan-6-one (XXXVII) (5.0 g) and 
methanolic potash (75 ml.; 5 %) was heated under reflux for 1 hour and the 
reaction mixture was poured in to water. It was extracted with ether and the 
ethereal solution was washed with water, dilute hydrochloric acid and water 
and dried (anhydrous sodium sulphate). Removal of the solvent gave the 
cycloketone (XXXVIII) which was crystallized from methanol (3.5 g), m.p. 
96-97° (reported" m.p. 97°). 
3p-Bromo-5a-cholestan-6-one (LIII) 
3a, 5-Cyclo-5a-cholestan-6-one (XXXVIII) (1.0 g) was heated under 
reflux with hydrobromic acid (1.25 ml.; 48%) in acetone (3.7 ml) for about 6 
hours. Most of the solvent was removed under reduced pressure and the 
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residue was diluted with water (10 ml). A solid thus obtained was 
recrystallized from methanol to give the bromoketone (LIII) (0.8 g) m.p 126-
127° (reported" m.p 123°). 
3p-Iodo-5a-cholestan-6-one (LIV) 
3a, 5-Cyclo-5a-cholestan-6-one (XXXVIII) (1.7 g) was dissolved in 
pure acetic acid (25 ml) and treated with hydroiodic acid (5 ml.; 54%). The 
turbid solution was made clear by addition of ether. The mixture was kept at 
room temperature for 20 hours and then it was poured into ice-cooled water 
and extracted with ether. The ethereal layer was washed with water, sodium 
bicarbonate solution (5%) and finally with water and dried (anhydrous sodium 
sulphate). Removal of the solvent gave an oil which was crystallized from 
23 
methanol to give the iodoketone (LIV) (1.27 g), m.p 138-139° (reported m.p 
137-138°). 
Reaction of 3p-bromo-5a- cholestan-6-one (LIII) with p-
mercapto acetic acid-ammonium carbonate in dry benzene: S-
Spiro-(3 P-bromo-5a-cholestane-6,2^)-thiazolidinone-47LV), S-
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Spiro-r3a.5-cvclo-5a-cholestane-6.2^)-thiazolidinone-47XL) and 
R-Spiro-(3a.5-cvclo-5a-cholestane-6,2^Vthiazolidinone-4^ 
(XLD. 
3P-Bromo-5a-cholestan-6-one (LIII) (2.0 g), P-mercaptoacetic acid 
(4.3 g) ammonium carbonate (4.6 g) in dry benzene (150 ml) was refluxed 
with removal of water in a Dean-Stark apparatus for 35 hrs. At the end of 
reaction, the benzene solution was washed with water, IN sodium hydroxide 
solution and water and dried over anhydrous sodium sulphate. The solvent 
was removed under reduced pressure and the semi solid (1.74 g) thus obtained 
was chromatographed over silica gel (40 g). 
Characterization of Compounds : 
S-Spiro-(3p-bromo-5a-cholestane-6. 2^)-thiazolidinone-4^ (LV) : 
Elution : pet. ether : ether (12:1), Yield : (0.47 g), semi solid. 
Analysis found C, 64.97; H, 8.91; N, 2.65; S, 5.93 
C29H48NOSBr requres: C, 64.99; H, 8.93; N, 2.66; S, 5.95% 
IR : Vmax. 3420, 3190 (N-H), 1680 (NHCO), 1410 (C-N), 690 cm'^  (C-Br) 
Chapter - 3(A) Synthesis of Steroidal Spirothiazolidinones : 
A Configurational Study. 
Page 171 
^H-NMR : 5 6.8 (brs, H-N-C=0), 3.75 (mc, H-3a, W'A = 16 Hz), 3.55 (s, 2H, 
-S-CH2-CO-), 1.06 (CIO-CH3), 0.68 (CI3-CH3), 0.90 and 0.85 (side chain 
methyl protons). 
Mass: m/z 537/539 [M+)], m/z 491/493, m/z 476/478 
S-Spiro-(3a. 5-cvclo-5a-cholestane-6.2^Vthiazolidinone-4^ (XL) : 
Elution : Pet. ether : ether (10:1), yield : (0.6 g), m.p. 226 - 227°'"* 
Analysis Found : C, 76.14; H, 10.28; N, 3.06; S, 7.01 
C29H47NOS requires C, 76.01; H, 10.23; N, 3.01; S, 6.95% 
IR : V max 3430, 3180(-N-H), 3080 (cyclopropane), 1665 (NHCO), 
1409 cm"^  (C-N) 
^H-NMR : 6 8.73 (brs, IH, NHCO), 3.45 (s, 2H, -S-CH2-CO), 0.55- 0.3 (mc, 
cyclopropane protons), 1.02 (CIO-CH3), 0.70 (CI3-CH3), 0.90 and 0.80 (side 
chain methyl protons) 
Mass : m/z 457 (M+), m/z 411, m/z 384. 
R-Spiro-(3a. 5-cvclo-5a-cholestane-6. 2^Vthiazolidinone-4^ (XLI) : 
14 
Elution : Pet. ether: ether (7:1), yield (0.49 g), noncrystallizable oil. . 
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Analysis Found : C, 76.14; H, 10.28; N, 3.06; S, 7.01 
C29H47NOS requires : C, 76.01; H, 10.23; N, 3.01; S, 6.95% 
IR : V max 3410, 3192 (N-H), 3075 (cyclopropane), 1685 (NHCO) and 1420 
cm"' (C-N). 
' H - N M R : 8 8.73 (brs, IH, NHCO), 3.32 (s, 2H, -S-CH2-CO) 0.50 - 0.30 (mc, 
cyclopropane protons), 1.01 (CIO-CH3), 0.75 (CI3-CH3) 0.95 - 0.85 (side 
chain methyl protons). 
Mass : m/z 475 (M+), m/z 411, m/z 384. 
Reaction of 3p-iodo-5a-cholestan-6-one (LIV) with P-mercapto 
acetic acid and ammonium carbonate: S-Spiro-[3p-iodo-5a-
cholestane-6. 2 ]^-thiazolidinone-4^ (LVI^ * S-Spiro-[3a. 5-cyclo-
5a-cholestane-6. 2 ]^-thiazoiidinone-4^ (XL) and R-Spiro-[3a. 5-
cyclo-5a-cholestane-6,2n-thiazoIidinone-4' (XLI). 
The 3P-iodo-5a-cholestan-6-one (LIV) (2.0 g), P-mercaptoacetic acid 
(4.3 g), ammonium carbonate (4.6 g) in dry benzene (150 ml) was refluxed 
with removal of water in a Dean-Stark apparatus for 32 hrs. At the end of the 
reaction, benzene solution was washed with water, IN sodium hydroxide 
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solution and water and dried over anhydrous sodium sulphate. The solvent 
was removed reduced pressure and the oily substance (1.72 g) was 
chromatographed over silica gel (30 g). 
S-Spiro-(3p-iodo-5a-cholestane-6.2')-thiazolidinone-4" (LVD ; 
Elution : Pet. ether : ether (10:1), Yield : (0.45 g), noncrystallizable oil. 
Analysis Found : C, 59.46; H, 8.01; N, 2.38; S, 5.46 
C29H48NOSI requires : C, 59.48; H, 8.05; N, 2.39; S, 5.47% 
IR : Vmax 3415, 3195 (N-H), 1685 (NHCO), 1412 (C-N), 510cm"' (C-1) 
' H - N M R : 8 6.5 (brs; IH, N-H), 3.8 (mc, IH, H-3a, W z^ = 18 Hz), 3.56 (s, 2H 
S-CH2-CO-), 1.03 (CIO-CH3), 0.69 (CI3-CH3), 0.95, 0.85 (side chain methyl 
protons). 
Mass : m/z 585 (M+), m/z 539, m/z 524. 
S-Spiro-(3a. 5-cvclo-5a-cholestane-6,2^VthiazoIidinone-4^ (XL) : 
Elution : Pet. ether : ether (7:1), yield : (0.52 g), m.p. 226 - 227°C. 
R-Spiro-(3a. 5-cvclo-5a-cholestane-6, 2^Vthiazolidinone (XLI) : 
Elution : Pet. ether : ether (5:1), yield : (0.45 g), noncrystallizable oil. 
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The compounds (XL) and (XLI) were found identical (m.p., m.m.p., 
TLC, IR, ' H - N M R and Mass) with the same compounds obtained when 3^-
bromo-5a-cholestan-6-one was treated with (3-mercaptoacetic acid ammonium 
carbonate under similar conditions. 
Chapter - 3(A) Synthesis of Steroidal Spirothiazohdinones 
A Configurational Study. 
Page 175 
REFERENCES 
1. A. R. Surrey and R. A. Cutler, J. Am. Chem. Soc; 76, 578 (1954). 
2. A. R. Surrey, J. Am. Chem. Soc; 71, 3354 (1949). 
3. H. O. Huisman, Angew. Chem; 82, 511 (1971). 
4. W. A. McLamore. W.E. Calmer, V. V. Bogert, F. C. Pennington and I. 
A. Sobmon, J. Am. Chem. Soc; 74, 2946 (1952). 
5. B. A. Sabin, J. Am. Chem. Soc; 74, 2947 (1952). 
6. F. C. Pennington, W. D. Celmer, W. M. McLamore, V. V. Bogert and 
J. A. Solomon, J. Am. Chem. Soc; 75, 109 (1953). 
7. Z. Paryzek and M. Kielczewski, Bull. Acad. Polon. Sci. Ser. Sci. Chim; 
23,9(1975). 
8. Z. Paryzek and M. Kielczewski, Bull. Acad. Polon. Sci. Ser. Sci. Chim; 
23,91(1975). 
9. C. Y. S. Chen and C. A. Swenson, J. Phys Chem; 73, 1363 (1969). 
10. C. Y. S. Chen and C. A. Swenson, J. Phys Chem; 73, 2999 (1969). 
11. L. J. Bellamy "The Infrared spectra of complex molecules", John 
Wiley, New York, page 214 (1958). 
12. R. M. Silverstein and G. C. Bassler, "Spectrometric identification of 
organic compounds", John Wiley, New York, page 124 (1981). 
Chapter - 3(A) Synthesis of Steroidal Spirothiazohdinones 
A Configurational Study. 
Page 176 
13. Z. Paryzek and M. Kielczewski, Bull. Acad. Polon. Sci Ser. Sci. Chim; 
22, 191 (1975). 
14. Shafmllah and H. All, J. Steroid Biochem; 12, 467 (1980). 
15. Shafmllah, H. All and M. R. Ansari, J. Ind. Chem. Soc; 58, 1211 
(1981). 
16.a. Shafmllah, I. H. Siddiqui, S. A. Ansari, E. H. Khan and Sheeba Shafi J. 
Ind. Chem. Soc.; 234/99, 1999 -— (Accepted). 
16.b. Shafmllah, E. H. Khan and Sheeba Shafi, "National Research Seminar 
on Frontier Areas in Chemistry", RP-12, 20* and 21* September, 1999. 
17. N. S. Bhacca and D. H. Wilhams "Applications of NMR spectroscopy 
in Organic Chemistry", Holden-Day San Francisco, page 51 (1964). 
18. Shafmllah and H. AH, Org. Mass spectrum; 16, 556 (1981). 
19.a. H. R. Nace and E. Capstack, Jr., J. Org. Chem; 26, 5020 (1961). 
19.b. R. B. Woodward and A. F. Clifford, J. Am. Chem. Soc; 63, 2727 
(1941). 
20. N. F. Blau and C. G. Struckwisch, J. Org. Chem; 27, 370 (1962). 
21. A. Windaus and 0. Dalmer, Chem. Ber; 52, 162 (1919). 
22. I. M. Heilbron, J. Hodges and F. S. Spring, J. Chem. Soc; 759 (1938). 
23. C. W. Shoppee and G. H. R. Summers, J. Chem. Soc; 1786 (1952). 
CHAPTER - 3 (B) 
\ = 
Chapter - 3(B) Synthesis of Steroidal Diastereomeric Oxathiolanes 
A Configurational Study. 
Page 177 
T H E O R E T T C A L 
A number of steroidal as well as non steroidal ketones have been 
reported to condense readily with [3-mercaptoethanol to furnish oxathiolanes. 
The methods for affecting the condensation of ketones with ethanedithiol or 
P-mercaptoethanol include use of zinc chloride and sodium sulphate , 
hydrogen chloride in ether , p-toluenesulphonic acid in benzene under 
3 4 
azeotropic distillation employing water separator and an exchange methods ' . 
HS - CH2 S—I 
R2C = 0 + I ,• R 2 / 
HO - CH2 " ^ O ^ 
Romo and co-workers^ showed that P-mercaptoethanol reacts readily in 
the presence of zinc chloride with unconjugated carbonyl group to yield the 
corresponding oxathiolanes. Thus androstan-17P-ol-3-one-17-acetate (I), 
etiocholan-17p-ol-3-one-17-acetate (III), estrone (V) and its acetate (VI), A -
androstan-3p-ol-17-one-3-acetate (IX), allopregnan-3p-ol-20-one (XI) and its 
3(3-acetate (XII) as well as A^-pregnan-3-ol-20-one (XV) and its 3p-acetate 
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(XVI) were converted into corresponding oxathiolanes (II, IV, VII, VIII, X, 
XIII, XIV, XVII and XVIII). 
OAc 
[ SH OH, ZnCl2 
(III) 5 P-H 
(V) X = OH 
(VI) X = OAc 
pSH 
L Q H , ZnCl2 
(VII) X = OH 
(VIII) X = OAc 
AcO 
SH 
'-OH,ZnCl2 
AcO 
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H 
(XI) X = OH 
(XII) X = OAc 
(XV) X = OH 
(XVI) X = OAc 
pSH 
-OH, ZnCl2 
(XIII) X = OH 
(XIV) X = OAc 
[ SH OH, ZnCl2 
(XVII) X = OH 
(XVIII) X = OAc 
Romo and co-worker also showed that a, P unsaturated ketones do not 
react with (3-mercaptoethanol in the presence of zinc chloride but a saturated 
carbonyl reacts selectively, A -androsten-3, 17-dione(XIX) afforded 
corresponding 17-oxathiolane (XX). 
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O' (XIX) 
o 
-SH 
0H,ZnCl2 
S O 
(XX) 
a, P-Unsaturated ketones react with p-mercaptoethanol in the presence 
of p-toluenesulphonic acid. Thus testosterone (XXI) and its acetate (XXII) 
were converted to corresponding oxathiolanes (XXIII and XXIV) in less than 
20% yield'. 
(XXI) X = OH 
(XXII) X = OAc (XXIII) X = OH (XXIV) X = OAc 
Androst-4-en-3,17-dione (XIX) under similar reaction conditions 
provided 3, 17-bisoxathiolane (XXV). 
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(XXV) 
(3-Mercaptoethanol undergoes 1,4-addition with sterically unhindered 
5,16 
a,P-unsaturated ketones in the presence of piped dine. Thus A ' - pregnnadin 
4,16 3P-ol-20-one-3-acetate (XXVI) and A ' -pregnnadin-3, 20-dione (XXVII) 
afforded corresponding 16P-hydroxyethylmercapto derivatives (XXVIII) and 
(XXIX) in excellent yields instead of oxathiolanes. 
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AcO (XXVI) 
(XXVII) 
AcO 
(xxvin) 
pSH 
- OH, P5)eridine 
(XXIX) 
S(CH2)2-OH 
S(CH2)2-OH 
Djerassi and Gormann reported that A ' 22 n-spirodien-3-one (XXX) 
with P-mercaptoethanol in the presence of p-toluenesulphonic acid furnished 
(XXXI) in about 20% yield. 
(XXX) 
rSH 
LOH,p-TsOH 
(CH2)20H 
(XXXI) 
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Djerassi and Gormann also obtained a number of oxathiolanes by 
refluxing the ketones with P-mercaptoethanol in dry benzene using p-
toluenesulphonic acid as a catalyst. This method is found satisfactory for the 
formation of oxathiolanes of saturated ketones (IX, XXXII, XXXIV and 
XXXVI) but unsaturated ketones like A'* -3-keto-steroids (XXI, XXXVIII and 
AcO 
H 
(XXXIV) 
S. . 0 
pSH 
l-OH,p-TsOH 
AcO 
(XXXV) 
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XL) gave the desired product in poor yield. 
pSH 
-OH,p-TsOH 
(XXXVI) 
I 
H (XXXVII) 
(XL) (XLI) 
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y-Mercaptopropanol in the presence of p-toluenesulphonic acid 
undergoes condensation with a number of ketones (IX, XXXIV, XXXVI and 
XLV) forming trimethylene oxathiolanes (XLII, XLIII, XLIV and XLVI)\ 
AcO 
AcO 
(XLII) 
(XLIV) 
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pOH 
LsRP-TsOH 
.0 
(XL VI) 
Fieser converted ketone (XLVII) into corresponding oxathiolane 
CsH 8J^17 
(XLVII) \^ (XLVIII) 
(XLVIII) using P-mercaptoethanol and BFs-etherate as condensing agent. 
Robert and Brown reported that the treatment of dehydrochoHc acid 
(XLIX) with P-mercaptoethanol in the presence of p-toluenesulphonic acid 
gave the dehydrocholic acid trimethyloethylene ketal (L). 
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COOH 
Eliel et al7 observed that when 5a-cholestan-3-one (XXXII) was 
treated with P-mercaptoethanol in dry benzene using p-toluenesulphonic acid 
as catalyst, two pure diasteroisomeric oxathiolanes (LI and LII) were obtained 
while the previous result^ showed the formation of a single product. 
CgHn 
G. Karmas obtained two diastereoisomeric oxathiolanes (LIII and 
LVI) from 5a-dihydrotestosterone acetate (I) using P-mercaptoethanol and 
p-toluenesulphonic acid. 
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OAc 
The treatment of 4-hydroxycholest-4-en-3-one (LV) with (3-
9 
mercaptoethanol provided two isomeric oxathiolanes (LVI and LVII) . 
C«H 8^17 
(LVI) (LVII) 
The treatment of 5a-cholestan-6-one (LVIII) and the 3P-chloro (LIX), 
3p-acetoxy (LX) and 3p-hydroxy (LXI) analogus with p-mercaptoethanol in 
the presence of borontrifluoride gave the corresponding 6P-oxy-6a-
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thiodimethylene (LXII - LXV) together with 6a-oxy-6P-thiodimethylene 
(LXVI - LXIX)^^ 
C«H 8^17 
(LIX) OAc 
(LX) CI 
(LXI) OH 
(LXIII) OAc 
(LXIV) CI 
(LXV) OH 
(LXVH) OAc 
(LXVHI) CI 
(LXIX) OH 
It was also found" that the treatment of 3a, 5-cyclo-5a-cholestan-6-
one (LXX) with P-mercaptoethanol in the presence of p-toluenesulphonic acid 
afforded oxathiolanes (LXXI - LXXIV) and other related products (LXX a-e). 
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^ S H 
L-0H,BF3 
AcOH 
CsH 8^17 
(LXX) o 
^ S H 
L-OH, 
p-TsOH 
R SH 
(LXXa) - S-CH2-CH2OH 
(LXXb) - O-CH2-CH2SH 
(LXXc) - S-CH2-CH2-OAC 
B R 
(LXXd) -S-CH2-CH2OH (LXXII) OTs 
(LXXe) -S-CH2CH2OAC (LXXIII) -SCH2CH2OH 
(LXXIV) -SCH2CH2OAC 
Cholest-5-en-3-one (XLVII), cholest-4-en-3-one (LXXV) and 4,4-
dimethylcholest-5-en-3-one (LXXVI) when reacted with 2-mercaptoethanol in 
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dry benzene furnished the isomeric oxathiolanes, (LXXVII, LXXVIII), 
12 (LXXIX - LXXX) and (LXXXI - LXXXII) respectively 
(LXXV) (LXXIX) 
C«H 8^17 
^ S H 
-OH 
CeHe o 
(LXXVI) (LXXXI) (LXXXII) 
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DISCUSSION 
Previous work done in our laboratory with regard to the synthesis and 
structure elucidation of steroidal oxathiolanes from their respective ketones 
need to be reported in order to provide a clear guideline for the identification 
of some new synthesized steroidal oxathiolanes and further extension of 
configurational studies in the case of isomeric oxathiolanes. 
5a-cholestan-6-one (LVIII), 3p-acetoxy-5a-cholestan-6-one (LIX) and 
3p-chloro-5a-cholestan-6-one (LX) and 3l3-hydroxy-5a-cholestan-6-one 
(LXI) were treated with (i-mercapto ethanol in the presence of BFs-etherate 
(as catalyst) in the usual manner to furnish their isomeric steroidal 
oxathiolanes 6P-oxy-6a-thiodimethylene-5a-cholestane (LXII), 6a-oxy-6(3-
thiodimethylane-5a-cholestane (LXVI), 3p-acetoxy-6(3-oxy-6a-thiodimethy-
lene-5a-cholestane(LXIII),3p-acetoxy-6a-oxy-6P-thiodimethylene-5acholes-
tane (LXVII), and 3P-chloro-6(3-oxy-6a-thiodimethylene-5a-cholestane 
(LXIV), 3p-chloro-6a-oxy-6p-thiodimethylene-5a-cholestane (LXVIII) and 
3p-hydroxy-6p-oxy-6a-thiodimethylene-5a-cholestane (LXV) and 3P-hydr-
oxy-6a-oxy-6P-thiodimethylene-5a-cholestane (LXIX) . 
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R 
(LVIII) H 
(LIX) OAc 
(LX) CI 
(LXI) OH 
BF3 - Etherate 
R 
(LXII) H 
(LXIII) OAc 
(LXIV) CI 
(LXV) OH 
R 
(LXVI) H 
(LXVH) OAc 
(LXVni) CI 
(LXIX) OH 
Analytical and spectral data are given in table-1 for structural 
assignment of different functionalities present in the above mentioned 
steroidal oxathiolanes. 
Table - 1 
Steroidal 
Oxathiolanes 
(LXII) 
(LXVI) 
m.p. 
CO 
56 
Oil 
IR(Vn,axCm" )^ 
1225 (-S-CH2-), 
1150, 1090 (C-0-) 
1220,1210(-S-CH2-), 
1155, 1095 (C-0-) 
NMR*(6(ppm)) 
4.32, 3.92, (t, 0-
CH2-), 2.78, (dd, 
J=7 and 3Hz, -S-
CH2-). 
4.03,(t,-O-CH2-), 
CU.(Ai|nax 
(nm), Mol. 
Rotation [6]) 
250, (-1381) 
241, (+3172) 
Mass 
(m/z) 
446 
446 
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(LXIII) 
(LXVII) 
(LXIV) 
(LXVIII) 
142 
106 
1725 (CH3COO-), 
1120, 1055 (C-0), 
1035 (oxathiolane 
ring) 
1740 (CH3COO-), 
1160, 1080 (C-0), 
1030, (oxathiolane 
152 
115 
ring) 
1270, 1230 (-S-
CH2), 1150 (C-0), 
1070 (oxathiolane 
ring), 760 (C-Cl). 
1270 (-S-CH2), 1155 
(C-0), 1070 
(oxathiolane ring), 
760(C-C1) 
2.93, (t, -S-CH2) 
4.7, (brm, W'/2 
=16 Hz, H-3a, 
axial), 4.28, 3.9, 
(t,-0-CH2-),2.86, 
(dd,J=6 and 3Hz, 
-SCH2), 2.03, (s, 
CH3COO-). 
4.7, (brm, W'A 
=16 Hz, H-3a, 
axial), 4.03 (brm. 
OCH2-), 2.96 (t, 
-SCH2-), 2.03 (s, 
CH3COO-). 
4.0 (m, 3H, -0-
CH2, H-3a), 2.86 
(dd, J=6 and 
3Hz, -S-CH2). 
4.05 (m, 3H, -0-
CH2, H-3a), 2.97 
(t, -SCH2). 
250, (-859 and 
-796) 
239, (+3516) 
251, (-612) 
273.5, (+2959) 
504 
504 
i 
1 
480/482 
(3:1) ! 
480/482 
(3:1) 
(a) A peaks for angular and side-chain methyl protons occurred between a 
range from 61.10-0.68. 
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(b) Oxathiolanes gave positive sodiumnitroprusside test for sulphur and 
positive Beilstein's test for halogen. 
To make a clear distinction between diastereomeric oxathiolanes by 
establishing their configurations, some more relevant studies were needed to 
provide stereochemical evidences. Configuration for a oxathiolane ring 
containing compound can be established by using shift reagent [Eu 
(DPM)3]'^. On adding shift reagent to a oxathiolane ring containing 
compound, the methylene protons attached to oxygen atom (O-CH2) showed a 
downfield shift in the NMR spectrum provided C-0 bonding to be equatorial. 
Since sulphur atom having the same electronegativity as carbon atom, does 
not associate with the shift reagent. When both internal and external TMS are 
used as standards, a diamagnetically induced shift of some NMR signals, such 
as those of the internal TMS and of proton distant from the site of association, 
becomes apparent. The signals of protons, close to the pseudocontact positions 
are paramagnetically shifted. Upfield shifts induced by Eu(DPM)3 were 
attributed to the pseudocontact' . The diamagnetic shifts mainly due to change 
in bulk susceptibility by the added europium complex which shifted the signal 
of internal TMS upfield with equal or greater than those of the protons which 
are located far from the site of association. 
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Table - II 
Sample + Tris Eu 
LXII (Neat) 
LXII + Eu(DPM)3 5.79 mg 
LXII+Eu(DPM)3 11.54 mg 
LXII+Eu(DPM)3 12.30 mg 
LXVI (Neat) 
LXVI+Eu(DPM)3 6.0 mg 
LXVI+Eu(DPM)3 11.16mg 
LXVI+Eu(DPM)3 15.81mg 
Induced chemical shifts (5H) of protons with 
increasing amount of Eu(DPM)3 
-O-CH2-
4.05 
4.00 
4.06 
4.15 
4.03 
4.2 
4.63 
4.91 
-S-CH2-
2.85 
2.83 
2.78 
2.80 
2.93 
3.0 
3.03 
3.34 
C-19 
0.98 
0.96 
1.00 
0.94 
0.98 
0.98 
1.03 
1.14 
C-18 
0.66 
0.66 
0.67 
0.61 
0.67 
0.67 
0.70 
0.72 
On comparing spectral data, which are tabulated in table-II, it is 
possible to conclude that compound (LXVI) where oxygen atom having 
Pseudoequatorial position, associates with the shift reagent, the down field 
shift of -O-CH2 protons is noted, whereas, for compound (LXII), -OCH2 
grouping of oxathiolane ring at C6 is axial in orientation. In the NMR spectra 
Chapter - 3(B) Synthesis of Steroidal Diastereomeric Oxathiolanes 
A Configurational Study. 
Page 197 
of the oxathiolanes (LXII-LXVI), (LXIII-LXVII) and (LXIV-LXVIII), the 
difference in splitting pattern for the peaks of O-CH2 and S-CH2 protons may 
be taken into account. Two methylene protons attached with axially oriented 
oxygen assumed to be magnetically non-equivalent, gave rise to two distorted 
triplets and a double doublet for compound (LXII). The distortion may be 
attributed to long-range coupling with S-CH2 (magnetically equivalent) 
protons and also due to non-planar structure of oxathiolane ring which results 
in the interaction between the axial oxygen and CIO-CH3 group. A double 
doublet for S-CH2 protons results by the splitting with pseudoaxial and 
pseudoequatorial protons of O-CH2 moiety. For isomer (LXVI) equatorial 
oriented O-CH2 having almost magnetically equivalent protons as for S-CH2 
protons gave rise to two triplets for both. The distortion in triplet of -O-CH2 
protons at 8 4.03 might be considered due to long range coupling. 
A significant change may be visualized in CD spectra of the isomeric 
oxathiolanes (LXII and LXVI). The compound (LXII) showed negative 
Cotton effect and CD maxima at 250 nm ([9] = - 1381) where as (LXVI) 
exhibited positive Cotton effect and CD maxima at 241 nm ([0] = + 3172). 
The difference in environment of the sulphur atom in (LXII) (sulphur 
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The validity of the above explanations is plausible to account for the 
difference in behaviour of other isomeric oxathiolanes (LXIII - LXVII) and 
(LXIV - LXVIII) on the basis of NMR and CD spectral data as illustrated in 
table - 1 . 
The mass fragmentation of the oxathiolanes (LXII - LXVI), (LXIII -
LXVII) and (LXIV - LXVIII) to their parent ketones were shown as follows: 
CgHn 
R m/z (M+) 
(LXII) H 446 
(LXVI) H 446 
(LXIII) OAc 504 
(LXVII) OAc 504 
(LXIV) CI 480/482 
(LXVIII) CI 480/482 
(LVIII) 
(LIX) 
(LX) 
R 
H 
OAc 
CI 
ot 
m/z 
386 
444 
420 / 42 
98^17 
-^000 
-2000 
234(5306) 
220'(659) 250(796) ^8*^17 
AcO 
237.5(2959) 
Ce"i7 
8"17 
CD Curves of Steroidal Oxathiolanes in dioxane at 24 °C 
Fig.l 
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The ratio of formation of molecular ion to its ketonic ion, as given in 
table-Ill, suggested an easy removal of CH2CH2S from oxathiolane molecular 
ion where S is axial, due to 1,3-diaxial interaction between CIO-CH3 and S. 
Tablg - 3 
(LXIV) 
(LXVII) 
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(LXVIII) 
(LXIV) 
The second example suitable to be reported here is the formation of 
3P-oxy-3a-thiodimethylene-5a-cholestan-6-one (LXXXIV), bis-3, 6-(P-oxy-
a-thiodimethylene)-5a-cholestane (LXXXV) 3a-oxy-3(3-thiodimethylene-5a-
cholestan-6-one (LXXXVI) and bis-3, 6-(a-oxy-P-thiodimethylene)-5a-
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cholestane (LXXXVII) from 5a-cholestane-3, 6-dione (LXXXIII) when 
treated with P-mercaptoethanol-BF3-etherate. 
(LXXXVI) (LXXXVII) 
Table (IV) gives analytical and spectral data for these steroidal 
oxathiolanes (LXXXIV-LXXXVII). CD curves were shown in Fig. 2. 
1,000 -
[e];^^859 
( L X X X V ) 
CD Curves of Steroidal Oxathiolanes in dioxane at 25 °C 
Fig. 2 
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Table - TV 
Steriodal 
oxathiolane 
(LXXXIV) 
(LXXXV) 
(LXXXVI) 
(LXXXVII) 
m.p. 
''C 
136° 
165° 
Oil 
155° 
IR (V max in cm' ) 
1715 (C=0), 1225 (-S-
CH2), 1150, 1090 (C-
0 linkage of 
oxathiolane ring) 1065 
(oxathiolane Linkage) 
1225, 1220 (-S-CH2), 
1150 (C-0 Linkage of 
oxathiolane ring), 
1070 (oxathiolane 
ring) 
1710 (C=0), 1220, 
1210 (-S-CH2), 1155, 
1095 (C-0 Linkage of 
oxathiolane ring), 
1070 (oxathiolane 
ring) 
1220 (-S-CH2), 1155 
(C-0 Linkage of 
oxathiolane ring), 1270 
1H-NMR*(5 
(ppm)) 
4.22 (t, -0 -
CH2), 3.05 (t, 
-S -CH2), 
4.15(t,2x-0-
CH2), 2.92 
(dd, 2x-S-
CH2), 
4.1 (t, -0-
CH2), 3.03 (t, 
-S-CH2), 
4.13 (t, 2x-0-
CH2), 2.96 (t, 
2X-S-CH2), 
CD. 
X,max(nm) 
Moi [0]) 
[e]''253 - -859 
[9^247-+967 
Mass 
(m/z) 
460 
520 
460 
520 
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(oxathiolane ring) 
Peaks for angular and side chain methyl protons occurred between a range 
from 5H 0.98 - 0.67. 
In continuation with this work and with the interest of obtaining all 
possible isomeric steroidal oxathiolanes to be identified by CD spectral 
studies, we subjected 5-hydroxy-5a-cholestane-3, 6-dione (LXXXVIII) to 
the same reaction and obtained 3P-oxy-3a-thiodimethylene-5-hydroxy-5a-
cholestan-6-one (LXXXIX), bis-3, 6-(p-oxy-a-thiodimethylene)-5-hydroxy-
5a-cholestane (XC), 6p-oxy-6a-thiodimethylene-5-hydroxy-5a-cholestan-3-
one (XCI) and 3a-oxy-3P-thio, 6p-oxy-6a-thio-bisdimethylene-5-hydroxy-
5a-cholestane (XCII),. The structure and stereochemistry of these steroidal 
oxathiolanes were established on the basis of I.R., H-NMR, Mass and CD 
spectral studies. 
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Reaction of 5-hydroxy-5a-cholestane-3. 6-dione (LXXXVIII) with B-
mercaptoethanol-BFj-etherate : 3p-Oxv-3a-thiodimethvlene-5-
hydroxy-5a-choIestan-6-one (LXXXIX), bis-3.6-(p-oxv-a-
thiodimeth yleneV5-hydroxy-5a-cholestane (XC^. 6B-oxv-6a-
thiodimethylene-5-hydroxy-5a-cholestan-3-one (XCD and 3a-oxv-
3P-thio,6p-oxv-6a-thio-bisdiniethvlene-5-hvdroxv-5a-cholestane 
(XCII). 
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Characterization of compounds : 
3p-Oxv-3a-thiodimethvlene-5-hvdroxv-5a-cholestane-6-one 
(LXXXIX). 
The oxathiolane, m.p. 120° was analysed for C29H48O3S (positive 
sodium nitroprusside test). In the IR spectrum, bands appeared at 3440 (OH), 
1710 (C=0), 1225 (-S-CH2), 1145 (-C-0) and 1055 cm'^  (oxathiolane ring). 
^H-NMR spectrum of the compound exhibited a triplet at 8 4.18 integrating 
for two protons assigned to -O-CH2 protons. Another triplet at 8 3.05 
integrating for two protons, can be ascribed to -S-CH2 protons. Methyl 
protons signals were obtained at 8 1.1 (CIO-CH3), 0.68 (CI3-CH3), 0.83 and 
0.76 (side chain methyl protons). The mass spectrum of oxathiolane gave 
molecular ion peak at m/z 476 and its ketonic ion peak is at m/z 416 (scheme-
1). The compound showed negative Cotton effect (fig.3.). On the basis of 
these analytical and spectral evidences, the oxathiolane is characterized as 3|3-
oxy-3a-thiodimethylene-5-hydroxy-5a-cholestan-6-one (LXXXIX). 
+22277 (240) 
200 250 300 350 
CD Curves of Steroidal Oxathiolanes in dioxane at 25 °C 
Fig. 3 
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o 
(LXXXIX) 
in/z476(M+ ) 
% " ' 
CH3C-H 
II 
S 
o 
in/z416 
Scheme - 1 
Bis-3.6-(p-oxy-a-thiodimethvlene)-5-hvdroxv-5a-cholestane(XC). 
The compound, m.p. 157° was correctly analysed for C31H52O3S2 
(positive sodium nitroprusside test). In the IR spectrum band appeared at 3500 
(OH), 1220 (S-CH2), 1145 (C-0) and 1055 cm'^  (oxathiolane ring). The ' H -
NMR spectrum showed two distorted triplets at 8 4.22 and 6 3.05 integrating 
for four protons each of two -O-CH2 and -S-CH2 moieties. The distortion in 
peaks may be attributed to long-range coupling. Signals were also appeared at 
5 1.06 (CIO-CH3), 0.66 (CI3-CH3), 0.91 and 0.78 (side chain methyl protons). 
The compound (XC) may be depicted as bis-3, 6-(P-oxy-a-thiodimethylene)-
5-hydroxy-5a-cholestane (XC). The compound (XC) as expected gave 
negative Cotton effect^ *' in CD spectrum (fig.3). The mass spectrum of 
oxathiolane (XC) gave molecular ion peak at m/z 536 (M+), 3-oxathiolane-6-
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ketonic fragment ion peak at m/z 476 and 3, 6-diketonic ion peak at m/z 416. 
Scheme-2 can easily explain the formation of these fragment ions. 
CgHn 
0 + 
1 
CH2-CH2-S 
0 + 
CH2-CH-SH 
m/z 536(M+) 
Scheme - 2 
6p-Oxv-6a-thiodimethvlene-5-hvdroxv-5a-cholestan-3-one(XCI): 
The compound m.p. 101° was analysed correctly for C29H48O3S 
(positive sodium nitro prusside test). In the I.R spectrum of oxathiolane (XCI) 
bands appeared at 3430 (OH), 1715 (C=0), 1225 (-S-CH2), 1140 (C-0) and 
1055 cm" (oxathiolane ring). H-NMR spectrum of the compound gave a 
triplet at 5 4.1 integrating for two protons assigned to -O-CH2 protons. 
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Another triplet at 5 3.15 integrating for two protons was assigned to -S-CH2. 
Methyl protons signals were obtained at 5 1.2 (CIO-CH3), 0.69 (CI3-CH3), 
0.85 and 0.78 (side chain methyl protons). The mass spectrum of gave 
molecular ion peak at m/z 476 (Mt) and its ketonic ion peak at m/z 416. The 
10 
compound under discussion showed negative Cotton effect (fig. 3). On the 
basis of above evidences the compound is characterized as 6P-oxy-6a-
thiodimethylen-5-hydroxy-5a-cholestan-3-one (XCl). 
CgHn 
(XCI) 
m/z 476 (M+) 
Scheme - 3 
m/z 416 
3a-Oxv-3p thio, 6p-oxv-6a-thio-bisdimethvIene-5-hvdroxv-5a-chol-
estane (XCID : 
Chapter - 3(B) Synthesis of Steroidal Diastereomeric Oxathiolanes 
A Configurational Study. 
Page 209 
The compound, m.p. 170° was analysed correctly for C31H52O3S2 
(positive sodium prusside test). The I.R spectrum of the oxathiolane gave 
bands at 3490 (OH), 1215 (S-CH2), 1140 (C-0) and 1050 cm"' (oxathiolane 
ring). H-NMR spectrum of the compound gave two distorted triplets at 8 4.15 
and 5 3.2 each integrating for four protons assigned to (2X-O-CH2) and (2x-S-
CH2) respectively. Methyl protons signals were obtained at 5 1.1 (CIO-CH3), 
0.62 (CI3-CH3), 0.87 and 0.75 (other methyl protons). The mass spectrum of 
the compound showed molecular ion peak at m/z 536 (M+) followed by C6-
oxathiolane-3-ketonic ion peak at m/z 476 and 3, 6-diketonic peak at m/z 416. 
Scheme-4 explains the formation of m/z 476 and m/z 416. 
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CgHn 
m/z 536 (Mt ) 
O 
H O p - S ; 
H) 
m/z 476 
H 
Scheme - 4 
The stereochemistry of oxathiolane moieties at C3 and C6 can be 
10 
assertained by CD study which gave (-)-ve Cotton effect (fig. 3). On the 
basis above evidences, the compound, m.p. 170° is characterized as 3a-oxy-
3|3-thio, 6P-oxy-6a-thio-bisdimethylene-5-hydroxy-5a-cholestane(XCII). 
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EXPERIMENTAL 
5a-Cholestane-3p, 5,6P-triol (XCIID 
A suspension of 20 g cholesterol in 200 ml of 88% formic acid was 
heated to 70-80° with stirring for 5 min. to form a derivative that is evidently 
the 3-formate, which separated as an oily layer, and cooled to 25°. The 
resulting thick paste of solidified formate was treated with 20 ml of 30% H2O2 
and shaken occasionally. The temperature usually raised to 35-40°, sometime 
there was an even more pronounced heat effect and in this case the 
temperature was controlled to 40° by cooling. After 45 min. the solid 
dissolved, the foam subsided, and a blue fluorescent solution resulted, but the 
temperature remained a few degrees above that of room temperature for about 
4 hrs. longer. After a total reaction time of 6-15 hrs., the mixture was treated 
with 300 ml of boiling water, stirred, allowed to cool, and the granular white 
solid collected, dried superficially dissolved in 600 ml of methanol, and the 
solution was treated with 20 ml of 25% sodium hydroxide solution, warmed 
on steam bath for 10 min., filtered, acidified and diluted with 200 ml water. 
The white solid precipitated, was collected after cooling, washed well with 
water and thoroughly dried. The triol (XCIII) so obtained was of high purity 
(19.7 g, 91%). Crystallization from methanol gave needles, m.p. 238-239° 
(reported", m.p. 237-239°). 
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5a-Cholestane-3p, 5-(lio[-6-one (XCIV) 
A one litre separating funnel was charged with 23 g of cholestane-3p, 
5a, 6p-triol, (XCIII) 450 ml ether, 75 ml methanol, 75 ml of water and 10.8 g 
(1.05 eqvts.) of N-bromosuccinimide and shaken. Oxidation was over in a few 
minutes and gave an orange yellow solution. On addition of water, the colour 
becomes lighter and the bulk of (XCIV) separated from the organic phase as 
colorless, shiny needles. The water phase was tapped off and the suspension in 
ether was washed with sodium sulphate solution, with sodium hydroxide 
solution (5%) and with water. The layer was then collected on a Buchner 
funnel and washed with ether to give firstcrop 19 g, m.p. 232-233°, successive 
concentration of mother liquor gave 3 g additional compound. Yield 22 g, 
m.p. and m.m.p. 233° (reported , m.p. 232-233°). 
5-Hydroxy-5a-cholestane-3,6-dione (LXXXVIII) 
On addition of 520 mg dichromate to a solution of 1.68 g of the 
cholestane-3P, 5a-diol-6-one (XCIV) in 20 ml of acetic acid, cooled to 30°, 
the product soon separated to give a thick paste. Water was added, 1.60 g of 
the product (LXXXVIII) (m.p. 220°) was collected and crystallized from 40 
ml of acetic acid and then from 360 ml of ethanol (1.04 g), m.p. 231° 
(reported , m.p. 232°). 
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Reaction of 5-hydroxy-5a-choIestane-3.6-dione (LXXXVIII) with p-
mercaptoethanol : 3p-Oxv-3a-thiodiinethvlene-5-hvdroxv-5a-chole-
stane-6-one (LXXXIX). bis-3. 6-rp-oxv-a-thiodimethvlene)-5-hvdr-
oxv-5a-cholestane (XC), 6p-oxv-6a-thiodimethvlene-5-hvdroxv-5a-
choiestan-3-one (XCF) and 3a-oxv-3p-thio, 6p-oxv-6a-thio-bis-
dimethylene-5-hydroxy-5a-cholestane(XCII). 
A solution of 5-hydroxy-5a-cholestane-3, 6-dione (LXXXVIII) (4.0 g) 
in acetic acid (120 ml) was treated with P-mercaptoethanol (4 ml) and BF3-
etherate (2 ml) and the reaction mixture was allowed to stand at room 
temperature for 2 hr. On completion of the reaction, methanol (20 ml) was 
added to it, the resultant solution thus obtained was poured into water and 
extracted with ether. The ethereal layer was washed successively with water, 
sodium bicarbonate solution (5%) and water and dried over anhydrous sodium 
sulphate. The solvent was distilled under reduced pressure to yield an oily 
product which was chromatography over silica gel (80 g). 
3P-Oxv-3a-thiodimethvlene-5-hvdroxv-5a-cholestane-6-one 
(LXXXIX) : 
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Elution : Pet. ether : ether (15:1), yield : (0.95 g), m.p. 120° 
Analysis found : C, 71.10; H, 10.10;S,6.71 
C29H48O3S requires : C, 71.11; H, 10.09; S, 6.72% 
IR : Vmax 3440 (-0H), 1710 (>C=0), 1225 (-S-CH2), 1145 (C-0 oxathiolane 
ring), 1055 cm' (oxathiolane ring). 
' H - N M R : 6 4.18 (t, -O-CH2), 3.05 (t, -S-CH2), 1.1 (CIO-CH3), 0.68 (C13-
CH3), 0.83 and 0.76 (side chain methyl protons). 
Mass : m/z 476 (M+, C29H48O3S), m/z416 (C27H44O3). 
CD : [61^ 2^97 = - 6504 
Bis 3.6-(P-Oxv-a-thiodimethvleneV5-hvdroxv-5a-cholestane (XC) : 
Elution : Pet. ether : ether (10:1), yield (0.65 g), m.p. 157° 
Analysis found : C, 69.40; H, 9.71; S, 11.93 
C31H52O3S2 requires : C, 69.41; H, 9.70; S, 11.94% 
IR : Vmax 3500 (-0H), 1220 (-S-CH2), 1145 (C-0), 1055 cm"^  (oxathiolane 
ring). 
^H-NMR : 6 4.22 (distorted, t, 2x -O-CH2), 3.05 (distorted, t, 2x - S-CH2), 
1.06 (CIO-CH3), 0.66 (CI3-CH3), 0.91 and 0.78 (side chain methyl protons). 
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Mass : m/z 536 (M+, C31H52O3S2), m/z 476 (C29H48O3S), m/z 416 
(C27H44O3) 
CD : [61^^93 = - 77723 and [e]"240 = + 22277 
6P-Oxv-6a-thiodimethvlene-5-hvdroxv-5a-cholestan-3-one(XCI): 
Elution : Pet. ether : ether (5:1), yield : (0.53 g), m.p. 101°. 
Analysis Found : C, 71.15; H, 10.13; S, 6.70 
C29H48O3S requires : C, 71.11; H, 10.09; S, 6.72% 
IR : Vmax 3430 (OH), 1715(C=0), 1225 (S-CH2), 1140 (C-0) and 1055 cm'' 
(oxathiolane ring). 
' H - N M R : 8 4.1 (t, -OCH2), 3.15 (t, -SCH2), 1.2 (CIO-CH3), 0.69 (CI3-CH3), 
0.85 and 0.78 (side chain methyl protons). 
Mass : m/z 476 (M+, C29H48O3S), m/z 416 (C27H44O3). 
CD: [ 9 ^ 9 6 - - 9 4 1 7 
3a-Oxv-3P-thio.6P-oxv-6a-thio-bis-dimethvlene-5-hvdroxv-5a-chol-
estane (XCII) : 
Elution : Pet. ether : ether (4:1), yield : (0.45 g), m.p. 170°. 
Analysis Found : C, 69.38; H, 9.69; S, 11.92 
C31H52O3S2 requires : C, 69.41; H, 7.70; S, 11.94% 
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IR : Vmax 3490 (OH), 1215 (-SCH2), 1140 (C-0) and 1050 cm"^  (oxathiolane 
ring) 
^H-NMR : 54.15 (distorted t, 2X-O-CH2), 3.2 (distorted, t, 2X-S-CH2), 1.1 
(CIO-CH3), 0.62 (CI3-CH3), 0.87 and 0.75 (side chain methyl protons). 
Mass : m/z 536 (M+, C31H52O3S2), m/z 476 (C29H48O3S), m/z 416 
(C27H44O3) 
CD : [ 0 ^ 9 5 = -49010 
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THEORETICAL 
To be of any use to us, an H-NMR spectrum must be assigned with 
respect to the hydrogens in the structure of a molecule of an organic 
compound. Once this has been done more information can be extracted such 
as the values of the couplings which give conformational information (for 
example via the Karplus equation). An assignment is also crucial in 
interpreting the results of other NMR experiments, such as nuclear overhauser 
effect (NOE) or relaxation time studies. If the structure is unknown, the 
spectroscopist attempts to fit the spectrum to a series of trial structures until a 
consistent assignment is found . This is the way 'H-NMR spectrum is used in 
structure elucidation. To explain the usefulness o f ' H - N M R spectroscopy ' H -
NMR spectrum of ethyl alcohol is taken. The H-NMR spectrum of pure 
anhydrous ethyl alcohol (1) is shown in Fig. 1 
(I) (Fig. 1) 
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Due to the presence of the electronegative substituent, the methylene 
protons should appear at the lower field than the methyl protons Fig.l. The 
spectrum of 1-0-methyl-a-D-glucopyranoside shown in fig. 2, is rather 
complex. Certain peaks can be assigned on the basis of shift arguments, for 
example an anomerie proton H and characteristically sharp methyl protons 
resonance of methyl group (B). A complete assignment could not be made by 
this spectrum alone . 
1 
bo 
. . . . , 
<T> 
1 
CO 
Co 
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CO 
en 
1 
CO 
x^  
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CO 
NJ 
(II) (Fig. 2) 
It has been shown that such an assignment can be made with the help of 
one two-dimensional spectrum. A two-dimensional NMR cosy spectrum 
comes in aid to make definite the position and orientation of various coupling 
protons leading to over all configurational and conformational picture of the 
molecule clear. Before dealing with the 2D-NMR spectroscopy few simple 
term and principle should be cleared at this stage. 
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* Cosy : Cosy stands for correlation spectroscopy ' ' 
* Fi and F2 : In two-dimensional spectroscopy intensity is plotted as 
function of two frequency axes usually called F] and F2 
Two forms of graphical display are commonly used to exhibit the two-
dimensional NMR cosy spectrum ' . 
* The stacked plot: In stacked plot a series of F2 spectra for different Fi-
values are plotted one above another. To show the spectral features 
clearly, each trace is shifted over by a constant amount relative to the 
preceding one. (Fig 3a). 
Contour : In the second mode of representation, the contour plot, the 
peaks in the stacked plot are viewed from above, then a section is taken 
at a certain height above the plane of the Fi and F2 axes and contours 
where this intersects the peaks are plotted (Fig 3b). The stacked plot 
(Fig. 3a) and contour plot (Fig. 3b) are shown for chloroform. 
• 
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100 (Hz) 
77.7 5(1^C) 
(III) (Fig. 3a,b) 
77.7 
^ F 2 
100 F 
(Hz) 
In the cosy spectrum, the Fi co-ordinates of the peaks in the two-
dimensional spectrum also correspond to those found in the normal one-
dimensional spectrum and to emphasize this point the one-dimensional 
spectrum has been plotted alongside of Fi axis. Homonuclear or heteronuclear 
cosy spectra (Fig. 4a and b) differs from each other, the point of difference is 
whether H-NMR one-dimensional spectrum or CNMR spectrum is plotted 
I T T 1 I T T 1 3 . 
along F2-axis. H- H-NMR homonuclear cosy spectrum (Fig. 4a) and H- C-
NMR heteronuclear cosy spectrum (Fig. 4b) of dibromo-adamantanone (4) 
were shown below. 
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1 u 1 H- H-NMR homonuclear cosy spectrum of dibromo adamantanone 
(IV) (Fig. 4a) 
./^ 
1 T ¥ 13/ H- CNMR heteronuclear cosy spectrum of dibromo adamantanone 
(IV) (Fig. 4b) 
• 
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Detail Study of 2D-NMR Cosy Spectrum of Ethyl Alcohol (1) 
H- H-NMR homonuclear cosy spectrum of ethyl alcohol is depicted in 
(Fig. 5a) in which methyl protons appear as triplet at 6 1.28, methylene 
protons as multiplet 5 3.62 and hydroxy proton as triplet at 5 5.28. To explain 
the couplings of protons present in ethyl alcohol following steps are to be 
followed. 
• The contours are numbered 1,2,3,4,5,6 and 7. 
A line (diagonal) is drawn from one comer to another joining contours 
1,2 and 3. These contours are known as diagonal peak multiplets. The 
contours 4,5,6 and 7 are known as cross-peak multiplets. 
Methyl protons which appear as triplet is because of the coupling with 
methylene protons which is confirmed by cross peak multilpets. 
Methylene protons which appear a multiplet due to coupling with 
methyl and hydroxyl protons as evidenced by cross peak multiplets 4 
and 7. 
• Hydroxyl proton, coupled with methylene protons appears as triplet 
cross peak multiplet 6 present in spectrum supports it. 
H- H-NMR homonuclear cosy spectrum for example of ethyl alcohol 
explains with full certainly the proton couplings and identifies the coupled 
protons. 
• 
• 
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H- H-NMR homonuclear cosy spectrum of ethyl alcohol 
^ ^ 1 3 c - N M R ( l ) ( F i g . 5 a ) 
CH2 C.H3 
C H 3 - C OH 
H H 
1 
80 60 
' H - " C - N M R heteronuclear cosy spectrum of ethyl alcohol 
(1) (Fig. 5b) 
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Heteronuclear one bond correlation plot for ethyl alcohol (J adjusted to 
140 Hz) is shown in Fig. (5b). The 5 1.28 was correlated to 5c 18 Hz (at A) 
and those of methylene protons of chemical shift 8 3.62 (at B) to 6c 58.0Hz. 
• In this example of ethyl alcohol, we find possible coupling of protons, 
or triplet for CH3, multiplet for CH2 and again a triplet for OH in the 
H-NMR spectrum. These couplings were possible because of the 
presence of cross peak multiplets 5, 4-7 and 6, which were present on 
either side of diagonal in H- H-NMR homonuclear cosy spectrum 
(Fig. 5a). Therefore it can be concluded that diagonal peak multiplet 
and cross peak multiplet indicate chemical shift and coupling of 
protons respectively. If there is no cross peak multiplet, there is no 
coupling and peak of the proton will be singlet. 
2D-NMR spectral study of 1-O-a-D-glucopyranoside. 
OMe B 
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In the cosy spectrum of 1-0-a-D-glucopyranoside (Fig. 6) 
the sharp resonance at 6 3.3 is clearly for the OMe group. 
The lowest field multiplet H at 54.68 is easily identified as the 
anomeric proton. H] on the basis of its characteristic chemical shift. 
• 
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With the aid of cosy spectrum it is possible to assign this spectrum by 
using the anomeric proton as a starting point and following the three bond 
couplings round the molecule. 
• Multiplet H shows a clear cross peak to C identifying C as H2. 
• Multiplet C shows a cross peak to E identifying the latter as H3. 
Multiplet E shows a cross peak to the highest field multiplet, A, which 
is partly obscured by the OMe resonance. 
We thus identify multiplet A as being fi:om H4. 
Multiplet A shows a cross peak to D, though this is some what 
obscured by the stronger cross-peak between A and E, D is therefore 
identified as H5. 
Finally, D shows cross-peaks with both F and G while F and G also 
show a cross peak between them. Thus F and G are the two-methylene 
protons 6 and 6'. 
The only slight difficulty with this assignment is in recognizing which 
of the multiplets E and D, a particular peak correlates with. Careful 
examination of the spectrum will show that cross peaks marked AE and CE 
align with in another and not with the cross-peaks marked DG and DF. Thus 
the cosy spectrum has enabled us to follow the chain of couplings round 
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the molecule and find complete assignment. If a proton is coupled to more 
than one neighbouring proton, the diagonal peak forms a comer of several 
squares. This makes it possible to identify the positions of the resonances of 
the coupled nuclei even in complicated spectra. As an example figure (7) 
shows the 500 MHz cosy spectrum of glutamic acid (5)^. 
CHOI 1 2 3 4 5 
HOOC-CH-CH2-CH2-COOH CH2R) 
CH213) 
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I I I I ' ' ' I I I I I I I I I I L_J 
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P2 
(V) (f'vi 7) 
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The spectrum at the upper and left edges of the diagram is the normal 
one-dimensional 500 MHz H-NMR spectrum. In the cosy spectrum we find 
three signals (1-3) on the diagonal which correspond to the three multiplets in 
the normal one-dimensional spectrum from these diagonal peaks and cross 
peaks we can draw two squares which enable one to see immediately which 
multiplets belong to the mutually coupled protons i.e. multiplets 1,2 and 3 
belong to protons at C3, C4 and C2. 
Thus the 2D-NMR cosy spectroscopy is an important aid in 
assigning H-resonance. It is for superior to decoupling experiments since it 
gives connectivity information on all the coupled nuclei. Since the protons at 
C3 are coupled both to one proton on C2 and to two protons on C4, the 
multiplet, which is to be assigned to the C3 protons, forms a comer of two 
4 
squares . 
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DTSCUSSION 
All the NMR spectra described up to now have two dimensions, the 
abscissa which corresponds to the frequency axis, from which one reads off 
the chemical shifts and the ordinate which gives the intensities of the signals. 
However, when we speak of a two-dimensional, 2D-NMR spectrum we 
understand this to mean a spectrum in which both the abscissa and the 
ordinate are frequency axis, with the intensities constitute a third dimension. If 
chemical shifts are plotted along one of the frequency axis and coupling 
constants along the other, we call this a two-dimensional (shift)-correlated 
NMR spectrum. From the practical NMR spectroscopist's point of view the 
most important 2D spectra of the latter type are those which show either H-
H or H- C chemical shift correlations. 
During our four decades in the field of steroids research we have faced 
time and again various stereochemical problems while interpreting spectral 
data of the synthesized compounds. 2D-NMR spectroscopy now has given a 
new spectral technique to overcome the confirmational uncertainity and 
justified the assignments of the spectral data. While writing this chapter we 
are ftilly aware of the fact that avoiding mathematical and other difficult 
parameter we are trying to study 2D-NMR spectroscopy taking the examples 
of steroidal compounds. For this purpose we have selected steroidal 
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compounds such as 3P-hydroxycholest-5-ene (VI) 2a, 7a-dibromocholest-4-
7 8 
ene-i, 6-dione (VII), 6-oxa-B-homo-5a-cholestan-7-one (VIII), 3P-acetoxy-
9 10 
6-amino (N, N dimethyl)-cholest-5-ene (IX), 3P-chloro-5a-cholestan-6-one 
(X) and 3P-acetoxy-5, 6P-dibromo-5a-cholestane (XI), for homo and hetero, 
nuclear cosy NMR spectral studies. 
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ITT 1 H- H-NMR Homonuclear Cosy Spectral Studies of 3p-Hvdroxv-
Cholest-S-ene rVD (Fig. Sa^ t : 
I T T 1 In H- H-NMR Homonuclear cosy spectral studies of 3(3-hydroxy-
cholest-5-ene (VI), normal one dimensional spectrum is plotted alongside with 
the two axis (Fj and F2) of cosy spectrum which identify the complete chain of 
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coupling protons. The important and pertinent point in H- H-NMR 
homonuclear cosy spectral are diagonal peak multiplets centred around the 
same F] and F2 frequency coordinates which indicate the chemical shifts and 
cross peak multiplets which are centred around different F] and F2 co-
ordinates and indicate the coupling. If there is no cross peak multiplets, there 
is no coupling and the peak in H-NMR spectrum must be singlet. H- H-
NMR homonuclear cosy spectral studies of 3P-hydroxy-cholest-5-ene (VI) 
exhibits a contour at 6 5.4 (H-6 olefmic). The contour at 8 3.48 for (H-3a) as 
diagonal peak multiplets has cross peak multiplets on either side of the 
diagonal. These peaks indicate coupling of H-3a with H-2 and H-4 protons. A 
singlet at 6 2.50 is of hydroxyl proton. 
^H-"C-NMR Heteronuclear Cosy Spectral Studies of 3p-hvdroxv-
cholest-5-ene (YD (Fig. 8b^: 
H- C-NMR Heteronuclear cosy spectral studies of 3(3-hydroxy-
cholest-5-ene (VI) correlates the signals obtained in H-NMR spectrum to 
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axis (Fi) and H-NMR chemical shifts to Y axis (F2). The cosy spectrum thus 
obtained correlates the signals at 6 5.4 ( H-6 Olefmic proton) to 6c 122 (C6), 8 
3.48 (mc, H-3a, axial) to 5c 72 (C3). 
2D-NMR spectral study of 2a.7a-dibromocholest-4-en-3-6-dione 
(VTT) (Fig. 9a, b ) : 
2D-NMR spectral study of 2a, 7a-dibromocholest-4-en-3, 6-dione 
(VII) was studied with the interest of its application to configurational study at 
bromine containing carbons. 
' H . ' H - N M R Homonuclear Cosy Spectrum of 2a. 7a-dibromo-
cholest-4-en-3. 6-dione ( V m (Fig. 9a) : 
The 2D-NMR homonuclear cosy spectrum of dibromoketone (VII) 
(Fig. 9a) explained the stereochemistry of bromine atom at C2 and C7 through 
the coupling of the protons at C2 and C7 whose chemical shift and 
multiplicity are given. If we study the H- H-NMR homonuclear cosy 
spectrum (Fig.9a) we find a sharp intense singlet appearing on diagonal at 8 
6.32. There is no connecting cross peak multiplet and therefore no proton is 
coupling with this proton which is assigned to C4-H (olefmic proton). A 
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double doublet at 8 4.85 (Jae=5Hz and Jaa = 14 Hz) is assigned to C2-proton. 
The Cosy spectrum shows so called cross peak multiplets at 5 2.49 and 2.65 
which means that the C2 proton is coupled to two protons at CI whose 
chemical shifts are 62.49 (H-la) and 82.65 (H-IP). The coupling constants 
implies that C2-proton is axial (^-oriented) and bromine is equatorial (a-
oriented). A doublet at 84.4 was assigned to H-Vp. The correlation spectrum 
(Fig. 9a) gave cross peak multiplets at 81.75 (assigned to (H-SP)). This 
indicates that the doublet at 8 4.4 is (J = 3 Hz) coupled with H-SP which is 
axial. Since the J value is 3 Hz therefore H-7-proton is equatorial (P-oriented) 
and C7-bromine is axial (a-oriented). 
Study of ^H-^^C-heteronuclear Cosy Spectrum of 2a. Ta-dibromo-
cholest-4-en-3. 6-dione (Vm (Fig. 9M : 
The signal at 8 6.32 (s, H-4olefinic) is correlated to 8c 126.5 (C4), 
84.85 (H-2p) correlated to 8c 49.13 (C2). H-7|3 appeared as a doublet at 84.4 
due to the coupling with H-8p and correlated to 8c 57.613 (C7), 81.78 (H-8p) 
is correlated to 8c 30.78 (C8). The Cl-H (a and p) are at 82.65 and 2.49 and 
correlated for CI at 8c 47.4. 
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2D-NMR spectral study of 6-oxa-P-homo-5a-choIestan-7-one (VIII) 
(Fig, 10a) : 
For H- H-NMR homonuclear cosy spectrum of the lactone (VIII), 
normal one dimensional spectrum is plotted alongside the two axis (F] and F2) 
of cosy spectrum, which reveal and identify the complete chain of coupled 
protons. 
^H-^H-NMR homonuclear of cosy spectrum of 6-oxa-p-homo-5a-
cholestan-7-one rVTin (Fig. lOa^ : 
In the H- H-NMR homonuclear cosy spectrum of lactone (VIII), the 
H-5a proton appeared at 5 4.17 in considerable downfield because of the 
presence of-O-CO- moiety adjacent to C5 as double doublet coupled by H-4a 
and H-4I3 protons with Jaa = 13 Hz, Jae = 5.5 Hz. The coupling is confirmed 
by cosy spectrum where two cross peak multiplets at 51.85 (H-4P) and 8 1.97 
(H-4a) were obtained. The H-7aPat 5 2.00 appeared as double doublet with 
Jea = 4.5 and Jgem = 13.5 Hz), andH-7aais found at 5 1.89 also as double 
doublet with Jaa = 15 and Jgem =13.5 Hz). TheH-7a protons are coupled with 
H-8P proton (at §1.80) which is axial in nature. 
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_ o 
CO w 
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'H-'^C-Heteronuclear NMR cosy spectrum of 6-oxa-P-honio-5a-
cholestan-7-one fVim (Fig. lOh^ : 
The ' H - N M R signal at 8 4.17 (H-5a) is correlated at 8c 83.864 (C5), 
the ' H - N M R peaks at 8 1.85 (H-4(3) and 8 1.97 (H-4a) are correlated to 8c 
39.441 (C4) and two another proton signals at 8 2.0 {H-7ap) and 8 1.89 (H-7ac^ 
were correlated at 8c 39.783 (C7), 81.80 (H-8(3) is correlated to 8c 30.78 (C8). 
Thus the H-NMR values for protons in C4, C5 and C7 were correlated with 
H- C-NMR hetero-nuclear cosy spectrum (Fig. 1 Ob). 
2D-NMR spectral study of 3p-acetoxv-6-amino (N, N-dimethvl) 
cholest-5-eneaXHFig. 11): 
' H - ^ H - N M R homonuclear cosy spectrum of 3P-acetoxv-6- amino (N, 
N-dimethyn cholest-5>-ene (JX) (Fig, l l a ^ : 
^H-^H-NMR homonuclear cosy spectrum of 3P-acetoxy-6-amino 
(N, N-dimethyl) cholest-5-ene exhibits a diagonal peak multiplet at 85.89 and 
so called cross-peak multiplets at 82.24, 1.85 and 1.70. It implies that H-3a 
proton is coupled by other protons whose shift is 8 2.24, 1.85 and 1.70. It 
seems that both the equatorial protons at H-4a and H-2a are equivalent 
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appeared at 82.24 and the H-4(3 and H-2P appeared at §1.70 and 1.85 
respectively. This conclusion is drawn from H- H-NMR-connectivities by 
cosy spectrum Fig. 11a. Out of the two-N-methyl protons, one methyl protons 
are appearing as singlet at 53.09 because cosy spectrum (Fig. 11a) does not 
show any cross-peak multiplet correlating this peak. Second N-methyl protons 
gave a doublet at 62.74 cosy NMR spectrum (Fig. 11a) has a cross-peak 
multiplet at 81.85. This shift corresponds to H-7P with J=4 Hz in the 
equatorial proton present at C7 coupled with the N-methyl protons. The 
acetate methyl protons had given a peak at 8 2.13 since there is no cross peak 
multiplet and therefore peak appeared as singlet. 
' H - ' ^ C - N M R heteronuclear cosy spectrum of 3p-acetoxv-6-ammo 
(N. N-dimethyi;> cholest-5-ene (JX^ (Fig. Uh) : 
In the H- C-NMR heteronuclear cosy spectrum of 3(3-acetoxy-6-
amino (N,N-dimethyl) cholest-5-ene (IX), the peak at 8 5.89 (H-3a) is 
correlated at 8c75.10 (C3). In the similar manner the two N-methyl peaks at 
83.09 and 2.74 are correlated at 8c 47.98 (C'l) and 44.78 (C'2). The peak at 
82.13 (s, -O-CO-CH3) is correlated to 8c 21.40 (H3C'3-COO). 
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^H-^H-NMR Homonuclear Cosy Spectrum of 3|3-chloro-5a-
cholestan-6-one (X) (Fig. 12a) : 
H- H-NMR homonuclear cosy spectrum of 3P chloro-5a-cholestan-6-
one (X) (Fig. 12a), explained that H-3a proton at 63.8 appeared as multiplet is 
coupled by H-2p (6 2.05), H-2a (5 2.08), H-4a (5 2.15) and H-4P (62.13). 
similarily H-5a proton at 62.28 is coupled by H-4a (2.15) and H-4p (6 2.13) 
because of presence of cross peak multiplets, on these chemical shifts. There 
isH-8p (61.76) and gem coupling between H-7a (6 2.30) and H-7p (6 2.33). 
' H - ' ^ C - N M R Heteronuclear Cosy Spectrum of 3p-chloro-5a-
cholestan-6-one m (X^ (Fig. 12h^: 
^H-'^C-NMR cosy spectrum (Fig. 12b) correlates 6 3.8 (H-3a) to 6c 
59.1 (C3), 6 2.28 (H-5a) to 6c 58.2 (C5), 62.33 and 2.30 (H-7p and H-7a) to 
6c 46.6 (C7), 62.15 and 2.13 (H-4a and H-4p) to 6c 39.426 (C4) and finally 6 
2.05 (H-2p) and 2.08 (H-2a) to 6c 32.447 (C2). 
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^H-^H-NMR Homonuclear Cosy Spectrum of 3|3- acetoxv 5, 6^-
dibromo-5a- cholestane (XI) (Fig. 13a) : 
H- H-NMR homonuclear cosy spectrum (Fig. 13a) gave a multiplete at 
5 5.48 well separated from the rest of the spectrum assigned to (H-3a), the 
cosy spectrum shows so called cross peak multiplets at 81.94 (H-2a), 1.64 (H-
2p), 2.59 (H-4a) and 2.27 (H-4p), this means that H-3a is coupled to C2 and 
C4 proton (both axial and equatorial), a peak found at 5 4.83 is assigned to H-
6a. The cosy spectrum (Fig.l3a) exhibits cross peaks multiplets at 5 2.66 and 
5 2.06. The (H-6a) which is equatorial in nature is coupled by C7 axial and 
equatorial proton appearing at 62.06 and 8 2.66 respectively. A peak at 8 2.66 
assigned to H-7p is coupled by H-6a (8 4.83), H-7p (8 2.66) and H-7a (8 
2.06). the peak at 82.06 assigned to H-7a is similarly coupled by H-6a (84.83) 
andH-8p(8l.88). 
' H - " C NMR Heteronuclear Cosy Spectrum of 3p-acetoxv,5.6p-
dibromo-5a- cholestane (XI) (Fig. 13b) : 
'H-^^C NMR heteronuclear cosy spectrum (Fig. 13b) correlates the 
chemical shift 8 and 8c and there by explaining a definite position of proton in 
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the spectrum, 6 5.48 (H-3a) is correlated to 8c 72.01 (C3), 6 4.83 (H-6a) to 6c 
56.09 (C6), 8 2.66 (H-7(3) 8 2.06 (H-7a) to 8c 31.18 (C7), 8 2.27 (H-4a), 8 
2.59 (H-4p) are correlated to 8c 41.94 (C4). Similarly 8 1.94 (H-2a) and 81.64 
(H-2P) are correlated to 8c 26.16 (C2). So by this heteronuclear one bond 
correlation of 3P-acetoxy-5, 6P-dibromo-5a-cholestane (XI) (Fig. 13b) 
complete assignment of different protons can be done. 
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EXPERTMENTAT. 
All melting points were observed on a Kofler hot block apparatus and 
are uncorrected. I. R. spectra were determined in KBr with JASCO A-100 
spectrophotometer. NMR spectra were recorded in CDCI3 on Varian XL-400 
MHz. Mass spectra were measured on a JEOL JMS DX-300 mass 
spectrometer. TLC plates were coated with silica gel. A 20% aqueous solution 
of perchloric acid was used as spraying agent. Light petroleum ether refers to 
a fraction of b.p. 60-80°. NMR values were given in ppm (s = singlet, d == 
doublet, dd = double doublet, t = triplet). 
Reaction of cholesterol (VT) with pyridium dichromate : 
To a solution of cholesterol (VI) (10 g) in N, N-di-methyl formamide 
(220 ml), pyridium dichromate (44 g) was added and the reaction mixture was 
stirred at room temperature for 4 hrs. the progress of the reaction was 
monitored with the help of TLC plates. After completion of the reaction, water 
(220 ml) was added and the reaction mixture was worked up with ether. The 
ethereal layer was washed with water, dilute hydrochloric acid, sodium 
bicarbonate solution (5%) and water and dried over anhydrous sodium 
sulphate. Evaporation of the solvent provided the yellow solid which was 
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recrystallized from methanol to give cholest-4-en-3, 6-dione (XII), yield 8.7 g, 
m.p. 124°C (reported^ V . p . 122-123°C). 
Reaction of cholest-4-en-3T 6-dione (XTI) with N-bromosuccinimide 
in the presence of benzoyl peroxide : 
To a solution of cholest-4-en-3, 6-dione (XII) (2 g) in dry benzene (60 
ml), N-bromosuccinimide (2g) was added under refluxed condition in small 
portions over a period of 3 hrs in the presence of benzoylperoxide (as 
catalyst). After complete addition, the reaction mixture was further heated for 
1 hr and then the solvent was evaporated under reduced pressure. The residue 
so obtained was dissolved in ether. The ethereal layer was washed with water, 
sodium sulphite solution (5%) and water successively and dried over 
anhydrous sodium sulphate. Removal of the solvents provided a brown solid 
which was chromatographed over silica gel column. Elution with petroleum 
ether : ether (8:1) provided a white solid which was recrystallized from 
methanol to afford 2a, 7a-dibromocholest-4-en-3, 6-dione (VII), yield 1.52 g, 
m.p. 179-180°C (reported'', m.p. 180°C). 
3p- Chlorocholest-5-ene (XIID ; 
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Freshly purified thionyl chloride (15 ml) was added to cholesterol (VI) 
(20g; 51.8 mmol) at room temperature. A vigorous reaction ensued with the 
evolution of gaseous products. When the reaction slackened the mixture was 
gently heated at a temperature of 50-60° on a water bath for 30 min and then 
poured onto crushed ice with stirring. The yellow solid thus obtained was 
filtered under suction and washed several time with ice cooled water and air 
dried. Recrystallization from acetone gave 3P-chlorocholest-5-ene (XIII) 
(19.2g; 47.466 mmol), m.p 95-96° (reported^^ m.p 96-97°). 
ChQkst=5=snsJxm' 
3p-Chloro cholest-5-ene (XIII) (10 g; 24.72 mmol) was dissolved in 
warm amyl alcohol (200 ml) and sodium metal (24 g) was added in small 
portions to the solution with continuous stirring over a period of 8 hr. The 
reaction mixture was heated occasionally during the course of the reaction in 
order to keep the sodium metal dissolved. The reaction mixture was poured 
into water, acidified with HCl and allowed to stand over night. A white 
crystalline solid thus obtained was fihered under suction and washed 
thoroughly with water and air dried. Recrystallization of the crude material 
from acetone gave cholest-5-ene (XIV) in cubes (7.2 g; 19.459 mmol), m.p. 
94-95° (reported '^* m.p. 89.5-91.2). 
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6-Nitrocholest-5-ene (XV) : 
A suspension of finely powdered cholest-5-ene (XIV) (6.0 g) in glacial 
acetic acid (50 ml) was vigorously stirred at room temperature and treated 
with nitric acid (15 ml, d, 1.5), followed by the addition of sodium nitrite (3.0 
g) over a period of 1 hour. The reaction mixture was poured into cold water 
and the yellow product thus obtained was extracted with ether. The ethereal 
layer was washed successively with water, sodium bicarbonate solution (5%) 
(until the washings were pink) and again with water and dried (anhydrous 
sodium sulphate). Removal of the solvent provided the desired compound 
(XV) as an oil which was crystallized from ethanol as leaflets (4.5 g), m.p. 
119-120° (^eported^^ m.p. 120-121°). 
3pChloro-6 nitrocholest-5-ene (X\D : 
To a well stirred mixture of 3p-chlorocholest-5-ene (XIII) (6g; 14.8 
mmol), glacial acetic acid (50 ml) and nitric acid (12.5 ml, sp,gr.l.52) at room 
temperature, was added sodium nitrite (1.8 gm), the mixture was further 
stirred for 1 hr. The content was diluted by the addition of water (100 ml) and 
the stirring was continued for 10 min more. The yellowish solid thus separated 
and air dried. The desired product (XVI) was recrystallization from methanol 
as needles (3.6 g; 8.009 mmol), m.p 150-152° (reported^^ m.p. 149°) 
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5a-Cholestan-6-one (XVII): 
6-Nitrocholest-5-ene (XV) (6.0 g) was dissolved in warm glacial acetic 
acid (120 ml) and water (12 ml) and zinc dust (12.0 g) was gradually added 
with shaking. The mixture was heated under reflux for 4 hours. Zinc powder 
(unreacted) was removed by filtration and the filtrate was diluted with water. 
5a-Cholestan-6-one (XVII) crystallized out as thin plates and was 
recrystallized from ethanol (3.5 g), m.p. 96-98° (reported'^, m.p. 98-100°). 
Baeyer-Villiger Oxidation of 5a-cholestan-6-one (XVII) : 
6-Oxa-B-homo-5a-cholestan-7-one(VIII): 
To a solution of 5a-cholestan-6-one (XVII) (5.0 g) in chloroform (50 
ml) was added a chloroform solution of perbenzoic acid (2.5 mole equivalent) 
and few crystals of p-toluenesulphonic acid and the reaction mixture was kept 
at room temperature for 72 hours. The progress of reaction was monitored by 
TLC and then it was poured onto crushed ice-water mixture and extracted with 
large excess of ether. The organic extract was washed successively with water, 
sodium bicarbonate solution (5%) and water and dried (anhydrous sodium 
sulphate). Removal of the solvents under reduced pressure gave an oil (3.3 g) 
which was chromatographed over silica gel (60 g, each fraction of 20 ml was 
taken). Elution with light petroleum - ether (4:1 and 2:1) gave the lactone 
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(VIII), recrystallized from light petroleum (1.75 g), m.p. 146-148°C. 
g (reported , m.p. 155°). 
3P-Acetoxv cholest-5-ene (XVIID : 
A mixture of cholesterol (VI) (50.0 g), pyridine (75 ml, freshly distilled 
over KOH) and freshly distilled acetic anhydride (50 ml) was heated on a 
steam bath for 2 hrs. The resulting brown solution was poured onto crushed 
ice-water mixture with stirring. A light brown solid was obtained which was 
filtered under suction, washed with water to remove pyridine and air dried. 
The crude product on recrystallization from acetone gave pure 3P-acetoxy-
cholest-5-ene (XVIII) (45.0 gm), m.p. 114-115° (reported''*, m.p. 116°). 
3p-Acetoxv-5.6p-(libroino-5a-cholestane (XI): 
To a solution of 3P-acetoxycholest-5-ene (XVIII) (14.5 g) in ether (100 
ml) was added gradually the bromine solution (9.6 g in 100 ml) of glacial 
acetic acid containing (1.0 g of anhydrous sodium acetate) with continuous 
stirring below 20°C. A white solid formed, which was filtered under suction 
and washed thoroughly with cold ether - acetic acid (3:7) mixture. The dried 
dibromide (XI) was crystallized fi-om acetone with traces of ethyl acetate and 
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methanol (15.78 g), m.p. 115-117° (reported", m.p. 114.5-118°). Compound 
showed a positive Beilstein's test. 
Reaction of 3P-acetoxv-5, 6P-dibromo-5a-cholestane (XI) with 
dimethylamine: 3P-Acetoxv-6-amino (N. N-dimethvl) cholest-5-
ene(IX) : 
To a solution of 3|3-acetoxy-5, 6|3-dibromo-5a-cholestane (XI) (1.5g) 
in benzene extra pure crystallizable (20ml), dimethyl amine (40%) solution 
(2.98 ml) was added gradually over stirring for half an hour at room 
temperature. The solvent was evaporated in vacuum and the residue was 
redissolved in ether. Ethereal layer was washed successively with water 
several times, very dilute hydrochloric acid solution, water, 
sodiumbicarbonate solution (5%) and water and dried over anhydrous sodium 
sulphate. Evaporation of the solvent gave an oil which was recrystallized from 
chloroform-methanol afforded 3P-acetoxy-6-amino (N, N-dimethyl) cholest-
5-ene (IX) as needles (l.lg), m.p.^ 165°C. the compound showed negative 
Beilstein's test. 
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3p-Chloro-5a-Cholestan-6-one (X); 
To a solution of 3p-chloro-6-nitrocholest-5-ene (XVI) (3.0 g; 6.674 
mmol) in hot glacial acetic acid (70 ml), zinc dust (6 g) was added gradually 
in small portions with constant shaking. The suspension was heated under 
reflux for 4 hr and water (6 ml) was added at regular intervals during the 
course of heating. The hot solution was filtered to remove unreacted zinc 
powder and the filtrate cooled to room temperature, followed by dilution with 
large excess of ice cold water. The organic matter was extracted with ether 
and ethereal solution was washed with NaHCOs solution (10%) and water and 
dried (Na2S04), evaporation of the solvent gave an oil which was crystallized 
from methanol (1.9 g; 4.518 mmol), m.p. 127°-129° (reported^" m.p. 129°). 
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THEORETICAL 
Steroidal drugs, hormones and other biologically active steroids 
possess pronounced and specific biological activities. These steroids play 
important role in metabolism and therapeutics. The knowledge of properties of 
these steroids stimulated us to intensify research on their synthetic 
modification. Cholesterol molecule is the basic skeleton of all steroidal drugs 
and hormones of natural and synthetic origin. Synthetic drugs have been 
prepared by doing modification in the structure of natural steroidal molecule 
or alteration in the basic cholesterol nucleus, it involves the introduction of 
hetero atom at various sites in steroidal nucleus ' . This alteration is always 
aimed to enhance the selectivity of these new derivatives in certain parameters 
of their biological activity. 
To fulfill this aspiration an attempt has been made to test some less 
complicated easily synthesized cholesterol derivatives reported in the past, 
while exposing these derivatives on albino rats brain exclusive and elaborative 
biochemical, pharmacological, behavioural and histopathological studies have 
to be conducted steroids used in this study are : 3P-acetoxy-5 bromo-6P-
succinimido 5a-cholestane, A (I) 3P-chloro 5-bromo-6P-amino-5a-cholestane 
B (II) 3p-acetoxy 6-phthalimido cholest-5-ene, C (III) and 6-Nitrocholest 5-
eno [3a,4a-d] oxazolidin-2'-one D (IV) '^ '^. 
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Literature lacks such type of previous studies or trial of these 
derivatives for the search of new steroidal drugs. Present research work is 
aimed to achieve this motive, work done in this study is based on the facts 
described below. Steroids are known to possess maximum receptors in the 
central nervous system, CNS of all vertebrates is highly enriched in various 
lipid . They play vital role in both the structure and function of neural 
membrane. These lipids are metabolically very active and thus their functional 
significance should not be overlooked. Studies on lipid profile in the CNS 
forms an important part of neurobiochemical investigations. 
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Present research work is confined only upto critical biochemical 
evaluation of total lipid and lipid fraction in major brain parts of albino rat 
(cerebrum, cerebellum, brain stem). Our second motive is to obtain detailed 
critical data based on structure activity co-relationship of cholesterol 
derivatives taken for trial. A large number of heterosteroids have been 
synthesized and screened for their chemical, biological, therapeutic and 
industrial potentials. Modification is done by substituting uncommon 
substituent (hetero atoms) at different position at unusual carbon fi-ame work 
of steroids, it resulted either in decrease or increase in certain biological and 
physiological properties ' ' . Adrenal glands produce steroidal hormones 
which are physiologically significant to our body. Destruction diseases of 
adrenal gland result in their deficiency of adrenal steroids. Symptoms in such 
cases could be studied as a symbol of deficiency of adrenal steroids. Addison 
(1855) was the first scientist who first time studied such clinical syndromes 
resulting fi-om the destruction diseases of adrenal glands. These experiments 
inspired to Brown Sequrad (1856) to do the pioneering experiments on the 
effect of adrenolactomy and concluded that "adrenal glands are essential to 
Hfe". 
By the third decade of this century it was generally recognized that the 
cortex rather than the medulla is the life maintaining portion of the gland. The 
complex nature of adrenocortical deficiency was dramatized in 1930s by 
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Partisan research group, oriented to study either the imbalance of electrolytes 
or the defects in carbohydrate metabolism present in the deficient state. Renal 
loss of Na was convincingly demonstrated to be a characteristic of 
adrenocortical insufficiency by Harrop and associates (1933) as well as by 
Loeb and co-workers . Equally convincing was the demonstration of a 
depletion of carbohydrate stores . Further more, hypoglycemia could be 
corrected by adrenocortical extracts . Glucose and glycogen formed under 
influence of the adrenal cortex during fasting appeared to be derived from 
tissue protein. From these studies emerged the concepts of two types of 
adrenocortical hormones. The mineral corticoids which primarily regulate 
electrolyte homeostasis and the glucocorticoids which are concerned with 
carbohydrate metabolism. This concept of dichotomy of salt and sugar 
hormones (mineralocorticoids and glucocorticoids) has proved useful at the 
present time in modified form. In 1932, the neurosurgeon Gushing described 
the syndrome of hypercorticism bear his name (Gushing 1932). The cases 
Gushing described were those of pituitary basopohilism recognized 
subsequently to be a consequence of hypersecretion of AGTH. 
The preparation of adrenocortical extracts with a reasonable degree of 
activity was first accomplished in 1930. By 1942, organic chemists had 
isolated, crystallized and elucidated the structure of 28 steroids from the 
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9 • 
adrenal cortex . Five of these compounds Cortisol (hydrocortisone, cortisone, 
corticosterone, 11-dehydrocorticosterone and 11-desoxycosterone) were 
demonstrated to be biologically active. Another decade passed before the 
principal mineralocorticoids was discovered in 1950. Deming and Leutscher 
made an attempt to find the principal active material and discovered that the 
extracts of urine from patients with edema induced Na retention and K 
excretion in adrenolactomized rats. The definite evidence for the source of the 
active material was provided who purified the compound with this activity 
from adrenocortical extracts. The substance was crystallized. The structure 
was established and the hormone was named aldosterone . 
In this same era the role of adenohypophysis was being elucidated by 
other investigators. The classical studies of Foster and Smith 1926 established 
the fact that hypophysectomy results in atrophy of adrenal cortex. By 1933, it 
had been demonstrated that cell free exfracts of the anterior pituitary has a 
stimulating effect upon the adrenal cortex of the hypopysectomized animal. 
Further chemical fractionation of such extracts led to the isolation of a 
hormone, ACTH, that acted selectively to cause chemical and morphological 
12 
changes in adrenal cortex. Its structure was established . The rate of release 
of ACTH from adeno hypopysis was shown to be determined by the balance 
of the adrenal cortex and the excitatory effects of the nervous system. 
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13 14 
A detailed analysis of the morphology of the adrenal cortex ' 
suggested that the specific function of Zonaglumerulosa is to autonomously 
elaborating a hormone regulated electrolyte balance. This hormone is now 
known to be aldosterone. Prolonged administration of sexual adrenocortical 
and thyroid hormones produces a feed back reaction causing diminished 
secretion of the corresponding glandotrophic hormones and also bring about 
morphological changes. This changes could be seen histologically discrenible 
in the glandular parenchyma of the adenohypopysis. 
In a similar manner, protracted administration of posterior-lobe 
hormones leads to noticeable morphological adaptive reaction in the 
magnocellular hypothalamus neurohypophyseal system (ORF - 1966). On the 
basis of these empirical finding it was thus conjectured that long term 
application of anterior lobe hormones would bring about morphological 
changes in the paracellular hypothalamic nuclei controlling adenohypophyseal 
activity (ORF - 1969). In 1949, Hench demonstrated the effects of cortisone 
and ACTH in the treatment of rheumatoid arthritis. As early as 1929 Hench 
had been impressed by the fact that arthritis patient when pregnant or 
Jaundiced, experienced a temporary remission, he believed that a metabolite 
was responsible for the remission. The possibility that the antirheumatic 
substance might be an adrenocortical hormone was entertained and as soon as 
cortisone was available it was tested in a case acute rheumatoid arthritis. 
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Fortunately an adequate dose was employed and the response was dramatic. 
Thereafter the detailed salutary effects of ACTH were also demonstrated . 
The noble prize in medicine was Jointly awarded to Kendall and Reichstein 
(who were responsible for much of the basic chemical research that led to the 
synthesis of the steroids) and to Hench, whose contribution has just been 
described. 
According to the British Medical Association reports (1968 on 
therapeutic abortion cited in the famous modies book of medical jurisprudence 
and toxicology), "Long term exposure of oral progestrins, androgens and 
estrogen causes foetal abnormality". The medical termination of pregnancy 
act, 1971 also legalize the abortion of the pregnant women, treated with 
steroidal drugs like cortisone or oral contraceptives . Contrary to above 
report recent study reveals that antenatal corticosteroids given for a short 
period (24hr and 1 week before birth) reduces respiratory distress syndrome, 
neonatal mortality by about 50% with comparable reduction in necrotising 
enterocolitis. 
The benefits of antenatal corticosteroids are likely to out weigh any 
Possible disadvantage due to maternal or neonatal infections. There is no 
evidence of major adverse neurodevelopmental out come in later childhood 
among infants of treated mother "' . Due to this protective effect academic 
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and professional bodies have recommended that with very few 
contraindications the use of antenatal corticosteroids may be considered in 
women likely to deliver prematurely (Royal College meet 1993, NIH 1995). 
Since these are the most effective single strategy for reducing the adverse 
consequences of preterm birth . 
Steroidal therapy has been used extensively in head injury its 
19 
effectiveness has documented in the work of Reulen et al. (1972) . Vanous 
high potency glucocorticoids chiefly dexamethasone have been used widely 
in the management of intracranial hypertension and brain edema. Use of these 
steroids may dramatically and rapidly reduces the focal and general signs of 
brain tumour . It has been confirmed by recent studies that combined oral 
contraceptive improve in the both acne and hirsutum. Role of parathyroid 
hormones and dihydrolachysterol is established in the reduction of lead 
toxicity from the bone. These hormones mobilize lead from the skeleton and 
augment the concentration of lead in blood and the rats of its excretion in 
21 
urine . In case of delayed neuropathy caused by organophosphorus 
compounds treatment with corticoid in such cases modify it for example 
delayed neuropathy caused by triortho - tolyl phosphate (TOTP), but the same 
treatment could not showed protective effect in the case of 0-0-Di-isopropyl 
phosphorofluoridate (DFP) induced delayed neurotoxicity .It is because due to 
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intrinsic differences between the organo phosphorus compound DFP and 
TOTP. 
Sex linked factors have been found to affect rheumatoid arthritis (RA) 
and muhiple sclerosis (MS) in a similar way but both diseases are slightly 
more common among women than man. During Pregnancy, in particular 
during the last trimester condition of both RA and MS tend to become better 
22 
but again become painful in post partmartum . Reason behind these changes 
are complex. Sex hormones or sex determined neuroendocrine factors may be 
23 
involved here . CoUaegen induced arthritis (CIA) and experimental 
autoimmune encephalomyelitis (EAE) are different models and affect 
different target organs but they are both dependent on autoaggressive T-Cells. 
Studies have proved that estrogen suppressess the pregnancy induced EAE 
24 
and the Collagen induced arthritis in mice . 
A lot of artificially synthesized hormones are being used in the general 
treatment, such as NS-3, an analogue of thyrotropin releasing hormone. 
Attempts are being done to produce safer and more effective steroids by 
25 
modifying their structure or incorporating them with other drugs . 
Synthetic glucocorticoids are widely used therapeutically for their 
immunosuppressive and antiinflammatory effects . Use of the adrenal 
27 
Steroids exert opposite effects on immune system in the mammalians . 
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Allauddin and M. Smith (1962)^^ M. Smith and M. F. Surgue (1964)^^ have 
critically reviewed the biological activities in steroids possessing N-atom both 
of natural and synthetic origin. At present steroidal drugs are the only drugs 
which fall under the category of life saving drugs. These drugs are used in 
highest medical emergency to save the life of million of sufferer everyday, 
steroidal drugs are commonly used on the occassions where generally any 
other non-steroidal drug fail to produce any curable effect. A lot of research 
work have been done in the field of hetero steroidal synthesis. Their 
30 31 32 
identification has been done by chemical and spectral studies ' ' . 
Steroidal drugs have been used for a wide range of diseases, for 
example, they are used as antiviral , antiallergic , anticonvulsant , 
antiulcer , analgesic , antifungal , antihypertensive , antifertility , nerve 
exciting , antimineralo , antibacterial , fungicidal , antithyroid ' ' and 
44 45 
growth inhibitor , in cardiac diseases , in skin disorders and as inflammation 
inhibitors . The most alarming international problem of population out burst 
is being tackled by steroidal drugs. Even though a lot of alternate non-
steroidal drugs devices and methods have invented to avoid the conception, 
still steroidal drugs are the first and favourite choice among the family 
planners. 
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When the steroidal hormones interact with the target tissues, these gets 
metaboHcally transformed into more or less active metabolites. For the 
hormones like androgen and testosterone. These transformations appear to be 
of particular importance, this also suggests that these steroids may be a 
perhormones. The brain, like the seminal vesicles, is able to convert 
testosterone to 5a-dihydrotestosterone (DHT) and 3a-5a-androstanediol V 
and VI) and also like the placenta converts testosterone to estradiol (VII) in 
scheme - 1. 
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ANDROGEN HORMONES 
AcetylatioD' 
O' ' : ' HO 
5a-Dihydrotestosterone 
eduction 
H H 
3a-5a-Andro$taanedioI 
(VI) 
OH 
I 
HO 17 p-Estradiol 
(VII) o 
Androstendione 
(VIII) 
Estrone 
(IX) 
Progesterone 
(X) 5a-Dyhydroprogesterone (XI) 
Scheme - 1 
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Conversion never occurs equally in all brain regions. Regional 
distribution of 5a-reductase activity towards testosterone in rat brain is found 
in mid brain and brain stem with intermediate activity in hypothalamus and 
thalamus and lowest activity in cerebral cortex. The pituitary has higher 5a-
reductase activity than any region of the brain and its activity is subjected to 
change as a result of gonadectomy, hormone replacement and post natal age. 
5a-Dihydrotestosterone has been implicated in hypothalamus and pituitary as 
a potent regulator to of gonadotropin secretion but is relatively inactive 
towards male rat sexual behaviour . 
It is interesting that progesterone (X) inhibits 5a-reductase activity 
towards (3H) testosterone and that (3H) progesterone is itself converted to 
(3H) 5a-dihydroprogesterone (XI). Progesterone competition for the 5a-
reductase may explain some of the antiandrogenicity of this steroids . The 
aromatization of testosterone to form estradiol (VII) and of androstenediols 
(VIII) to form estrone (IX) has been described in brain tissue in vitro and in 
vivo ' . Aromatization is higher in hypothalamus and limbs structure than in 
cerebral cortex or pituitary gland in noncastrated animals is higher in male 
than in female brains. Aromatization has been found in brains of reptiles and 
51 52 
amphibia as well as in mammals ' . The capacity to aromatize testosterone 
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and related androgens may therefore be a general property of vertebrate 
brains. The functional role of aromatization has been studied most extensively 
in the rat, male sexual behaviour is facilitated by estradiol and testosterone . 
54 
Facilitation of male sexual behaviour can be blocked by these steroids . 
Similar situation exists in birds, amphibia and reptiles, testosterone and 
estradiol can stimulate hetero typical sexual behaviour in male and females. 
Curiously, not all mammals are like the rat. For example, male sexual 
behaviour of the guinea pig and rhesus monkey is restored by nonaromatizble 
androgens androstenendione and dihydrotestosterone . A number of other 
steroids transformation occur in brain tissue, but this metabolism does not 
appear to be of importance for interaction of those hormones with putative 
receptor sites. It has been found that both (3H) estradiol and (3H)-
corticosterone are recovered from their binding sites in brain . 
Corticosteroids have numerous wide spread effect on living system, 
they influence carbohydrate, protein and lipid metabolism, electrolyte and 
water balance and the functions of cardiovascular system, kidney, skeletal 
muscles, nervous system and other organs and tissues. Further more the 
corticosteroids endow the organism with the capacity to resist many types of 
nexious stimuli and environmental changes. In the absence of the adrenal 
cortex, survival is possible but only under the most rigidly prescribed 
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condition for example, food must be available regularly, sodium chloride 
ingested in the relatively large quantities and environmental temperature 
maintained with in a suitably narrow range. A given dose of corticosteroids 
may be physiological or pharmacological depending on the environment and 
activities of the organism. Under favourable condition, a small dose of 
corticosteroids maintains the adrenalectomized animal in a state of well being. 
Under adverse condition a relatively large dose is needed, if the animal is to 
survive. This same large dose given repetitively under optimal condition 
induces hypercorticism that is sign of corticosteroids excess. The function in 
the secretary activity of a normal subject are presumed to reflect the body's 
varying requirement for corticosteroids. The action of corticosteroids are often 
complexly related to the fiinction of other hormones. For example in the 
absence of lipolitic hormones, Cortisol, even in large concentration has 
virtually no effect on the rate of lipolysis in adipose tissue in vitro. Likewise, a 
sympathomimetic amine become evident. The necessary but not sufficient role 
of corticosteroids acting in concert with other regulatory forces has been 
termed "Permissive". 
Estimates of the potencies of naturally occurring and synthetic 
corticosteroids in the categories of Na^ retention (Reduction of Na^ excretion 
by the kidney of the adrenalectomized animal), hepatic deposition of glycogen 
in fasted andrenalectomized animals and inflammatory effect (inhibition of 
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the action of an agent that induces inflammation) are presented in Table-1. It 
should be noted that such values are not fixed ratios but very considerably 
with the condition of the bioassays used. Potencies of steroids as judged by 
their ability to sustain life in the andrenalectomized animal closely parallel 
those determined for Na retention. Potencies based on deposition of linear 
glycogen antiinflammatory effect, work capacity of skeletal muscles and 
involution of lymphoid tissues closely parallel one another. The 
corticosteroids have been classified in to mineralocorticoids and 
57 
glycocorticoids, according to the potencies in the two categories . 
TABLE - 1 
Relative Potencies of Corticosteroids 
Na"^  Hepatic Anti-
Retention Glycogen inflammatory 
Deposition effect 
Natural Steroids 
Cortisol 1* 1 1 
Cortisone 0.8* 0.8 0.8 
Corticosterone 15 0.35 0.3 
11-Desoxy 
Corticosterone 100 0.00 0.00 
Aldosterone 3000 0.3 ? 
Synthetic Steroids 
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Prednisolone 1 * 
Triamcinolone 0.00 
* Promotes excretion of Na under certain circumstances. Glucocorticoids 
are widely used therapeutically for their immunosuppressive and anti-
inflammatory effects. 
Adrenal steroids have been found to facilitate a form behavioural 
adaptation. In the absence of external stressors adrenal steroids are also 
secreted in varying amounts accounting to the time of day. In noctumally 
active animals as the rat and in animals such as human being which are active 
during the day, the peak of this basal secretion always occurs near the end of 
the sleep period. Thus it is conceivable that adrenal steroid secretion may 
modulate behaviour as a function of the time of day. Indeed it has been 
reported that adrenal steroids modify the detection and recognition thresholds 
for a variety of sensory stimuli and influence the occurrence of the so-called 
58 59 
rapid eye movement or paradoxical phase of sleep ' . Desoxy corticosterone, 
the prototype of the mineralocorticoids is highly potent in regard to Na 
retention but without effect on hepatic glycogen deposition Cortisol the 
prototype of the glucocorticoids is highly potent in regard to linear glycogen 
deposition but weak in regard to Na retention. The naturally occurring 
corticosteroids, Cortisol and cortisone, as well as synthetic corticosteroids such 
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as prednisolone and triamcinolone, are classified as glucocorticoids. However 
corticosterone is a steroids that has modest but significant activities in both 
categories. In contrast, aldosterone is exceedingly potent with respect to Na 
retention but has only modest potency for linear glycogen desposition. At rates 
secreted by the adrenal cortex or in doses that exert maximal effect on 
electrolyte balance, aldosterone has no significant effect on carbohydrate 
57 
metabolism, it is thus classified a mineralocorticoids . 
Change in the molecular structure may bring about changes in 
biological potency as a result of alteration in absorption protein binding rate of 
metabolic transformation, rate of excretion ability to traverse membrane and 
intrinsic effectiveness of the molecule at its site of action, in the follow 
paragraph, modification of the pregnane nucleus that have been of value in 
therapeutic agent are described in following figures. Following list show the 
effect of the modification discussed relative to Cortisol. 
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TABLE - 2 
Relative Potencies And Equivalent Doses Of Corticosteroids. 
Compound 
Relative Relative Duration Approx. 
Antiinfla Retaining of action Equiv. 
mmatory Na^ Dose 
Potencies Potency (mg) 
Cortisol (Hydrocortisone) 
Tetra Hydrocortisol Prednisone 
('^'-Cortisone) Prednisolone 
(^'-Cortisol) 
^6a-Methyl Prednisolone 
Flurocortisone (9a-Flurocortisol) 
11-Desoxycortisol 
Cortisone (1 l-Dehydrocortisol) 
Corticosterone 
Triamcinolone (9a-fluro-16a-methyl 
Prednisolone) 
Betamethasone (9a-fluro-l 6P-methyl 
Prednisolone) 
Dexamethasone (9a-fluro-methyl 
Prednisolone) 
Paramethasone (6a-fluro-16a-methyl 
Prednisolone) 
1 
0 
4 
4 
5 
10 
0 
0.8 
0.35 
5 
25 
25 
10 
1 
0 
0.8 
0.8 
0.5 
125 
0 
0.8 
15 
0 
0 
0 
0 
S 
-
1 
1 
1 
s 
-
s 
s 
1 
L 
L 
L 
20 
-
5 
5 
4 
-
-
25 
-
4 
2 
0.75 
0.75 
*S = Short or 8 to 12 hour biological half life. 
I = Intermediate or 12 to 36 hour biological half life. 
L = Long or 36 to 72 hour biological half life. 
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2V CH2OH 
2 0 c = 0 
(XII) 
Cortisol 
(XIII) 
CH3 p^CHsO 
These dose relationship apply only to oral or intravenous 
administration; relative potencies may differ greatly when injected intra-
musculary or into joint spaces. 
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DTSCUSSION 
Two groups (controlled and experimental) each of 6 male albino rats of 
the average weight 200 ± 20 grams were separately taken for each steroidal 
derivative. Intraperitonial injection (3.0 mg/kg body weight of steroidal 
derivative dissolved in peanut oil) were given daily for 10 days, on 11' day 
animals were sacrificed for biochemical studies. The concentration of total 
lipids, cholesterol, gangliosides and rate of lipid peroxidation was determined 
in major brain parts cerebrum, cerebellum and brain stem. 
TOTAL LTPTDS : 
The major structural and functional constituent of biological membrane 
are lipids, they also serve as essential component of several crucial enzyme 
systems, as fuel molecules as highly concentrated energy store . In 
mammalian central nervous system, lipids comprise over half of the dry 
weight . Almost all the lipids in CNS are found in membranes of cells. 
Different types of membranes accumulate different types of lipids. These 
brain lipids are constantly being synthesized replacing other molecules in 
membranes . Lipids in the brain modulate the structure fluiding and of 
function of the biomembrane . The brain lipids constitute components of ion 
channels and neurotransmitter receptors. On the other hand, they are also 
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major constituents of myelin . Lipids in the brain makes upto 65% of the dry 
64 
weight of the white matter and 34 - 40% of gray matter . Distinct regional 
differences occur in lipids contents, turn over in cell types and various 
pathways and centers of the brain . Changes in the level of total lipids in the 
brain may occur by various physiological and chemical stressors and 
aging ' . Changes in lipid fractions are induced by the steroids estrogen and 
/TO 
progesterone in discrete brain parts . In the present study an attempt has been 
made to study the elevation, deprivation in the level of total lipids in the 
various parts of brain in albino rats. As far as the survey of literature is 
concerned, no previous report on the structure activity relationship of various 
derivatives of cholesterol on the brain lipid profile is available following the 
administration of four derivatives of cholesterol A(I), B(II), C(III) and 
2fl b c 
D(IV) ' ' , injected ip 3.0 mg/kg body wt for 10 days in albino rats. 
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AcO Br 
3P-Acetoxy-5-bromo- 3P-ChIoro-5-bromo-6P-amino-5a 
6P- succinimido-5a-cholestane(A). cholestane(B). 
(I) 11) 
AcO 
H-N 
3P-Acetoxy-6-phthalimido 
cholest-5-ene (C). 
(Ill) 
6-Nitrocholest-5-eno [3a, 4a-d] 
oxazolidin-2'-one (D). 
(IV) 
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TABLE-3 m 
Results: 
Effects of steroidal derivatives on different regions of albino rat 
brain, injected 3.0 mg/kg body weight for 10 days, ip (n = 6) 
Parameter 
T 
O 
T 
A 
L 
L 
I 
P 
I 
D 
S 
Brain 
region 
Cerebrum 
Cerebellum 
Brain Stem 
Control 
(Average) 
0.404 
0.544 
0.423 
A 
** 
0.203 
** 
0J41 
** 
0.281 
Experimental 
Structure - Activity - Correlation 
% 
Change 
^9.4 
-36.7 
-33.0 
B 
0.174 
NS 
0.445 
0J06 
% 
Change 
-57.2 
-18.2 
-28.5 
C 
* ** 
1J59 
*** 
1.284 
*** 
2.1S1 
% 
Change 
232 J 
128.0 
394.5 
D 
*** 
0.715 
*** 
1.673 
NS 
0.455 
% 
Change 
78J 
215.0 
• 
10.9 
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C = Control; % = Percentage 
A = 3P-Acetoxy-5-bromo-6P-succinimido-5a-cholestane (I) 
B = 3P-Chloro-5-bromo-6P-amino-5a-cholestane (II) 
C = 3P-Acetoxy-6-phthaIimido-cholest-5-ene (III) 
D = 6 Nitro cholest-5-eno[3a, 4a-d] oxazolidin-2 -one (IV) 
Values : *P<0.05; **P<0.01; ***P<0.001 
NS = Not significant 
n = No of rats. 
Table - 3 (I) shows the effects of four steroidal derivatives (3P-
acetoxy-5-bromo-6P-succinimido-5a-cholestane (A) (I); 3P-chIoro-5-bromo-
6P-amino-5a-cholestane (B) (II); 3P-acetoxy-6-phthalimido-cholest-5-ene (C) 
(III); 6-nitro cholest-5-eno [3a, 4a-d] oxazolidin-2 -one (D) (IV) on the total 
lipids concentration in rats brain. The 3P-acetoxy-6-phthalimido (C) (III) 
produces significant increase of 232.3% in the cerebrum and 128.0% in the 
cerebellum, while most significant increase of 394.5% in the total lipid 
contents is observed in brain stem. 
The 6-nitrocholest-5-eno [3a, 4a-d] oxazolidin-2 -one (D) (IV) 
produced significant 215.0% increase in the total lipids contents of cerebellum 
and of cereberum 78.3% is observed, while insignificant increase 10.9% 
occurs in brain stem. 
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The 3(3-chloro-5-bromo-6|3-amino-5a-cholestane (B) (II) produces 
significant decrease of 57.2% and 28.5% in the concentration of total lipids in 
cerebrum and brain stem respectively and of insignificant 18.2% decrease in 
cerebellum. 
The 3P-acetoxy-5-bromo-6P-succinamido-5a-(A) (I) produced 
significant decrease of 49.4%, 36.7% and 33% in the concentration of total 
lipids in cerebrum, cerebellum and in brain stem respectively. 
HCONTROL 
B 
C 
CEREBRUM CEREBELLUM BRAIN STEM 
Regional alteration in the level of total lipids in different regions of rat 
brain following the administration of 3P-acetoxy-5-bromo-6P-succinimido-
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5a-cholestane (A) (I), 3|3-chloro-5-bromo-6(3-amino-5a-cholestane (B) (II), 
3P-acetoxy-6-phthalimido-cholest-5-ene (C) (III) and 6-nitrocholest-5-eno 
[3a, 4a-d] oxazolidin-2'-one (D) (IV), 3 mg/kg body weight ip for 10 days. 
In the comparative study of the effects of four steroidal compounds on 
major regions of rat brain (cerebrum, cerebellum and brain stem), the total 
lipids contents were found insignificant depletion with the administration of B 
(II) and D (IV) derivatives on cerebellum and brain stem of rat brain 
respectively and induced by compound C (III) where most significant increase 
is 394.5% on brain stem. In the cerebrum gradual significant rise was 
observed following the administration of A (I), B (II), C (III) and D (IV) 
compounds respectively. 232.3% Maximum significant rise was observed with 
the C (III) derivative, 215.0% significant increase was observed with the D 
(IV) compound and -57.2% significant decrease was observed with the B (II) 
compound and -49.4% significant decrease was observed with the compound 
A (I). In cerebellum administration of A (I) and B (II) derivatives of 
cholesterol result in the significantly and gradual decrease in total lipids 
contents - 36.7% and - 28.5%, with the C (III) and D (IV) derivatives a 
significant increase was observed of 128.0% and 78.3% respectively. In brain 
stem administration of compound A (I) and B (II) derivatives of cholesterol 
results in significantly and gradual decrease in total lipids contents - 33.0% 
and - 18.2%, with the C (III) and D (IV) derivatives of cholesterol produced 
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most significant increase of 394.5% and of insignificant increase of 10.9% 
was estimated. 
Activity of 3P-acetoxy-5-bromo-6P-succinimido (A) (I) in the three 
brain parts gives the trend of decreased values of total lipids contents is in the 
order : cerebrum (-44.4%)> cerebellum (-36.7%) > brain stem (-33.0%)). 
Activity of 3p-chloro-5-bromo-6p-amino (B) (II) gives the decreased 
values of total lipids contents in this order : cerebrum (-57.2%) > cerebellum 
(-28.5%) > brain stem (-18.2%). Activity of 3(3-acetoxy-6-phthalimido (C) 
(III) gives the rising trend of total lipids contents : brain stem (394.5%) > 
cerebrum (232.5%) > cerebellum (128.0%). Activity of 6-nitrocholest-5-eno 
(D) (IV) gives the rising trend as : cerebellum (215.0%) > cerebrum (78.3%) > 
brain stem (10.9%). 
Changes in the Lipids contents and lipids composition must be due to 
changes in rates of anabolism, catabolism or these processes are controlled by 
the activities of appropriate enzymes. Hazzard and co-workers (1969) have 
suggested that a reduced lipoprotein lipase activity may be a factor 
contributing to the increased plasma lipids. 
Depletion of unsaturated lipids is associated with alteration in 
membrane fluidity^^ and the changes in the activity of membrane bound 
enzymes and receptors^". Polyunsaturated fatty acids are by themselves, 
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capable of causing damages to the cell membranes, tissues and may contribute 
to the postraumatic decline in the blood flow as well as reactive unflammatory 
responses. Interestingly lipids of various tissues are known to be in a dynamic 
steady state and there is continuous replacement of existing molecules by new 
71 
ones . Present study reveals the effects of four different derivatives of 
cholesterol on lipids contents of various parts of brain, is different on each 
part. Earlier it was concluded that estrogen affects the lipids contents 
differentially in the various parts of the brain. 
CHOLESTEROL : 
Cholesterol is a major and only sterol, present in the significant amount 
in the central nervous system^^, it is also an important component of biological 
membranes. Membranes are generally thought to consist of phospholipid 
bilayer into which membrane proteins are embedded, yet cholesterol 
molecules are present in most animal structures. Due to its amphipathic nature 
bearing an OH-group and a hydrocarbon skeleton with rigid rings and a 
branched chain of eight carbon, cholesterol is perfectly suited to mesh with 
lipid bilayer"*"*. Cholesterol accounts for about 10% of dry weight of the brain 
in contrast to less than 1% found in most other organs. The constancy of the 
amount of cholesterol in the brain suggests that the sterol is metabolically 
Stable . Unesterified cholesterol has been suggested as a lipid characteristic of 
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myelin sheath, as it occurs in white matter in a higher concentration than in 
gray matter '^*. About 25% of cholesterol is present in myelin lipid by weight 
and approximately 70% of total brain, cholesterol is present in myelin . 
77 
Cholesterol is thought to act as convenor in absorption of fats. It has been 
reported a parallelism between cholesterol content of blood and the fatty acids. 
Due to abundance of cholesterol in nervous tissues and its variation in mental 
diseases, it may function as an insulating medium for myelin sheaths. Sterols 
are thought to have a role in maintaining the balance between the cell 
permeability and the membrane equilibrium of living cells. Brain microsomes 
are the sites of cholesterol biosynthesis^^ Cholesterol is synthesized from 
acetate and precursors via mevalonic acid. Both the biosynthesis and the 
deposition of cholesterol in the CNS is most rapid. Biosynthesis of cholesterol 
in brain is most rapid during active myelination, but adult brain retains the 
capacity to synthesize cholesterol when precursors such as acetate or 
mevalonate are available. 
Fatal or neonatal brain prior to myelination contains relatively little 
cholesterol. It has been found^' varying amounts of the sterol in new bom rat 
brain. In rat brain, total levels of sterol ester increase from birth to 40 days. A 
decline is also noticed in human and guinea pig brain cholesterol (62.3%) and 
denosterol (31.1%). The major sterol and small to trace amount of other 
sterols were also detected^*^ relative to total phospholipid and glycolipid, in 
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which changes in whole brain and myelin are compared. Earlier studies in our 
laboratory on the alteration in cholesterol level following the intramuscular 
administration of ethynylestradiol and 0.5 mg norgestrel on the regional lipids 
level of cholesterol was found decreased in hypothalamus, hippocampus, 
amygdaloid nucleus midline nuclei of thalamus and gyrus cinguli . It has 
been observed a depleted level of cholesterol in brain stem and spinal cord but 
it was elevated in cerebellum following the ip administration of estrogen in 
female rabbit. 
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TABLE-3 gi) 
Results: 
Effects of steroidal derivatives on different regions of albino rat 
brain, injected. 3.0 mg/kg body weight for 10 days ip, (n=6) 
Parameter 
C 
H 
O 
L 
E 
S 
T 
E 
R 
O 
L 
Brain 
region 
Cerebrum 
Cerebellum 
Brain Stem 
Control 
(Average) 
0.0M9 
0.0023 
0.0089 
1 
A 
*** 
0.0038 
** 
0.0016 
*** 
0.0014 
Experimental 
Structure - Activity- - Correlation 
% 
Change 
-74.3 
-30.40 
-84.0 
B 
o.oo;o 
:'o 
Change 
-86.8 
*** 1 
0.0012 
*** 
0.00093 
-55.6 
-89.7 
C 
*** 
0.0034 
NS 
0.0020 
*** 
0.0673 
% 
Change 
-77J 
^.8 
691.8 
D 
**• 
0.0083 
«** 
0.0182 
** 
0.0046 
% 
Change 
-43.2 
810.0 
-50.0 
1 
1 
1 
C = Control; % - Percentage 
A = 3P-Aceto.\y-5-bromo-6P-succinimido-5a-cholestane (I) 
B = 3P-ChIoro-5-bromo-6P-amino-5a-cholestane (II) 
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C = 3P-Acetoxy-6-phthaliinido-cholest-5-ene (III) 
D = 6-NitrochoIest-5-eno[3a, 4a-d] oxazolidin-2 -one (IV) 
Values : *P<0.05; **P<0.01; ***P<0.001 
NS = Not significant 
n = No of rats. 
Table - 3 (II) shows that 6-nitro cholest-5-eno (D) (IV) produces most 
significant increase 810% in cerebellum, while significant decrease is 
observed 50% of brain stem and 43.2% in cerebrum. 
3P-Acetoxy-6-phthalimido (C) (III) produces most significant increase 
691.8% in the concentration of cholesterol in brain stem and significant 
decrease 77.3% in cerebrum, while it produces an insignificant deprivation in 
cerebellum (4.8%). 
3(3-Chloro-5-bromo-6p-amino (B) (II) produces significant decrease 
89.7% in brain stem, 86.8% in cerebrum and 55.6% in the concentration of 
cholesterol in cerebellum. 
3[3-Acetoxy-5-bromo-6P-succinimido (A) (I) produces significant 
decrease in the cholesterol level in brain stem (84.0%) in cerebrum (74.3%) 
and in cerebellum (30.4%). 
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1 
1 
d 
s 1 
-DID 
0.07 
0.06 
0.05 
0.04 
0.03 
0.02 
691.8% 
i CONTROL 
I B 
1 0 
CEREBRUM CEREBELLUM BRAIN STEM 
Regional alteration in the levels of cholesterol following the 
administration of 3P-acetoxy-5-bromo-6(3-succinimido-5a-cholestane (A) (I), 
3P-chloro-5-bromo-6p-amino-5a-cholestane(B)(II), 3|3-acetoxy-6-phthalimi-
do-cholest-5-ene (C) (III) and 6-nitrocholest-5-eno [3a, 4a-d] oxazolidin-
2'one (D) (IV), 3 mg/kg body weight ip for 10 days in different regions of rat 
brain. 
In the present study four derivatives of cholesterol 3P-acetoxy-5-
bromo-6P-succinimido-5a-cholestane (A) (I), 3(3-chloro-5-bromo-6P-amino-
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5a-cholestane (B) (II), 3[3-acetoxy-6-phthalimido-cholest-5-ene (C) (III), 
6-nitrocholest-5-eno [3a, 4a-d] oxazolidin 2'-one (D) (IV) were injected in 
the 4 groups of ablino rats ( 3 mg/kg body wt ip. for 10 days), changes in the 
cholesterol level estimated in the cerebrum, cerebellum and brain stem. 
However no systematic work on structure activity correlation is done so 
far on the various derivatives of cholesterol on the brain. Earlier Islam et. 
al.,^^ has studied the effect of estrogen and primovlar (having slight difference 
in the structure) on cholesterol level in the estrogen treated rabbits. It shows 
regional heterogeneity in exhibiting a depletion in the brain stem, spinal cord 
and increase in the cholesterol level in the cerebellum following 30 days 
administration. Primovlar treated rabbits shows the depletion of cholesterol 
level in hippo campus, amygdaloid nucleus, midline nuclei of the thalamus 
and gyrus cinguli in his study Islam also noted that alteration of cholesterol 
level was only significant after 90 days administration. 
In the present study effect of the four derivatives were evaluated in the 
brain of albino rats, activity of these steroids in the cerebrum is as following. 
Four of these steroidal derivatives A (I), B (II), C (III) and D (IV) gives 
significant decrease in the cholesterol level, among these B (I) gives 86.8%, C 
(III) (77.3%), A (I) (74.3%) and D (IV) (43.2%) in cerebrum. In the 
cerebellum compound D (IV) gives the most significant increase of 810.0% 
while compound B (II) and A (I) give significant decrease of 55.6% and 
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30.4% respectively, whereas compound C (III) gives 4.8% insignificant 
depletion in cholesterol level. 
In the brain stem activity of compound C (III) gives most significant 
rise in cholesterol level (691.8%) while compound A (I), B (II) and D (IV) 
gives the significant decrease of 84.0%, 89.7% and of 50.0% respectively in 
cholesterol level. 
Analysis of the effects of compound A (I) on all the three brain parts 
reveals its maximum effect on brain stem (-84.0%) than cerebrum (-74.3%) a 
significant decrease and less effective on cerebellum is of-30.4%o. Analysis 
of the effects of compound B (II) on different parts of the brain reveals its 
maximum effect on brain stem (-89.7%) than cerebrum (-86.8%) and then in 
cerebellum (-55.6%), its shows significant decrease on all parameters. The 
activities of compound C (III) on these three brain parts reveal its most 
significant increase of 691.8% on brain stem and then in cerebrum (-77.3%) 
is of significant decrease, whereas insignificant decrease in the cholesterol 
level in cerebellum (-4.8%) is reported in this study. 
Analysis of the effects of compound D (IV) on three brain parts reveals 
its most significant increase of 810.0% on cerebellum, where as significant 
decrease on brain stem (-50.0) and on cerebrum (-43.2%) in the cholesterol 
level is reported. 
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A comparative study related to the activity of all four derivatives 
reveals that steroidal derivative (compound) D (IV) exerts its most significant 
rise on cerebellum (810.0%) and induced depletion in the cholesterol level. 
Compound C (III) induces most significant rise on brain stem of 691.8% and 
also gives maximum depletion in cerebrum and insignificant depletion on 
cerebellum of-4.8 is reported. Compound B (II) induces maximum significant 
decrease in brain stem, cerebrum and cerebellum, compound A (I) induces 
maximum depletion on brain stem, cerebrum and cerebellum respectively. 
GANGl.TOSTDES : 
Gangliosides are the sialic acid containing glycosphingolipids, which 
81 82 83 84 
are highly enriched in the CNS of vertebrate, including man ' ' ' . Sialic 
acid is the generic name for N-acylneuraminic acid, the acyl group of sialic 
acid in the human brain is always the acetyl form . N-acetyl neuraminic acid 
is commonly abbreviated as Neu Nac. Gangliosides are localized in two 
fractions of brain. Major gangliosides of the brain are GMl, GM2, GM3, 
GDI a, GDlb and GT and other minors are GD3, GD2 and sialylagal 
actosylceramide are also present. Gangliosides under go characteristic 
changes in content and composition during development . In particular they 
87 88 
appears to be functionally involved in the control of axonal ' out growth 
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synaptogenesis and the establishment of cell contact. More over in adult 
nervous system, the individual gangliosides have been suggested to play a role 
as membrane bound receptors or co-receptors for toxins, drugs viruses 
hormones transmitters etc. . Gangliosides are generally synthesized in 
neuronal perikarya and are transported to the nerve ending along with 
89 90 91 90 
macromolecules ' ' . Local synthesis within the axons and nerve endmg 
92 
or even at the plasma membrane level can not be excluded. Gangliosides are 
involved in nerve impulse conduction since they act as receptor sites for 
neurotoxins ' . Irwin and Samson reported the certain types of behavioural 
stimulations (stress, sensory stimulation, learning exercise) seems to be 
accompanied by alterations in gangliosides metabolism. Mental retardation 
and neurological dysfunction are major signs in nearly all the lipid storage 
diseases, apparently because of abnormal deposition of the different 
glycosphingolipids in the CNS due to defective disorders in degradative 
enzyme pathways, resulting in retardation of development paralysis dementia 
and blindness . Biosynthesis of brain gangliosides occurs by sequential 
addition of monosacharides or N-acetylneuraminic acid to the carbohydrate 
chain, starting from ceramide degradation of brain gangliosides. It proceeds by 
sequential removal of monosacharides and Neu-Nac (N-acetyl neuraminic 
acid) by glycosides and neuraminidases ' . Gangliosides are responsible for 
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98 
the humeral immune response . Evidences accumulated throughout the 1980s 
99 
indicate the humeral immunity to gangliosides is frequently neuropathies , 
98 r 
for example guillain barre syndrome . The gangliosides mixture of bovme 
brain gangliosides (GMl, GDI a, GDlb, GTlb) has been widely used in trials 
of the treatment of peripheral neuropathies . Gangliosides have been used 
for treatment of various degenerative toxic and metabolic neuropathies in 
Europe although their efficiency remains controversial . Patients with 
multifocal motor neuropathy have high titer serum antibodies against the 
gangliosides GMl^^. In lewis rats, myelin induced experimental allergic 
neuritis or animal model of human acute gullian barre syndrome can be 
depressed and delayed by adding gangliosides mixmre (GMl, GDI a, GDlb, 
GTlb) to the immunization compound. However gangliosides may enhance 
the induction of adjuvant arthritis since externally applied gangliosides 
produce antibodies 
I Chapter - 51 Steroidal Compounds Induced Alteration On Lipid 
Meubolism Of Different Regions Of Rat Brain 
Page. 291 
T A B L E - 3 f i m 
Effects of Steroidal derivatives on different regions of albino rat 
brain, injected 3.0 mg/kg body weight for 10 days ip. (n=6) 
Parameter 
G 
A 
N 
G 
L 
I 
O 
S 
I 
E 
S 
Brain 
region 
Cerebrum 
Cerebellum 
Brain Stem 
Control 
(Average) 
0.0024 
0.00045 
0.00026 
A 
*« 
0.0029 
«* 
0.00031 
%** 
0.00006 
Experimental 
Structure - Activity - Correlation 
% 
Change 
45.0 
-27.9 
-77.8 
B 
** 
0.0014 
*** 
0.00018 
** 
0.00013 
% 
Change 
-50.0 
-62.5 
-45.8 
C 1 % 
*** 
0.0049 
Change 
88.5 
1 
1 
i 
t 
0.00400 716 J 
1 
! 
*** 
0.00370 1133.0 
D 
* 
0.0019 
*** 
0.0084 
*** 
0.00140 
0 ' 
/o 
Change 
; 
I 
-20.8 1 
i 
I 
i 
2000 
508.6 
C = Control; % = Percentage 
A = 3P-Aceto.\y-5-bromo-6P-succinimido-5a-cholestane (I) 
B = 3P-Chloro-5-bromo-6p-amino-5a-cholestane (II) 
C = 3P-Acetoxy-6-phthalimido-cholest-5-ene (III) 
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D = 6-Nitrocholest-5eno[3a, 4a-d] oxazolidin-2 -one (IV) 
Values : *P<0.05; **P<0.01; ***P<0.001 
NS = Not significant 
n = No of rats. 
Table - 3 (III) shows that the 6-nitro cholest 5-eno (D) (IV) produces 
most significant increase in the level of gangliosides in cerebellum (2000.0%) 
and brain stem (508.6%), it produces insignificant decrease (20.8%) in 
cerebrum. 3P-Acetoxy-6-phthalimido (C) (III) produces most significant 
increase in level of gangliosides in brain stem (1133%), cerebellum (716.3%) 
and significant rise in cerebrun (88.5%) is observed. 3P-Chloro-5-bromo-6P-
amino (B) (II) produces significant decrease in cerebellum (62.5%), cerebrum 
(50.0%) and in brain stem (45.8%). 3(3-Acetoxy-5-bromo-6[3 (A) (I) produces 
significant decrease in level of gangliosides in brain stem (77.8%) and in 
cerebrum (45.0%). While insignificant decrease is observed (27.9%) in 
cerebellum. 
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CEREBRUM CEREBELLUM BRAINSTEM 
Regional alteration in the levels of gangliosides in different regions of 
rat brain following the administration of 3|3-acetoxy-5-bromo-6P-succinimido-
5a-cholestane (A) (I), 3P-chloro-5-bromo-6|3-amino-5a-cholestane (B) (II), 
3P-acetoxy-6-phthalimido-cholest-5-ene (C) (III) and 6-Nitrocholest-5-eno 
[3a, 4a-d] oxazolidin-2'-one (D) (IV), 3 mg/kg body weight ip, for 10 days. 
Studies on gangliosides had been done earlier in our laboratory. 
Intramuscular administration of 100 |a.g estrogen daily for 30 days to female 
rabbit was followed by decrease in gangliosides in cerebellum and spinal cord 
103 
while an elevated level was observed in cerebral cortex and brain stem 
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There is no previous report on the classified study on structure activity 
correlation on the level of gangliosides in the brain while using four 
derivatives of cholesterol (A (I), B (II), C (III) and D (IV)). In the present 
study changes were found as following in the cerebrum, cerebellum and brain 
stem. When the activity of steroidal derivatives (compound A (I), B (II), C 
(III), D (IV)) was measured in the different brains parts of albino rat following 
the administration of 3.0 mg/kg body wt. of steroids for 10 days, significant 
rise in the gangliosides contents from the effect of compound C (III) (88.5%) 
and compound A (I) (45.0%) where as significant decrease in gangliosides 
from the effect of compound B (II) (-50.0%) and compound D (IV) (-20.8%) 
is estimated in cerebrum. 
In the cerebellum, maximum and most significant increase with the 
administration of compound D (IV) (2000.0%) and compound C (III) 
(716.3%) in the contents of gangliosides is reported, where as significant 
decrease in content of gangliosides with compound B (II) (-62.5%) and 
compound A (I) (-27.9%) is reported. 
Estimation of gangliosides in the brain stem shows most significant 
increase with the administration of compound C (III) (1133.0%) and 
compound D (IV) (508.6%), while significant decrease in content of 
gangliosides with compound A (I) (-77.8%) and compound B (II) (-45.89) is 
estimated. 
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Analysis of the effects of compound C (III) on three brain parts reveals 
its maximum and most significant increase on brain stem (1133.0%) and on 
cerebellum (716.3%), while on cerebrum (88.5%) in gangliosides content is 
reported. 
Similarly analysis of the effects of compound D (IV) reveals it 
maximum and most significant increase on cerebellum (2000.0%) and on 
brain stem (508.6%) where as insignificant decrease on cerebrum of (-20.8%) 
is estimated. 
Effects of compound (B) (II) reveals it significant decrease on 
cerebellum (-62.5%), cerebrum (-50.0%) and brain stem (-45.89%) in content 
of gangliosides is reported. 
In the analysis of effects of compound A (I) reveals its significant 
increase on cerebrum (45.0%) and significant decrease on brain stem (-77.8%) 
and on cerebellum (-27.9%) in the contents of gangliosides is estimated. 
A comparative study of four steroidal derivatives reveals that 
compound D (IV) exerts its maximum and most significant increase on 
cerebellum (2000.0%) and on brain stem (508.6%) in the contents of 
gangliosides whereas compound C (III) also produces maximum and most 
significant rise on brain stem (1133.0%), cerebellum (716.3%) and on 
cerebrum (88.5%) is reported. While compound A (I) and B (II) produce 
significant decrease in the contents of gangliosides on three major parts of 
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brain. Compound A (I) shows significant increase on cerebrum (45.0%) in the 
study of gangliosides level. 
LTPTD PERQXIDATTON : 
Brain contains large amounts of lipids that are rich in polyunsaturated 
fatty acids. The unsaturated bonds of membrane lipids can readily react with 
104 
free radicals and under go peroxidation . Lipid peroxidation has been 
identified as a basic deterioative reaction in the cellular mechanism . It is an 
autocatalytic free radical process. Biomembrane and subcellular organelles are 
the major sites of lipid Peroxidation . Quantitative studies of enzymatic 
inactivation by lipid peroxidation have shown that sulfhydryl enzymes are 
107 
most susceptible to inactivation . Each lipid peroxide is a free radical and 
once initiated the process of peroxidation can become auto catalytic as each 
lipid peroxide products. The lipid peroxides readily decompose to liberate 
highly reactive carboxyl fragment such as melondialdehyde (MDA), X-3-
carbondialdehyde is one of the final products of free radical chain reaction 
108 
which takes place during lipid peroxidation . The H2O2 and other reaction 
give O2 species if not scavenged efficiently are known to give rise to 
potentially toxic intermediates, namely hydroxy radical (OH) and singlet 
Chapter - 5 Steroidal Compounds Induced Alteration On Lipid 
Metabolism Of Different Regions Of Rat Brain 
Page. 297 
(O2). These oxidants in the presence of metal ions, resuh in the formation of 
lipid peroxidation 
Gutteridge has shown that melondialdehyde is the major species 
responsible for thiobarbituric acid reactive products (TBA-RS). Whether the 
substances undergoing free radical induced damage are poly unsaturated fatty 
acids, amino acids, carbohydrates or nucleic acids. Therefore, measurement of 
thiobarbituric acid substance is one of the evaluating the extent of the damage 
due to free radicals. However the best induced effect of free radical attack is 
that causing lipid peroxidation i.e. oxidation of a methylene bridge of 
unsaturated fatty acids, resulting in the formation of lipid peroxides and 
hydroperoxides finally leading to fragmentation of lipids. As biomembranes 
are rich in unsaturated fatty acid, such reaction may lead to the disintegration 
of membrane structure and finally to irreversible cell damage 
Initiation of lipid peroxidation in a membrane or free fatty acid is due 
to the attack of any species that has sufficiently reactivity to abstract a 
hydrogen atom. Since a hydrogen atom has only one electrons, this leaves 
behind an unpaired electron on the carbon atom. The carbon radical in a 
polyunsaturated fatty acid tend to be stabilized by a molecular rearrangement 
to produce a conjugated diene, which rapidly reacts with O2 to give 
hydroperoxy radical. Hydroperoxy radicals abstract hydrogen atoms firom 
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Other lipid molecules and so continues the chain reaction of lipid peroxidation. 
The hydroperoxy radical combines with the hydrogen atom that it abstracts to 
give a lipid hydroperoxide 112 
LH = Fatty acid, LOOH = Lipid hydro peroxides, 
L° = Lipid alkyl radical 
L00° = Lipid peroxy radicals. 
Initiation : 
LH + O2 • Free radicals, L° (1) 
LOOH 
Propagation. 
L° + 02 
L00° + LH 
Termination. 
L00° + L00° 
L00° + L° 
L° + L° 
• Free radicals, LOO"^  
• LOO' 
• LOOH + L° 
• LOOL + O2 
• LOOL 
(2) 
• LL 
Oxygen free radical induced oxidative damage has been implicated in 
the aetiology of a number of diseases, including atherosclerosis, inflammation, 
cancer, and ischemia reperfusion ' ' . Toxicity of uraemia is due atleast 
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116 damaging effects There is considerable evidence suggesting the 
involvement of free radicals and lipid peroxidation in atherogensesis . 117 
T A B L E - 3 gV) 
Resu l t s : 
Effects of steroidal derivatives on different regions of albino rat 
brain, injected 3.0 mg/kg body weight 10 days ip, (n=6) 
Parameter Brain 
region 
Control 
(Average) 
L 
I 
p 
I 
D 
P 
E 
R 
O 
X 
I 
D 
A 
T 
I 
O 
N 
Exper imenta l 
S t ruc tu r e - Activity - Corre la t ion 
Change I Change 
% 
Change 
D % I 
Change 
Cerebrum 0.0065 0.0020 -66.7 0.0048 -31.4 
NS 
0.0077 16.7 0.0040 -36.5 
Cerebellum 0.0070 0.00007 -98.9 
NS 
0.0077 2.7 
NS 
0.0074 5.71 0.0032 -543 
Brain Stem 0.0057 0.0016 -72.9 0.0017 -71.6 
NS 
0.0052 -7.14 
NS 
0.0046 14.8 
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C = Control; % = Percentage 
A = 3P-Acetoxy-5-bromo-6P-succinimido-5a-cholestane (I) 
B = 3P-Chloro-5-bromo-6p-amino-5a-cholestane (II) 
C = 3P-Acetoxy-6-phthalimido-cholest-5-ene (III) 
D = 6-Nitrocholest-5eno[3a, 4a-dl oxazolidin-2 -one (IV) 
Values : *P<0.05; **P<0.01; ***P<0.001 
NS = Not significant 
n = No of rats. 
Table - 3 (IV) shows the data obtained for the rate of lipid Peroxidation 
following the administration of four steroidal derivatives. 
3p-Acetoxy-5-bromo-6(3-succinamido (A) (I) produces significant 
decrease of 98.9% in cerebellum 72.9% in brain stem and of cerebrum 
(66.7%)) is observed. 
3p-Chloro-5-bromo-6P-amino (B) (II) produces significant decrease of 
71.6% in brain stem and 31.4% in cerebrum. While insignificant depletion of 
2.7% is reported in cerebellum of rats brain in the study. 
6-Nitro cholest-5-eno (D) (IV) produces significant decrease of 54.3% 
in cerebellum and 36.5% in cerebrum, while insignificant depletion of 14.8% 
found in brain stem. 
3p-Acetoxy-6-phthalimido (C) (III) produces insignificant increase of 
16.7% in cerebrum and of 5.71% in cerebellum. While insignificant decrease 
of 7.14%) is reported in brain stem of rats brain in the study. 
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0.008 
0.007 
I 0.006 
I 0.005 
I 0.004 
I 0.003 
t 0.002 
t 0.001 
0 
• CONTROL 
• A 
@ B 
m D 
CEREBRUM CEREBELLUM BRAINSTEM 
Regional alteration in the level of rate of lipid peroxide formation in 
different regions of rat brain following the administration of 3P-acetoxy-5-
bromo-6|3-succinimido-5a-cholestane (A) (I), 3P-chloro-5-bromo-6P-amino-
5a-cholestane (B) (II), 3P-acetoxy-6-phthalimido-cholest-5-ene (C) (III), 
6-Nitrocholest-5-eno [3a, 4a-d] oxazolidin-2'-one (D) (IV), 3.0 mg/kg body 
weight ip for 10 days. 
In the present study, following the administration of compounds A (I), 
B (II), C (III) and D (IV), derivatives of cholesterol where rate of lipid 
peroxidation was estimated. Compound A (I) gives significant decrease 
(-76.7%) in the rate of lipid peroxidation, whereas compounds B (II) and D 
Chapter - 5 Steroidal Compounds Induced Alteration On Lipid 
Metabolism Of Different Regions Of Rat Brain 
Page. 302 
(IV) gives relatively less significant decrease of -31.4% and -36.5% 
respectively, while compound C (III) gives insignificant enhancement (16.7%) 
in cerebrum of rats brain. Effects of these four derivatives on cerebellum 
shows significant depletion in the rate of lipid peroxidation as A (I) (-98.9%) 
and D (IV) (-54.3%). Whereas compounds B (II) and C (III) result in an 
insignificant rise (2.7%), (5.71%) respectively in the rate of lipid peroxidation 
in cerebellum. In brain stem compounds A (I) and B (II) give significant 
decrease of (-72.9%) and (-71.6%) respectively, where as compound D (IV) 
gives insignificant enhancement of (14.8%), while compound C (III) gives a 
insignificant decrease of (-7.14%), in the rate of lipid peroxidation. 
A comparative study of effects of steroidal compounds on different part 
of brain, in which compound A (I) gives most significant decrease on 
cerebellum, cerebrum and brain stem respectively, where as compound B (II) 
shows maximum significant decrease in brain stem and cerebrum respectively 
and insignificant increase is reported on cerebellum. Compound C (III) 
exhibits insignificant increase on cerebrum and cerebellum while insignificant 
decrease on brain stem is reported. Whereas compound D (IV) exhibits 
significant decrease in cerebellum and cerebrum respectively and insignificant 
increase on brain stem is estimated in rate of lipid peroxidation of rat brain. 
On a comparative study we found to decrease the content of lipid peroxidation 
and a tool for lowering the aging. 
Chapter - 5 Steroidal Compounds Induced Alteration On Lipid 
Metabolism Of Different Regions Of Rat Brain 
Page. 303 
EXPERIMENTAL 
All the chemicals used in this study were of analytical reagent grade. 
We used the instruments in this study are DU-6 Beckman spectrophotometer, 
metabolic shaker (NSW, India), Digestor (Designed in our centre), 
homogenizer (Yorco scientific industries). Albino rats of charles foster strain 
(200±20 grams) obtained from animal house, J. N. Medical College, A.M.U., 
Aligarh. The steroidal compounds, 3P-acetoxy-5-bromo-6[3-succinimido-5a-
cholestane A (I), 3p-chloro-5-bromo-6p-amino-5a-cholestane B (II), 3(3-
acetoxy-6-phthalimido-cholest-5-ene (C) (III) and 6-nitrocholest-5-eno [3a, 
4a-d] oxazolidin-2'-one D (IV) were prepared according to literature 
J 2a,b,c 
procedures 
Healthy male albino rats (Fig.l) of Charles Foster Strain, obtained from 
the animal house of J. N. Medical College, A.M.U., Aligarh were used in the 
present study. They were divided into four groups. 
Group 1 ;6 rats wt. - 200 ± 20 g 
Group 2;6rats wt. = 200 + 20 g 
Group 3;3 rats wt. = 200 ± 20 g 
Group 4;3 rats wt. = 200 ± 20 g 
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Solution Preparation And Dose Administration : 
3.0 mg /kg body weight steroids were given to the rats .the solution for 
injection to the rats were prepared in a pea nut oil and was made keeping in 
mind that the amount of the oil to be injected to the animal should not exceed 
approximately 0.5ml,to avoid the accumulation of fat (lipids) in albino rats. 
The solution was prepared by adding 240 mg reference steroids in 20ml of 
peanut oil .The steroids were injected intraperitonially with the help of 2ml 
tuberculin glass syringe and 26 number needle. A new needle for each animal 
was used daily .The syringe were sterilized each day by boiling in water and 
rinsing with methanol. 
Group 1: (Control) of 3 albino rats were injected normal saline equal to the 
volume of steroidal solution for 10 days. 
Group 1: (Experimental) of 3 albino rats were injected 3P-acetoxy-5-romo-
6^- succinimido-5a-cholestane (A) (I), 3.0 mg /kg body weight for 10 days. 
Group 2: (Control) of 3 albino rats were injected normal saline equal to the 
volume of steroidal solution for 10 days. 
Group 2: (Experimental) of 3 albino rats were injected 3|3-chloro-5-bromo-
6p-amino 5a-cholestane (B) (II), 3.0 mg/kg body weight for 10 days. 
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Group 3: (Experimental) of 3 albino rats were injected 3P-acetoxy-6-
phthalimido-cholest-5-ene (C) (III), 3.0 mg/kg body weight for 10 days. 
Group 4: (Experimental) of 3 albino rats were injected 6-nitrocholest-5-eno 
[3a, 4a-d] oxazolidin-2'-one (D) (IV), 3.0 mg/kg body weight for 10 days. 
Dissection Of Different Parts Of The Rat's Brain : 
For all biochemical investigations, fresh unfixed brain (Fig. 2) was 
used .The brain and spinal cord were removed rapidly from individual rats and 
dissected out on an ice plate. The blood clots adhering to brain were removed 
by washing with cold normal saline. There after, the cerebrum, cerebellum, 
and brain stem (Fig. 3) were rapidly dissected out and weighed to the nearest 
milligram on an electrical balance were pooled and used for biochemical 
analysis. For biochemical and most of the histochemical studies where 
perfusion of the rat brain was not required the animal were sacrificed. 
Exposure Of The Brain And Its Removal: 
The skeletal covering over the skill were removed with the use of a 
small pair of bone forceps, scalpel scissors and nail clippers. Great care was 
taken to avoid any laceration of brain tissue. After exposing the brain surface 
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Brain stem 
Dissection of Different Parts of Rat Brain 
Fig. 3 
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from the top and sides, it was gently detached from the base of skull and 
removed. 
Extraction And Purification Of Brain Lipids : 
Lipids from brain region were extracted and purified immediately after 
118 
dissection of the animal by the method of Fotch et. al., . This method was 
partially modified in our laboratory for isolation of lipids from discrete areas 
of the brain. Different parts of the brain were weighed and homogenized 
(10% w/v) in a glass homogenizer to a final volume of 6 ml chloroform : 
methanol mixture (2:1, v/v). Each homogenate was shaken periodically for an 
hour and filtered through sintered glass frinnel (G-4) under vacuum 
(Fig. 4). The residue of each test tube was again homogenized with 2 ml 
chloroform : methanol mixture and filtered. The resultant residue was washed 
several times with the solvent mixture to ensure complete extraction of lipids. 
The final volume of each extract was made upto 10 ml with chloroform-
methanol mixture in a graduate test tube. Thereafter 2.5 ml of 0.9% NaCl was 
added to the extract in each test tube. This was shaken vigorously on test tube 
for complete mixing and placed at -20°C in a deep freeze overnight for 
complete separation of the two layers. The junction of the layers of each test 
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ID. 3 cm 
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Designed in IBRC, A.M.U., Aligarh. 
Fig. 4 
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tube was marked. The upper aqueous layer was taken out with a specially 
designed syringe (Fig. 5) without disturbing the interfacial fluff. This upper 
layer was used for the estimation of gangliosides. 
The lower lipid layer was made homogeneous by adding required 
amount of methanol, make the final volume to 10 ml and transferred to round 
bottom flask and dried under vacuum at 40 °C. In order to remove proteins, 
the residue was dissolved in chloroform : methanol : water mixture (64:32:4 
v/v) and evaporated to dryness. The contents were suspended in chloroform : 
methanol (2:1 v/v) mixture and evaporated to dryness. The process was 
repeated again untill moisture was completely removed from lipids. The lipids 
were then suspended in chloroform, filtered free of any protein and filtrate 
was dried under vacuum at 40°C. The dried lipids were solubilized to a known 
volume with chloroform and stored at-20°C till further use. This extract was 
used for the estimation of total lipids, triglycerides and cholesterol. 
Estimation Of Total Lipids : Total Lipids were estimated according to the 
119 
method of woodman and price 
Colour was developed with the help of colouring reagent (phospho-
vanillin) in the presence of sulphuric acid (H2SO4) and absorbance was read at 
540 nm. The details of the reaction are given below. Sulphuric acid acts upon 
the double bond on lipid to produce carbonium ion which simultaneously 
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A standard solution of 0.5 mg brain lipid/ml in chloroform : methanol 
mixture (2:1 v/v) was prepared by diluting 1.0 ml of refrigerated stock 
solution (50 mg brain lipid / 10 ml) in chloroform : methanol mixture in a 10 
ml volumetric flask and the volume was made upto mark with chloroform : 
methanol mixture. 
6.0 Grams of potassium dihydrogen orhto Phosphate (KH2PO4) and 
0.39 grams of vanillin were dissolved by heating in double distilled water and 
made up the volume to 100 ml in a volumetric flask (colouring reagent) 
Lipids were isolated from the rat brain by the technique described in 
the extraction and purification of lipids. 
0.1 ml of brain extract in duplicate was taken in 18 x 150 mm coming 
test tube. Concentrated sulphuric acid (2.5 ml) was added to test tube and 
heated on boiling water bath for 20 minutes. After cooling 5.0 ml of colouring 
reagent was added and absorption was read at 540 nm after exactly 10 minutes 
in DU-6 Beckman spectrophotometer against a reagent blank. A calibration 
curve of absorbance in concentration (100-600 jig) of standard brain lipids 
0.400 -
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AMOUNT OF TOTAL LIPIDS (mg) 
Standard Graph of Total Lipids 
Method 
Woodman and Price, (1972) 
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was prepared by adopting the same procedure as described above. The values 
of the standard curve were plotted by least square method. The absorbance of 
total lipids in brain samples were compared with curve and finally calculated 
by the following formula. 
Calculation ; 
CxV 
Total Lipids (mg/g of fresh brain weight) = 
VtxWt 
Where 
C = Concentration of lipids in |lg in 0.1 ml extract. 
V = Total volume of the total lipids extract 
Vt = Volume taken for the estimation. 
Wt = Fresh weight of the tissue in mg. 
Estimation Of Cholesterol: 
Total cholesterol was estimated according to the method of Zlatis 
. , 120 
et.al. . 
Cholesterol dissolved with acetic acid in the presence of FeCls - H2SO4 
reagent gets dehydrogenated to 3.5 cholestadiene or 2,3-cholestadiene which 
T 1 1 1 1 — I 1 r 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 
AMOUNT OF CHOLESTEROL (mg) 
Standard Graph of Cholesterol 
Method 
Zlatisetal. (1954) 
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simultaneously polymerizes and reacts with FeCls to form a violet coloured 
complex which is measured clorimetrically at 570 nm. 
Standard Solution: 
A standard solution of 1.0 mg/ml cholesterol in acetic acid was 
prepared by diluting 1.0 ml of stock solution (100 mg cholesterol in 10 ml 
acetic acid) in 10 ml volumetric flask and the volume was made to 10 ml with 
acetic acid. 
Stock Ferric Chloride Regent: 
5.0 gm of anhydrous ferric chloride was dissolved in 50 ml of glacial 
acetic acid. 
Working Ferric Chloride Reagent: 
1.0 ml of stock ferric chloride was diluted to 100 ml with concentrated 
sulphuric acid. 
Brain extract (0.05 ml) was taken in duplicate in dry 15 x 150 mm test 
tubes, dried and dissolved in 3 ml glacial acetic acid. Working Ferric Chloride 
solution (2 ml) was added and the contents were mixed thoroughly. The tubes 
were kept in dark for 30 minutes and the optical density was then measured at 
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570 nm. Reagent blank and standard cholesterol solution were also run 
simultaneously. 
Calculation : 
Standard curve of cholesterol was used to calculate the amount of 
cholesterol in the samples and results were expressed as mg/cholesterol/g 
tissue weight. 
C x V 
Cholesterol (mg/g of fresh brain weight) = 
VtxWt 
Where 
C = Concentration of cholesterol in jig in 2.0 ml extract. 
V = Total volume of cholesterol extract 
Vt = Volume taken for the estimation. 
Wt = Fresh weight of the tissue in mg. 
Estimation Of Gangliosides : 
121 
Gangliosides were estimated according to Pollet et. al. , after 
83 
modification in the methods of Svennerholm (1980) , Miettinene and Takki-
Luukkainer(1959). 
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Bound sialic acids in the gangliosides were isolated carefully without 
their degradations. When samples are heated at 100°C in a boiling water bath 
for 30 minutes in resorcinol reagent, the pentose sugar moieties break up and 
make a coloured complex with resorcinol reagent. This coloured complex is 
extracted in organic solvent (butyl acetate and n-butanol; 85:15, v/v). organic 
Phase was taken and absorbance was measured at 580 nm. 
Standard Solution : 
A stock standard was prepared by dissolving 100 mg N-
acetylneuraminic acid in double distilled water and making the final volume to 
100 ml. This gives 1.0 mg N-acetylneuraminic acid/ml. Working standard was 
prepared by taking 1.0 ml of stock standard solution and diluting it to 10 ml in 
a volumetric flask with double distilled water. This is 100 |ig/ml of N-
acetylneuraminic acid/ml. 
Resorcinol Reagent: 
This reagent was prepared by mixing 10 ml of 3.0% resorcinol solution 
in double distilled water, 80 ml of concentrated HCl, 0.25 ml of 0.1 N copper 
sulphate and double distilled water upto 100 ml mark in a volumetric flark. 
Resorcinol reagent (2 ml) was added to 2.0 ml of the upper layer 
(aqueous) of lipid extract and heated in a boiling water bath for 30 min. After 
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cooling to room temperature, 5.0 ml of mixture of butyl acetate and n-butanol 
(85:15, v/v) was added to each tube. The tubes were shaken thoroughly and 
kept for 15 minutes to separate organic phase. About 3-4 ml of organic phase 
was taken and absorbance was measured 580 nm against a reagent blank. A 
standard curve with absorbance of different concentrations of n-
acetylneuraminic acid (5-30 |j,g) having 2 ml final volume was prepared by 
treating in the same way as samples. The absorbance of test samples were 
compared with those of standard curve and gangliosides were quantitated as 
below. 
Calculation : 
C x V 
Gangliosides (mg/g of fresh brain weight) = 
VtxWt 
Where 
C = Concentration of gangliosides in mg in 2.0 ml extract. 
V = Total volume of the upper extract 
Vt = Volume taken for the estimation. 
Wt = Fresh weight of the brain tissue in mg. 
Determination Of The Rate Of Lipid Peroxidation : 
The procedure of Utely et. al. , was used for finding out the rate of 
lipid peroxidation. 
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0.15 M Potassium Chloride : 
This solution was prepared by dissolving 2.8 gm KCl in 250 ml double 
distilled water. 
10% Trichloroacetic Acid (TC\) : 
10% TCA was prepared by dissolving 10 gm TCA in 100 ml distilled 
water. 
0.67% Thioharbitunc Acid TTBA^ : 
Thiobarbituric acid 0.67 gm was dissolved in 25 to 50 ml double 
distilled water by adding two pellets of NaOH. The pH of the solution was 
adjusted to 7.2 with the help of IN HCl and volume was made upto 100 ml 
with double distilled water. 
Different parts of the brain were homogenized (10% v/v) in chilled 
0.15 M KQ and then Brain extract 0.5 ml with 3.6 ml TCA was taken, 
precipitate comes thereafter homogenate was pipetted in centrifuge tube and 
protein was precipitated because of addition of 10% TCA and the reaction 
mixture was centrifuged at 5000 rpm for 10 minutes. Two ml of clear 
supernatant was mixed with 1.5 ml of 0.61% TBA and 1.0 ml of double 
distilled water, placed in a boiling water bath for 10 minutes cooled and the 
absorbance of the colour was read at 532 nm. The rate of lipid peroxidation 
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was expressed as nanomoles of melondialdehyde (MDA) formed/minutes 
using extinction coefficient 1.56x10 as described by Utely et. al. 
Calculation : 
Lipid Peroxidation was calculated using the farmuUa. 
O.DxlOOO X 1000 X 1000 x total vol x 8 
Nanomoles of MDA formed/mln = 
1.56x100000x1000x10 
Where, 
MDA = Melondialdehyde, 
O.D = Change of optical density, 
Statistical Analysis; 
The data were analysed using student's "t" test significant difference 
between means of treated and control groups were calculated and "P" values 
were obtained. 
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